US4711245A - Sensor for components of a liquid mixture - Google Patents
Sensor for components of a liquid mixture Download PDFInfo
- Publication number
- US4711245A US4711245A US06/607,699 US60769984A US4711245A US 4711245 A US4711245 A US 4711245A US 60769984 A US60769984 A US 60769984A US 4711245 A US4711245 A US 4711245A
- Authority
- US
- United States
- Prior art keywords
- enzyme
- glucose
- electrode
- ferrocene
- mediator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 239000007788 liquid Substances 0.000 title claims abstract description 5
- 102000004190 Enzymes Human genes 0.000 claims abstract description 105
- 108090000790 Enzymes Proteins 0.000 claims abstract description 105
- 150000001875 compounds Chemical class 0.000 claims abstract description 36
- 238000006243 chemical reaction Methods 0.000 claims abstract description 25
- 238000012546 transfer Methods 0.000 claims abstract description 13
- 229910052751 metal Inorganic materials 0.000 claims abstract description 10
- 239000002184 metal Substances 0.000 claims abstract description 10
- 150000002902 organometallic compounds Chemical class 0.000 claims abstract description 4
- 229940088598 enzyme Drugs 0.000 claims description 102
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 claims description 76
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 67
- 239000008103 glucose Substances 0.000 claims description 65
- 108010015776 Glucose oxidase Proteins 0.000 claims description 46
- 235000019420 glucose oxidase Nutrition 0.000 claims description 45
- 239000004366 Glucose oxidase Substances 0.000 claims description 44
- 229940116332 glucose oxidase Drugs 0.000 claims description 44
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 27
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims description 27
- 239000001301 oxygen Substances 0.000 claims description 22
- 229910052760 oxygen Inorganic materials 0.000 claims description 22
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 229910052799 carbon Inorganic materials 0.000 claims description 14
- 239000012528 membrane Substances 0.000 claims description 12
- 230000027756 respiratory electron transport chain Effects 0.000 claims description 11
- 102000003983 Flavoproteins Human genes 0.000 claims description 10
- 108010057573 Flavoproteins Proteins 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 108010042687 Pyruvate Oxidase Proteins 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- 229920002301 cellulose acetate Polymers 0.000 claims description 5
- 229920000159 gelatin Polymers 0.000 claims description 5
- 235000019322 gelatine Nutrition 0.000 claims description 5
- 241000588624 Acinetobacter calcoaceticus Species 0.000 claims description 4
- 108060006006 Cytochrome-c peroxidase Proteins 0.000 claims description 4
- 102100033220 Xanthine oxidase Human genes 0.000 claims description 4
- 108010093894 Xanthine oxidase Proteins 0.000 claims description 4
- 108010048916 alcohol dehydrogenase (acceptor) Proteins 0.000 claims description 4
- 230000003197 catalytic effect Effects 0.000 claims description 4
- GPRSOIDYHMXAGW-UHFFFAOYSA-N cyclopenta-1,3-diene cyclopentanecarboxylic acid iron Chemical compound [CH-]1[CH-][CH-][C-]([CH-]1)C(=O)O.[CH-]1C=CC=C1.[Fe] GPRSOIDYHMXAGW-UHFFFAOYSA-N 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 108010021809 Alcohol dehydrogenase Proteins 0.000 claims description 3
- 102000007698 Alcohol dehydrogenase Human genes 0.000 claims description 3
- 108091023020 Aldehyde Oxidase Proteins 0.000 claims description 3
- 102100036826 Aldehyde oxidase Human genes 0.000 claims description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 3
- LDSUEKXPKCHROT-UHFFFAOYSA-N cyclopenta-1,3-diene-1-carboxylic acid;iron(2+) Chemical compound [Fe+2].OC(=O)C1=CC=C[CH-]1.OC(=O)C1=CC=C[CH-]1 LDSUEKXPKCHROT-UHFFFAOYSA-N 0.000 claims description 3
- BXVLTNLCEUMARW-UHFFFAOYSA-N cyclopenta-1,3-diene;cyclopenta-2,4-diene-1-carboxylic acid;iron(2+) Chemical compound [Fe+2].C1C=CC=[C-]1.OC(=O)C1C=CC=[C-]1 BXVLTNLCEUMARW-UHFFFAOYSA-N 0.000 claims description 3
- 238000002513 implantation Methods 0.000 claims description 3
- YTOVAWUSMUMHIM-UHFFFAOYSA-N iron(2+);5-methylcyclopenta-1,3-diene Chemical compound [Fe+2].C[C-]1C=CC=C1.C[C-]1C=CC=C1 YTOVAWUSMUMHIM-UHFFFAOYSA-N 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 230000001681 protective effect Effects 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 239000004332 silver Substances 0.000 claims description 3
- 239000001828 Gelatine Substances 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 150000003278 haem Chemical class 0.000 claims 2
- RNSRNNYIVZDRFQ-UHFFFAOYSA-N cyclopenta-1,3-diene 2-cyclopenta-2,4-dien-1-ylethanol iron(2+) Chemical compound [Fe++].c1cc[cH-]c1.OCC[c-]1cccc1 RNSRNNYIVZDRFQ-UHFFFAOYSA-N 0.000 claims 1
- VGBAECKRTWHKHC-UHFFFAOYSA-N cyclopenta-1,3-diene;1-ethenylcyclopenta-1,3-diene;iron(2+) Chemical compound [Fe+2].C=1C=C[CH-]C=1.[CH2-]C=C1C=CC=C1 VGBAECKRTWHKHC-UHFFFAOYSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 25
- 238000003556 assay Methods 0.000 abstract description 10
- 238000006555 catalytic reaction Methods 0.000 abstract description 10
- 238000012544 monitoring process Methods 0.000 abstract description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 63
- 239000000243 solution Substances 0.000 description 36
- 230000004044 response Effects 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 22
- 239000000758 substrate Substances 0.000 description 19
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- 239000000872 buffer Substances 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 14
- 238000002484 cyclic voltammetry Methods 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 239000010410 layer Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 12
- 230000002829 reductive effect Effects 0.000 description 11
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 10
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- -1 ferrocenes Chemical class 0.000 description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 239000010439 graphite Substances 0.000 description 7
- 229910002804 graphite Inorganic materials 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 229920006395 saturated elastomer Polymers 0.000 description 7
- 238000001075 voltammogram Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 102000004316 Oxidoreductases Human genes 0.000 description 6
- 108090000854 Oxidoreductases Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 230000002452 interceptive effect Effects 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 5
- 102000028526 Dihydrolipoamide Dehydrogenase Human genes 0.000 description 5
- 108010028127 Dihydrolipoamide Dehydrogenase Proteins 0.000 description 5
- 108010063907 Glutathione Reductase Proteins 0.000 description 5
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 5
- 108010060059 Sarcosine Oxidase Proteins 0.000 description 5
- 102000008118 Sarcosine oxidase Human genes 0.000 description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical class [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 5
- 239000000370 acceptor Substances 0.000 description 5
- 229910002091 carbon monoxide Inorganic materials 0.000 description 5
- 239000004020 conductor Substances 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 230000005518 electrochemistry Effects 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- 239000010931 gold Substances 0.000 description 5
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 5
- 229910052697 platinum Inorganic materials 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 4
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 4
- 239000008351 acetate buffer Substances 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 229940075397 calomel Drugs 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 239000003822 epoxy resin Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- KYMNSBSWJPFUJH-UHFFFAOYSA-N iron;5-methylcyclopenta-1,3-diene;methylcyclopentane Chemical compound [Fe].C[C-]1C=CC=C1.C[C-]1[CH-][CH-][CH-][CH-]1 KYMNSBSWJPFUJH-UHFFFAOYSA-N 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 229920000647 polyepoxide Polymers 0.000 description 3
- 239000001488 sodium phosphate Substances 0.000 description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 3
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- 102100023319 Dihydrolipoyl dehydrogenase, mitochondrial Human genes 0.000 description 2
- 108700033765 EC 1.1.3.1 Proteins 0.000 description 2
- 108010015133 Galactose oxidase Proteins 0.000 description 2
- 241000589236 Gluconobacter Species 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 108010093096 Immobilized Enzymes Proteins 0.000 description 2
- 108010008292 L-Amino Acid Oxidase Proteins 0.000 description 2
- 102000007070 L-amino-acid oxidase Human genes 0.000 description 2
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 241000042032 Petrocephalus catostoma Species 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 241001478288 Pseudomonas thermocarboxydovorans Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 108090000321 Transferred entry: 1.17.3.2 Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 239000001166 ammonium sulphate Substances 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 238000006701 autoxidation reaction Methods 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- RTQKADYFUHJWST-UHFFFAOYSA-N cyclopenta-1,3-diene 2-cyclopenta-2,4-dien-1-ylbutanoic acid iron(2+) Chemical compound [Fe++].c1cc[cH-]c1.CCC(C(O)=O)[c-]1cccc1 RTQKADYFUHJWST-UHFFFAOYSA-N 0.000 description 2
- 125000000058 cyclopentadienyl group Chemical group C1(=CC=CC1)* 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 229910001651 emery Inorganic materials 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 108010054770 glucose dehydrogenase (pyrroloquinoline-quinone) Proteins 0.000 description 2
- 108010062584 glycollate oxidase Proteins 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229940043230 sarcosine Drugs 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000013060 ultrafiltration and diafiltration Methods 0.000 description 2
- NUYNQYILQHTROB-NSULPUJOSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyheptanal Chemical compound CC(O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O NUYNQYILQHTROB-NSULPUJOSA-N 0.000 description 1
- VRYALKFFQXWPIH-PBXRRBTRSA-N (3r,4s,5r)-3,4,5,6-tetrahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)CC=O VRYALKFFQXWPIH-PBXRRBTRSA-N 0.000 description 1
- ZRKMQKLGEQPLNS-UHFFFAOYSA-N 1-Pentanethiol Chemical compound CCCCCS ZRKMQKLGEQPLNS-UHFFFAOYSA-N 0.000 description 1
- 102100038837 2-Hydroxyacid oxidase 1 Human genes 0.000 description 1
- MIRVMMXIKNPZSA-BTVCFUMJSA-N 2-hydroxyacetic acid (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C(CO)(=O)O MIRVMMXIKNPZSA-BTVCFUMJSA-N 0.000 description 1
- WFVBWSTZNVJEAY-UHFFFAOYSA-L 3-[8,13-bis[1-[2-amino-3-(methylamino)-3-oxopropyl]sulfanylethyl]-18-(2-carboxyethyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid;iron(2+) Chemical compound [Fe+2].[N-]1C(C=C2C(=C(CCC(O)=O)C(C=C3C(=C(C)C(=C4)[N-]3)CCC(O)=O)=N2)C)=C(C)C(C(C)SCC(N)C(=O)NC)=C1C=C1C(C)=C(C(C)SCC(N)C(=O)NC)C4=N1 WFVBWSTZNVJEAY-UHFFFAOYSA-L 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- VDJKJPMLWJWQIH-UHFFFAOYSA-M 5-ethylphenazin-5-ium;ethyl sulfate Chemical compound CCOS([O-])(=O)=O.C1=CC=C2[N+](CC)=C(C=CC=C3)C3=NC2=C1 VDJKJPMLWJWQIH-UHFFFAOYSA-M 0.000 description 1
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 108010025188 Alcohol oxidase Proteins 0.000 description 1
- 229920003319 Araldite® Polymers 0.000 description 1
- BVCWWOZPVFDJPG-GEMLJDPKSA-N CC(O)C(O)=O.OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O Chemical compound CC(O)C(O)=O.OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O BVCWWOZPVFDJPG-GEMLJDPKSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 108010075031 Cytochromes c Proteins 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000012011 Isocitrate Dehydrogenase Human genes 0.000 description 1
- 108010075869 Isocitrate Dehydrogenase Proteins 0.000 description 1
- 102100039905 Isocitrate dehydrogenase [NADP] cytoplasmic Human genes 0.000 description 1
- HWMVXEKEEAIYGB-UHFFFAOYSA-K Isocitric acid, DL- Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C(O)C(C([O-])=O)CC([O-])=O HWMVXEKEEAIYGB-UHFFFAOYSA-K 0.000 description 1
- 229910004861 K2 HPO4 Inorganic materials 0.000 description 1
- 108090000841 L-Lactate Dehydrogenase (Cytochrome) Proteins 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- 101710169152 L-amino oxidase Proteins 0.000 description 1
- IFQSXNOEEPCSLW-DKWTVANSSA-N L-cysteine hydrochloride Chemical compound Cl.SC[C@H](N)C(O)=O IFQSXNOEEPCSLW-DKWTVANSSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- HRNLUBSXIHFDHP-UHFFFAOYSA-N N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]benzamide Chemical compound NC1=CC=CC=C1NC(=O)C(C=C1)=CC=C1CNC1=NC=CC(C=2C=NC=CC=2)=N1 HRNLUBSXIHFDHP-UHFFFAOYSA-N 0.000 description 1
- XNPOFXIBHOVFFH-UHFFFAOYSA-N N-cyclohexyl-N'-(2-(4-morpholinyl)ethyl)carbodiimide Chemical compound C1CCCCC1N=C=NCCN1CCOCC1 XNPOFXIBHOVFFH-UHFFFAOYSA-N 0.000 description 1
- XJLXINKUBYWONI-NNYOXOHSSA-N NADP zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 229910017917 NH4 Cl Inorganic materials 0.000 description 1
- 108010063734 Oxalate oxidase Proteins 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 241000786363 Rhampholeon spectrum Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001356 alkyl thiols Chemical class 0.000 description 1
- PMMURAAUARKVCB-UHFFFAOYSA-N alpha-D-ara-dHexp Natural products OCC1OC(O)CC(O)C1O PMMURAAUARKVCB-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical compound OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 description 1
- 238000004082 amperometric method Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- HVURSIGIEONDKB-UHFFFAOYSA-N benzene;chromium Chemical compound [Cr].C1=CC=CC=C1.C1=CC=CC=C1 HVURSIGIEONDKB-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- CKUKUDWLDAJRIZ-UHFFFAOYSA-N cyclopenta-1,3-diene 1-cyclopenta-2,4-dien-1-ylbutan-1-ol iron(2+) Chemical compound [Fe++].c1cc[cH-]c1.CCCC(O)[c-]1cccc1 CKUKUDWLDAJRIZ-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011026 diafiltration Methods 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000081 effect on glucose Effects 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000003411 electrode reaction Methods 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 238000006056 electrooxidation reaction Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000012623 in vivo measurement Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- SIAPCJWMELPYOE-UHFFFAOYSA-N lithium hydride Chemical compound [LiH] SIAPCJWMELPYOE-UHFFFAOYSA-N 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 108010060938 metalloflavoproteins Proteins 0.000 description 1
- MFPODHWDVFPSKC-BTVCFUMJSA-N methanol;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O MFPODHWDVFPSKC-BTVCFUMJSA-N 0.000 description 1
- 108010036691 methylamine dehydrogenase Proteins 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000005486 organic electrolyte Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 229940039748 oxalate Drugs 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- 229960002036 phenytoin Drugs 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229940113116 polyethylene glycol 1000 Drugs 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- REQCZEXYDRLIBE-UHFFFAOYSA-N procainamide Chemical compound CCN(CC)CCNC(=O)C1=CC=C(N)C=C1 REQCZEXYDRLIBE-UHFFFAOYSA-N 0.000 description 1
- 229960000244 procainamide Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000002468 redox effect Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 101150035983 str1 gene Proteins 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 239000008362 succinate buffer Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003115 supporting electrolyte Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940065721 systemic for obstructive airway disease xanthines Drugs 0.000 description 1
- YBRBMKDOPFTVDT-UHFFFAOYSA-O tert-butylammonium Chemical compound CC(C)(C)[NH3+] YBRBMKDOPFTVDT-UHFFFAOYSA-O 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical compound FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
- A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6848—Needles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/004—Enzyme electrodes mediator-assisted
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/817—Enzyme or microbe electrode
Definitions
- This invention relates to equipment and methods for detecting the presence of, measuring the amount of, and/or monitoring the level of, one or more selected components in a liquid mixture.
- the invention will be described, inter alia, with reference to one particular in vivo measurement, the determination of glucose in a diabetic human subject by the use of equipment which, while usable on a specific or occasional basis also lends itself to temporary or permanent implantation. While the provision of sensors for components in biological fluids is one object of the invention, other and broader objects are not hereby excluded.
- a fall in the level of oxygen tension resulting from poor tissue perfusion is a particular problem for detecting glucose in blood taken from subcutaneous tissue of diabetics.
- the inventors have carried out in vitro studies of enzyme-catalyzed reactions using a mediator (e.g. phenazine methosulfate or phenazine ethosulfate) in solution to transfer the electrons arising from the enzyme, during its action, directly to the electrode, as described in Biotechnology Letters 3 pp 187-192 (1981).
- a mediator e.g. phenazine methosulfate or phenazine ethosulfate
- the mediator must rapidly transfer electrons between the enzyme and the electrode at a rate representative of the rate of the enzyme-catalysed reaction rate.
- the mediator should be sensitive to potential differences of the enzyme; however, the mediator's response should be relatively insensitive to the presence of interfering substances.
- the mediator should be capable of effecting electron transfer for a broad range of enzymes and under a broad range of conditions such as temperature and pH. The mediator should not be toxic to cells or carcinogenic.
- glucose oxidase which is not dependent on oxygen as the mediator of electron transfer.
- Previously described electron acceptors for glucose oxidase include hexacyanoferrate (III), and a range of organic dyes; the former is not readily entrapped at an electrode; the latter, though widely used in spectrophotometric measurements, have a number of disadvantages for electromechanical use including ready autoxidation, instability in the reduced forms and pH-dependent redox potentials.
- the invention features, as electrode sensor mediators, organometallic compounds known as metallocenes, and more specifically (bis)polyhaptometallocenes which include two organic ring structures, each with conjugated unsaturation, and a metal atom sandwiched between the rings, so that the metal atom is in electron-sharing contact with each atom in the ring.
- the mediator is composed of at least two organic rings, each of which has at least two double bonds in a conjugated relationship; a metal atom is in electron-sharing contact with those rings.
- the mediators are broadly useful in electrode sensor systems having two conductors insulated from each other, each of which is in contact, via a conductive surface, with a mixture of compounds that includes the selected compound to be sensed.
- An enzyme capable of catalyzing a reaction at a rate representative of the selected compound concentration is in contact with the mixture, and the mediator compound transfers electrons between the enzyme and the conductive surface of one of the conductors at a rate representative of the enzyme catalyzed reaction rate.
- ferrocene-type compounds are particularly useful mediators.
- Other compounds that are envisaged as mediators include ruthocene-type compounds and dibenzene chromium. Insoluble compounds, particularly ferrocenes, are most preferable.
- Ferrocene has, as its fundamental structure, an iron atom held “sandwiched” by bonds between two cyclo-pentadienyl rings. It is an electroactive organometallic compound, acting as a pH-independent reversible one-electron donor.
- Various derivatives are available (e.g. with various substituents on the ring structure, possibly in polymer form) differing in redox potential, aqueous solubility and binding constant to enzymes.
- the redox potential of the parent compound is +422 mV vs NHE.
- E'o can be varied between +300 and +650 mV.
- the water-solubility of the carboxyl-substituted ferrocenes is greater than that of the parent compound. Further description will be found in Kuwana T., 1977, ACS Symposium Series, 38: 154.
- mediator compounds of this type are ferrocene itself, 1,1'-ferrocene dicarboxylic acid, dimethyl ferrocene, and polyvinyl ferrocene, e.g. of average molecular weight of about 16000.
- ferrocenes Whilst ferrocenes had been found to be of limited value in spectrophotometric assays as a result of their poor solubility in aqueous solution and low extinction coefficients, we have found them to be more suited to a bio-electrochemical system. Ferrocene-type compounds have advantages over other mediators used with enzyme/substrate reactions for charge-transfer purposes. Specifically, ferrocenes have:
- ferrocene meets the stringent demands placed on the mediator.
- ferrocene compounds readily shuttle electrons between the enzyme and the conductive electrode surface at a rate that is high enough to render potentially conflicting reactions insignificant.
- the response covers as large a region as possible to enhance the precision of the concentration reading.
- the ferrocene compound can be concentrated at the electrode surface in sufficient amounts to enhance electron transfer.
- the ferrocene compound is covalently bound to the electrode and/or the enzyme, the bonding does not interfere with the mediating function.
- the ferrocene compound selected should be relatively insoluble in water for most application. It should be stable and non-responsive to interfering substances such as oxygen or pH.
- the rate of electron transfer with ferrocene must be dependent on the rate of the enzyme-catalyzed reaction. That is, the ferrocene effects electron transfer during the period of catalytic ativity at a rate representative of that activity.
- ferrocene-type compounds in an extraordinarily broad range of sensor systems.
- ferrocene can mediate electron transfer for a broad range of enzymes.
- the preferred enzymes are non-oxygen-specific flavo-protein enzymes or quinoproteins Glucose oxidase and glucose dehydrogenase are particularly preferred enzymes.
- Glucose oxidase ( ⁇ -D-glucose:oxygen oxidoreductase, of enzyme classification EC 1.1.3.4) is a well known type of enzyme.
- Bacterial glucose dehydrogenase is of more recent discovery, and is believed to be a quinoprotein with a polycyclicquinone prosthetic group (PQQ).
- PQQ polycyclicquinone prosthetic group
- a bacterial glucose dehydrogenase in the present invention has certain advantages over the use of a glucose oxidase.
- the major advantage is that it can give an oxygen-insensitive glucose sensor, since the enzyme does not use oxygen as an electron acceptor.
- a suitable enzyme can be purified (as described in more detail below) either by conventional chromatographic techniques or by two-phase aqueous partition from a range of micro-organisms.
- a preferred micro-organism is Acinetobacter calcoaceticus but various Gluconobacter species (e.g. Gluconobacter oxidans) or Pseudomonas species (e.g. Pseudomonas fluorescens, Pseudomonas aeruginosa) can also be used.
- the purpose of such an electrode is to detect the presence of, measure the amount of and/or monitor the level of one or more selected components capable of undertaking a reaction catalysed by the said enzyme.
- 1,1-dimethylferrocene is a particularly preferred mediator.
- the selected component to be sensed is preferably the substrate for the enzyme-catalyzed reaction.
- the enzyme and/or the mediator are confined at the conductive surface of one of the conductors.
- the mediator transfers electrons from the enzyme to the electrode surface.
- the trend in E° values is in agreement with that expected on the basis of substituent effects.
- electron-donating groups stabilize the positive charge and hence promote oxidation more so than electron withdrawing groups.
- the electrode is designed to determine glucose in vivo.
- the enzyme is therefore preferably a glucose oxidase, or possibly a glucose dehydrogenase, for example a bacterial glucose dehydrogenase.
- the electrically conductive material of the electrode itself can be a metal, particularly silver, or carbon either as a pre-formed rod or as an electrode shape made up from a paste of carbon particles or a carbon fibre.
- Surface condition of the electrode is usually important. If metal, the surface can be roughened where it contacts the active materials (enzyme and/or mediator). If solid carbon, the surface can be "oxidised” i.e. previously heat-treated in an oven with oxygen access.
- the dehydrogenase is preferred, and of the mediators the ferrocene-type compounds are preferred.
- enzyme immobilisation materials or polymeric electrode admixtures e.g. TEFLON, or long-chain alkyl derivatives of mediators of increased molecular weight and thus decreased mobility, can be incorporated.
- polymeric electrode admixtures e.g. TEFLON, or long-chain alkyl derivatives of mediators of increased molecular weight and thus decreased mobility
- the electrode comprises a carbon core, a layer of ferrocene or a ferrocene derivative at a surface thereof and a layer of glucose oxidase or glucose dehydrogenase at the surface of the ferrocene layer.
- the enzyme layer is peferably immobilised at the surface of the underlying mediator, retained in a self-sustaining gel layer thereupon and/or has a retention layer thereover permeable to the glucose molecules.
- the carbon core can itself be solid or a stiff paste of particles. Normally, it will present a smooth surface for the ferrocene or ferrocene derivative, which may be adhered thereto in a number of ways, for example,
- the enzyme to be coated on to the ferrocene or ferrocene derivative can be the glucose oxidase or the bacterial glucose dehydrogenase.
- the glucose oxidase can be immobilised to the underlying surface e.g. by the carbo-diimide material DCC (1-cyclohexyl-3(2-morpholino ethyl) carbo-diimide metho-p-toluene sulphonate) which gives a thin strongly bound layer, a good linear response to low glucose concentrations, and oxygen insensitivity (because of the competition from the ferrocene with oxygen for electrons transferred to the enzyme redox centre from the substrate).
- DCC immobilisation of glucose oxidase on ferrocene also extends the top end of the linear range of the sensor from about 2 mM to 40 mM.
- the bacterial glucose dehydrogenase can also be immobilised at the mediator surface, but may be merely deposited from an evaporatable solution, or held in a gelatin layer.
- a protective membrane surrounds both the enzyme and the mediator layers, permeable to water and glucose molecules.
- This can be a film of dialysis membrane, resiliently held e.g. by an elastic O-ring. It can however also with advantage be a layer of cellulose acetate, e.g. as formed by dipping the electrode into a cellulose acetate solution in acetone or polyurethane. Membranes may be applied by dip, spray or spin coating techniques. It will be apparent that while the invention has primary relevance to a sensor electrode, especially such an electrode specific for glucose, it also relates to the combination of such an electrode and temporary or permanent implantation means, e.g. a needle-like probe.
- an electrode connected or connectable, with signal or control equipment, more especially with an insulin administration means, constitutes an aspect of the invention.
- a method of monitoring a diabetic subject involving the use of a temporarily or permanently implanted electrode as described above is also within the scope of the invention.
- the electrodes according to the invention permit the manufacture of an improved macro-sensor for use in hospital analytical glucose-sensing instruments of the existing type.
- the advantages compared to known instruments would be that the increased linear range together with very low oxygen sensitivity would allow omission of the dilution step involved in blood analysis in current instruments.
- the response times of such electrodes are short (24-36 seconds for 95% of steady state depending on complexity of solution).
- the electrodes of the invention, on the macro-scale could be incorporated into simple, cheap electronic digital read-out instruments for doctors surgeries or diabetic home-testing kits.
- a small version of the macro-sensor would be possible in a device which automatically takes a blood sample from the finger, brings it into contact with the sensor, amplifies the signal and gives a digital readout.
- a micro-version of the sensor in a watch type device for monitoring glucose interstitial fluid in the skin could also be envisaged. It would be worn on the wrist and would have a disposable sensor cartridge in the back with one more more separate, fine, needle-type sensors. Each would feed into the electronics which if several sensors were used would cross-refer the current inputs to ensure reliability.
- connection of such devices to external insulin delivery systems could act as a feedback control loop for an insulin pump.
- a device could be housed in the cannula used to feed insulin into the body from a pump and again serve as a sensor for the feedback loop.
- Other uses such as a hypoglycaemia alarm, or digital read-out monitor, are also possible.
- the enzymes that can be used with ferrocene-mediated systems include: flavo-proteins that are capable of using a variety of electron acceptors, including oxygen; and NADPH-or NADH-linked enzymes such as lipoamide dehydrogenase and glutathione reductase; dehydrogenase enzymes, termed quinoproteins, that contain the above-mentioned polycyclicquinone prosethtic group (PQQ).
- flavo-proteins that are capable of using a variety of electron acceptors, including oxygen
- NADPH-or NADH-linked enzymes such as lipoamide dehydrogenase and glutathione reductase
- dehydrogenase enzymes termed quinoproteins, that contain the above-mentioned polycyclicquinone prosethtic group (PQQ).
- flavoproteins that generate H 2 O 2 appears in Clark et al. Biotechnol. Bioeng. Symp. 3: 377 (1972). Particularly preferred flavoproteins are: lactate oxidase, pyruvate oxidase, xanthine oxidase, sarcosine oxidase, lipoamide dehydrogenase, glutathione reductase, aldehyde oxidase, glucose oxidase, glycollate oxidase, L-amino oxidase, galactose oxidase. Ferrocenes are also suitable mediators for methanol oxidase and carbon monoxide oxido reductase.
- Suitable quinoproteins include glucose dehydrogenase, alcohol dehydrogenase, methanol dehydrogenase.
- a list of PQQ quinoproteins appears in Quine et al. J. TIBS 6: 728 (1981).
- heam-containing enzymes can be used in ferrocene-mediated electrode systems.
- Such enzymes include: horseradish peroxidase, yeast cytochrome C peroxidase, lactate dehydrogenase (i.e. yeast cytochome B2), and horse heart cytochrome C peroxidase.
- the current measured includes a Faradaic component which results from electron transfer to and from an electro-active species in the solution. If the rate of electron transfer between the electro-active species is sufficiently fast, the Faradiac current is controlled by the rate of diffusion of the electro-active species.
- the enzyme-catalyzed reaction causes a perturbation in the voltammogram that depends on the reaction rate, compared with the time required for the voltage sweep.
- the preferred enzymes are the flavo-protein enzymes which are not oxygen-specific and the quino-protein enzymes, and, in particular, enzymes catalyzing glucose reactions such as glucose oxidase and glucose dehydrogenase.
- the compound selected to be measured is the substrate for the enzyme, and the enzyme and mediator are confined at the electrode surface.
- the electrode is exposed to a mixture containing the selected compound, and the enzyme becomes catalytically active, generating a current representative of the compound's concentration.
- FIG. 1 is a diagrammatic longitudinal cross-section through a glucose sensor electrode
- FIG. 2 is a graph of the current sensed by the electrode of FIG. 1, against glucose concentration
- FIG. 3 is a diagrammatic longitudinal cross-section of the electrode of FIG. 1 located within a hypodermic needle;
- FIG. 4 is a diagrammatic longitudinal cross-section through a yet further glucose sensor electrode
- FIG. 5 is a graph analogous to FIG. 2 for the electrode of FIG. 4;
- FIG. 6 is a graph analogous to FIG. 2 for an electrode incorporating a glucose dehydrogenase.
- FIG. 7 shows a circuit which may be used for D.C. cyclic voltammetry
- FIG. 8 shows a two-compartment cell for D.C. cyclic voltammetry
- FIG. 9 is a FPLC profile of co-oxidoreductase from Pseudomonas thermocarboxydovorans.
- FIG. 10 is a voltammogram of carboxyferrocene.
- GDH Quinoprotein Glucose Dehydrogenase
- the method is based on the method of J A Duine et al (Arch Microbiol, 1982 vide supra) but with modifications as follows.
- Triton X-100 extracts were combined and treated with 0.01 mgml -1 of deoxyribonuclease I for 15 minutes at room temperature. The resulting suspension was then centrifuged at 48000 xg for 25 minutes at 4° C. The supernatant from this centrifugation was then treated with ammonium sulphate. The yellow protein precipitating between 55 and 70% ammonium sulphate was resuspended in 36 mM Tris/39 mM glycine containing 1% Triton X-100 and dialysed against that buffer at 4° C. for 5 hours.
- Example 1 The method of Example 1 was repeated.
- the method is based on the partitioning of proteins between two liquid phases. The steps were:
- the cell-free extract was the mixed for 15 minutes at room temperature with 50% (w/v) polyethyleneglycol 1000, 50% (w/v) sodium phosphate, pH 7.0 and distilled water in the proportions of 2:4:3:1 respectively. This mixture was centrifuged at 5000 rpm for 5 minutes to break the emulsion.
- the lower layer was aspirated off and desalted immediately, by either diafiltration using an Amicon hollow-fibre ultrafiltration cartridge of 10000 mwt cut off, or by passage through a Sephadex G50 (medium grade) gel filtration column.
- Example 3 The procedure of Example 3 was repeated using 1,1'-ferrocene dicarboxylic acid instead of ferrocene.
- the value of Eo' was determined to be +420 mV, and the second order rate constant of the ferricinium ion and reduced glucose oxidase was again 10 4 m -1 S -1 , thus confirming the conclusions drawn from Example 3.
- a graphite rod 13 (FIG. 1) with an oxidised surface, 30 mm long ⁇ 0.9 mm diameter is glued with epoxy resin into a nylon tube 14-25 mm long, 0.9 mm inside diameter, 1.3 mm outside diameter.
- the end 15 of the electrode is dipped into a solution of dimethyl ferrocene, (10 mg/ml) in toluene, and the solvent is then allowed to evaporate.
- the end 15 of the electrode is placed into a solution of water soluble DCC (25 mg/ml) in acetate buffer, pH 4.5 for 1 hour. It is then rinsed, in buffer only, for 5 minutes and thereafter placed in a solution of glucose oxidase (10 mg/ml) in acetate buffer, pH 5.5, for 11/2 hours before again rinsing in buffer.
- the tip of the electrode 15, with the layers of dimethyl ferrocene and immobilised enzyme is then dipped into a solution of cellulose acetate dissolved in acetone and N,N'-dimethyl formamide and put into ice water for several minutes, to give a protected and stable electrode.
- This electrode was connected to a potentiostat, together with a suitable counter electrode and calomel reference electrode and placed in a solution containing glucose.
- the potential of the working electrode is kept at +100 mV to 300 mV relative to the calomel electrode, i.e. as low as possible to avoid oxidation of potentially intefering substances.
- a current is produced which is proportional to the glucose concentration.
- the time for 95% of response is less than 1 minute and the electrode gives a near linear response over the range 0-32 mM glucose, as shown in FIG. 2.
- Slow loss of activity of ferrocene due to slow loss of ferricinium ion
- FIG. 3 shows in section an electrode structure in which an electrode (references as in FIG. 1) of much smaller size is held within a hypodermic needle 16 plugged at its point 17 but with side windows 18 for passage of blood or other body fluid.
- an electrode references as in FIG. 1
- the small size of such an electrode and its linear response over a large range of glucose concentrations makes it possible to use the electrode for in vivo glucose determination on both severely diabetic and normal individuals.
- a carbon rod 19 (FIG. 4) Ultra carbon, grade U5, 6 mm ⁇ 15 mm with a metal connector 20 secured in one end was sealed in glass tubing 21 (borosilicate, 6 mm i.d. ⁇ mm) with an epoxy resin (araldite). (not shown). The exposed surface at 22 was polished with emery paper and washed with distilled water. The entire rod was heated in an oven for 40 h at 200° C. to give an oxidised surface at 22.
- the characteristics of the above electrode were determined in a nitrogen-saturated buffer solution (0.2M sodium phosphate, pH 7.3) and are shown in FIG. 5.
- the curve is linear from 2 to 25 mM glucose and reaches saturated current at 100 mM in glucose.
- Electrodes as above were stored in 20 mM NaPO 4 , pH7 for 4 weeks at 4° C. as a stability test and thereafter re-examined as above. The results were within 10% and usually with 5% of results with a freshly made electrode.
- a stiff carbon paste was made up from 1.6 g of Durco activated charcoal and 2.5 ml of liquid paraffin.
- a pasteur pipette of 6 mm internal diameter was blocked 2 mm from its wide end by a silver disc to which a connecting wire was soldered. The space between the disc and the end of the pipette was filled with the carbon paste, and the surface of the paste was polished with paper until smooth and even.
- a single 20 microliter drop of a toluene solution of ferrocene (20 mg/l) was placed on the smooth surface and allow to spread and evaporate to leave a film of the ferrocene.
- Example 2 A further drop of 25 microliters of bacterial glucose dehydrogenase solution as obtained in Example 1, containing between 1 and 10 mg of protein per ml, was placed on this ferrocene surface and allowed to spread.
- a cover of dialysis membrane was secured over the so-coated end of the electrode by a tight-fitting O-ring.
- Example 7 The procedure of Example 7 was repeated but using as electrode the same carbon paste packed into the space defined between the end of a length of nylon tubing and a stainless steel hypodermic needle shaft inserted therein terminating 2 mm. short of the tubing end, so as to define a small electrode body.
- the electrode was further fabricated using only 5 microliters of the ferrocene solution and 1 microliter of the enzyme solution.
- Example 8 The procedure of Example 8 was repeated using as electrode a solid carbon rod (Ultracarbon grade U5 6 mm diameter) within a Pyrex glass tube 3 cm long and 6 mm internal diameter and connected to a stainless steel hypodermic shaft, giving a construction similar to that shown in FIG. 4.
- the end of the carbon rod was polished smooth with emery cloth and aluminium oxide powder prior to the application of the ferrocene solution.
- a gelaton-entrapped glucose dehydrogenase was prepared by mixing at 37° C., 25 mg gelatin, 0.5 ml of the glucose dehydrogenase solution as described in Example 9 and 2.5 microliters of TEMED. After complete dissolving of the gelatin 200 microliters of the solution was spread over an area of 2 cm 2 and allowed to dry under a stream of cold air.
- Example 10 was repeated using a disc of the gel of 1 mm 2 area and applying it instead of the drops of enzyme solution in the construction of example 10.
- dc cyclic voltammetry was used to demonstrate the ability of a ferrocene compound (usually ferrocene monocarboxylic acid) to generate and enhance anodic current in the presence of each of the following enzymes, together with their respective substrates:
- dc cyclic voltammetry which is a controlled potential electrochemical method, is based upon the maintenance within cell 30 of the potential of the working electrode (WE) with respect to a reference electrode (RE) by making a current pass between the working and counter electrode (CE).
- a 380Z micro-computer (Research Machines Ltd), interfaced to a potentiostat via digital-to-analogue and analogue-to-digital converters, was used for the potential step methods.
- the potentiostat incorporates a multiplexer which facilitates both switching and monitoring of more than one working electrode.
- the cells contained a 1 cm 2 platinum gauze counter electrode 33 and a saturated calomel electrode, 34 type K401 (supplied by V. A. Howe Radiometer Electrodes) accurate in the range -10° C. to 60° C., as reference. All potentials are referred to the saturated calomel electrode (SCE), which is +241 mV at 20° C. versus the normal hydrogen electrode (NHE).
- SCE saturated calomel electrode
- Working electrodes were polished before each experiment using an alumina-water paste on cotton wool and then washed with deionised water.
- Electrochemical experiments were performed under thermostatic control by using a Churchill chiller thermocircular connected to a water bath into which the electrochemical cell was placed.
- dc cyclic voltammetry experiments are performed in argon-saturated solutions using the following protocol.
- Substrate is then added to the cell, typically to a final concentration of 10 mM and always in excess of the Michaelis-Menten constant for the enzyme.
- a set of voltammograms are recorded to assess the effect of the substrate upon the electrochemistry of the mediator.
- Enzyme is then added to final concentrations in the range 10-100 uM. If an enhanced anodic current is obtained, and the dependence of the current function upon the scan rate was indicative of a catalytic reaction, the experiment is repeated adding the substrate as the final component to insure that the reaction was dependent upon the presence of substrate.
- the flavo-proteins pyruvate oxidase (EC 1.2.3.3), xanthine oxidase (EC 1.1.3.22), sarcosine oxidase (EC 1.5.3.1), lipoamide dehydrogenase (EC 1.8.1.4) and glutathione reductase (EC 1.6.4.2) were supplied by Boehringer and stored at -20 C.
- the respective concentrations of the flavo-proteins are expressed in terms of the amount of catalytically-active flavin.
- Carbon monoxide oxido-reductase was isolated from Pseudomonas thermocarboxydovorans by Dr. J. Colby, Biochemistry Department, Sunderland Polytechnic and supplied at a concentration of 8.6 mg ml -1 , in phosphate buffer containing 50% ethanediol as a stabilizer. Before use, the enzyme was dialysed against 20 mM Tris-HCl (pH 7.5) at 4° C., and purified by FPLC using an analytical Mono-Q column.
- the enzyme was loaded on to the column at a concentration of 1.0 mg ml -1 in 20 mM Tris-HCl pH 7.5 (buffer A) and eluted with a linear ionic strength gradient using buffer B (A +1.0M KCl). Carbon monoxide oxido-reductase eluted as one major peak at an ionic strength equivalent to 35% buffer B, as shown in FIG. 9.
- Sodium lactate, sodium isocitrate, sarcosine, sodium pyruvate, xanthine, cholesterol, potassium, oxalate, choline, reduced nicotinamide adenine dinucleotide (NADH) and reduced nicotinamide adenine dinucleotide phosphate (NADPH) were supplied by Boehringer. Carbon monoxide was supplied by BOC. Ferrocene monocarboxylic acid was supplied by Fluorochem.
- Enhancement of the anodic current is characteristic of a catalytically-coupled reaction and can be interpreted in terms of the following scheme, ##STR2## where R is the ferrocene, O is the ferricinium ion and Z the reduced glucose oxidase.
- the enhanced anodic current results from the reaction between the reduced glucose oxidase and the ferricinium ion, the latter being generated at oxidizing potentials.
- the kinetics of the homogeneous reaction between glucose oxidase and a number of ferrocene derivatives were analyzed by the theory developed by Nicholson and Shain. From the data, a pseudo-first order rate constant, independent of scan rate, can be derived.
- Glucose oxidase (EC 1.1.3.4 type 2, from Aspergillus niger), was supplied by Boehringer Mannheim, had an activityof 274 IU/mg.
- D-glucose (AnalaR) was from BDH;
- ferrocene and its derivatives were from Strem Chem. Co. All solutions were prepared from Aristar grade reagents (BDH) in high purity water (Millipore); supporting electrolyte was 0.1M K 2 HPO 4 adjusted to the required pH with HClO 4 , glucose solutions were stored overnight to allow equilibration of ⁇ - and ⁇ -anomers. Properties of this enzyme are given in the table below;
- Heparinised plasma samples from human diabetics were supplied by the Metabolic Unit, Guy's Hospital, London., and had been previously analysed for glucose with a Yellow Springs Instruments, Ohio, glucose analyzer.
- the potentiostatically-controlled steady-state current measurements were made using a cell, designed to accommodate up to seven enzyme electrodes, with a working volume of 100 ml with separate compartments for counter and reference electrodes.
- Current-time curves were recorded with a Bryans Y-t BS-271 recorder.
- the temperature of the electrochemical cells during experiments were controlled to within ⁇ 0.5° C. with a Churchill thermocirculator.
- Graphite foil 1 mm thick, supplied by Union Carbide was the base sensor. Electrodes were constructed by cutting the graphite into 4 mm diameter discs and sealing into glass rods with epoxy resin. The electrodes were then heated at 200° C. in air for 40 hours, allowed to cool, 15 ul of 1,1'dimethylferrocene (0.1M in toluene) was deposited on to the surface of the electrode and air-dried. Covalent attachment of the glucose oxidase to the oxidised graphite surface was achieved by a method similar to that described by Bourdillon.
- the electrodes were placed in 1 ml of a solution of water-soluble 1-cyclohexyl-3-(2-morpholine ethyl)carbodiimide metho-p-toluene sulphonate from Sigma Chem. Co. (0.15M in 0.1M acetate, pH 4.5), for 80 mins at 20° C., washed with water and then placed in a stirred solution of acetate buffer (0.1M, pH 5.5) containing glucose oxidase (12.5 mg/ml.) for 90 mins at 20° C. After washing, the electrodes were covered with a polycarbonate membrane (Nucleopore, 0.03 um) and stored in buffer containing 1 mM glucose at 4° C.
- the electrode response was stabilized by continuous operation of the electrode under potentiostatic control at 160 mV in 8 mM glucose over a 10 hours period. Thereafter the electrodes were found to give a more stable response during 100 hours further operation. In 8 mM buffered glucose, the electrodes gave a mean current decrease of 3% ⁇ 1 over this period. All electrodes which had been modified with glucose oxidase had undergone this pre-conditioning process.
- Electrodes gave a linear current response in the range 0.1-35 mM glucose and finally saturate at approximately 70 mM glucose. In the linear region, the electrodes showed a rapid response time reaching 95% of the steady state-current in 60-90 secs.
- the reproducibility of the electrode construction protocol was investigated by measuring the steady-state current for each electrode in 8 mM glucose.
- the batch of prototype electrodes gave a mean current response of 7.9 uA with a standard deviation of 2.8.
- the immobilization protocol for the ferrocene-based electrode is important in changing the apparent Michaelis-Menten constant, K M ', of glucose oxidase for glucose which results in the high upper limits of linearity. If the electrode response is kinetically rather than diffusion-controlled, i.e. the steady-state current is independent of whether the solution is quiescent or stirred, K M ' may be calculated.
- K M ' may be calculated.
- interfering, or potentially interfering substances are listed in table 5 below. All of the listed substances are substrates for glucose oxidase, however the relative rates of reaction are much lower than that of the primary substrate, glucose. Although experiment showed that the effect on glucose assay of these substances was minimal, it is envisaged that in the absence of glucose the sensor of the present electrode could be employed to assay for any of the listed substrates.
- L-cysteine HCl (0.08 mM), reduced glutathione (0.49 mM), sodium formate (7.35 mM), D-xylose (8.00 mM) ⁇ -galactose (7.77 mM) and ⁇ -mannose (7.77 mM) did not cause any observable interference to the electrodes response to glucose.
- the present electrode has an equal or faster response time, the ability to operate under anaerobic conditions, greater oxygen insensitivity (important in blood samples, where oxygen concentration is variable), extended linear range covering the complete physiological range and comparable specificity. It is additionally proposed, in accordance with the present invention that among the mediators named figure the thiol or like sulphur derivatives of ferrocene, whereby the mediator can link directly to a gold electrode.
- the thiol group can be directly or indirectly attached to one ring of the ferrocene structure, e.g. by a lower alkyl group containing 1 to 6 carbon atoms.
- the simple thio(ferrocene)-SH can be used, prepared as in J. Chem Soc. 692 (1958) Knox and Pauson.
- Other more complex thiol-like compounds are possible e.g. 1,2,3-trithia-(3)-ferrocenophane in which the two rings are linked by a chain of sulphur atoms (a mixture of substances with different numbers of chain sulphur atoms is possible.)
- the gold electrode can be prepared for repeated use e.g. by dipping into solutions of such compounds, so as to link the mediator ferrocene structure to the conductive metal.
- Ferrocene thiopentane Ferrocenyl thiobutane
- Acid (2) (12 g) was dissolved in ether (distilled from sodium/potassium) and treated with lithium hydride (1.27 g) in a nitrogen atmosphere. When reaction was complete the excess lithium aluminium hydride was destroyed using ethyl acetate and then water. The organic phases were separated and the aqueous phase washed with ether (2 ⁇ 20 ml). The organic phases were combined and dried (MgSO 4 ) and after filtration the solvent was removed on the rotary evaporator 4. The red oil resulting had two components. Column chromatography (30 cm ⁇ 2 cm) on silica eluted with 1:1 ether:hexane gave the alcohol and an ester.
- a ferrocene includes various derivates (e.g. with various substituents on the ring structures, possibly in polymer form) differing in redox potential and aqueous solubility.
- Hill also describes (p. 53) various ligand assay schemes including those in which the ligand is bound to ferrocene and all system components are freely diffusing (i.e., in solution).
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Optics & Photonics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
TABLE 1 ______________________________________ Ferrocene derivative Eo Solubility E ______________________________________ 1,1'-dimethyl- 100 I,D -- acetic acid 124 S 370 hydroxyethyl- 161 S -- ferrocene 165 I,D 335 1,1'bis(hydroxymethyl)- 224 S 385 monocarboxylic acid 275 S 420 1,1'-dicarboxylic acid 385 S -- chloro- 345 I,D -- methyl trimethylamino- 400 S -- ______________________________________
TABLE 2 ______________________________________ Enzyme Substrate ______________________________________ Flavo-proteins Pyruvate Oxidase [EC 1.2.3.3] Pyruvate L-Amino Acid Oxidase [EC 1.4.3.2] L-Amino Acids Aldehyde Oxidase Aldehydes Xanthine Oxidase [EC 1.1.3.22] Xanthines Glucose Oxidase Glucose Glycolate Oxidase [EC 1.1.3.1] Glycolate Sarcosine Oxidase [EC 1.5.3.1] Sarcosine Lactate Oxidase Lactate Glutathione Reductase [EC 1.8.1.4] NAD(P)H Lipoamide Dehydrogenase [EC 1.6.3.4] NADH PQQ Enzymes Glucose Dehydrogenase Glucose Methanol Dehydrogenase Methanol and other Alkanols Methylamine Dehydrogenase Methylamine Haem-Containing Enzymes Lactate Dehydrogenase Lactate (Yeast Cytochrome B2) Horse-Radish Peroxidase Hydrogen Peroxide Yeast Cytochrome C Peroxidase Hydrogen Peroxide Cupro-protein Enzymes Galactose Oxidase [EC 1.1.3.1] Galactose Metalloflavoproteins Carbon Monoxide Carbon monoxide Oxidoreductase ______________________________________
TABLE 3 ______________________________________ Rates of glucose oxidase oxidation measured atpH 7 and 25° C. ferrocene derivative Eo/mV vs SCE ##STR1## ______________________________________ 1,1'-dimethyl- 100 44 ferrocene 165 15 vinyl- 250 18 carboxy- 275 115 1,1'-dicarboxy- 385 15 trimethylamino- 400 300 ______________________________________
TABLE 4 ______________________________________ source; Aspergillus Niger RMM; 186,000 Co-factor 2FAD Co-substrate Oxygen Optimum pH 5.6 K.sub.m Glucose 3.0 mM ______________________________________
TABLE 5 ______________________________________ Substrate Relative Rate ______________________________________ β-D-glucose 100 2-deoxy-D-glucose 25 6-methyl-D-glucose 2 D-mannose 1 α-D-glucose 0.6 ______________________________________
F.sub.c --CH.sub.2 --CH.sub.2 --CH.sub.2 --CH.sub.2 --COOCH.sub.3
F.sub.c --CH.sub.2 --CH.sub.2 --CH.sub.2 --CH.sub.2 --CH.sub.2 SH
Claims (27)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB838312259A GB8312259D0 (en) | 1983-05-05 | 1983-05-05 | Enzyme-containing sensors |
GB8312259 | 1983-05-05 | ||
GB848405263A GB8405263D0 (en) | 1984-02-29 | 1984-02-29 | Electrode systems |
GB8405263 | 1984-02-29 | ||
GB8405262 | 1984-02-29 | ||
GB848405262A GB8405262D0 (en) | 1984-02-29 | 1984-02-29 | Electrode systems |
GB813034 | 1984-10-23 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US06/436,106 Continuation-In-Part US4545382A (en) | 1981-10-23 | 1982-10-22 | Sensor for components of a liquid mixture |
Publications (1)
Publication Number | Publication Date |
---|---|
US4711245A true US4711245A (en) | 1987-12-08 |
Family
ID=27262080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US06/607,699 Expired - Lifetime US4711245A (en) | 1983-05-05 | 1984-05-07 | Sensor for components of a liquid mixture |
Country Status (4)
Country | Link |
---|---|
US (1) | US4711245A (en) |
EP (1) | EP0125137B1 (en) |
CA (1) | CA1219040A (en) |
DE (1) | DE3483019D1 (en) |
Cited By (393)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4836904A (en) * | 1985-03-28 | 1989-06-06 | Medisense, Inc. | Graphite electrode with modified surface |
US4840893A (en) * | 1983-12-16 | 1989-06-20 | Medisense, Inc. | Electrochemical assay for nucleic acids and nucleic acid probes |
US4857167A (en) * | 1987-06-05 | 1989-08-15 | Monsanto Company | Oxygen-stable substituted ferrocene reference electrode |
US4876195A (en) * | 1985-12-26 | 1989-10-24 | Takeda Chemical Industries, Ltd. | Process for producing 2-keto-D-glucaric acid |
US4897173A (en) * | 1985-06-21 | 1990-01-30 | Matsushita Electric Industrial Co., Ltd. | Biosensor and method for making the same |
US4929313A (en) * | 1984-11-23 | 1990-05-29 | Massachusetts Institute Of Technology | Amperometric electrochemical ion sensors and method for determining ion concentration |
US4953552A (en) * | 1989-04-21 | 1990-09-04 | Demarzo Arthur P | Blood glucose monitoring system |
US4956063A (en) * | 1988-03-31 | 1990-09-11 | Orbisphere Laboratories (Inc.) | Ozone measuring method |
US4968400A (en) * | 1986-11-20 | 1990-11-06 | Terumo Kabushiki Kaisha | Enzyme sensor |
US4997541A (en) * | 1988-12-10 | 1991-03-05 | Dragerwerk Aktiengesellschaft | Dosimeter having a reusable electrochemical measuring cell |
US5063149A (en) * | 1988-08-04 | 1991-11-05 | Imperial Chemical Industries Plc | Performing an enzyme-catalyzed reaction |
US5089112A (en) * | 1989-03-20 | 1992-02-18 | Associated Universities, Inc. | Electrochemical biosensor based on immobilized enzymes and redox polymers |
US5149630A (en) * | 1984-01-26 | 1992-09-22 | Forrest Gordon C | Methods of assay |
US5149629A (en) * | 1987-04-07 | 1992-09-22 | Ramot University Authority For Applied Research And Industrial Development Ltd. | Coulometric assay system |
US5173165A (en) * | 1989-10-13 | 1992-12-22 | Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) | Enzyme electrode and the use thereof |
US5176632A (en) * | 1989-05-29 | 1993-01-05 | Ampliscientifica S.R.L. | Wearable artificial pancreas |
US5185256A (en) * | 1985-06-21 | 1993-02-09 | Matsushita Electric Industrial Co., Ltd. | Method for making a biosensor |
US5205920A (en) * | 1989-03-03 | 1993-04-27 | Noboru Oyama | Enzyme sensor and method of manufacturing the same |
US5208154A (en) * | 1991-04-08 | 1993-05-04 | The United States Of America As Represented By The Department Of Energy | Reversibly immobilized biological materials in monolayer films on electrodes |
US5236567A (en) * | 1989-05-31 | 1993-08-17 | Nakano Vinegar Co., Ltd. | Enzyme sensor |
US5262305A (en) * | 1991-03-04 | 1993-11-16 | E. Heller & Company | Interferant eliminating biosensors |
US5262035A (en) * | 1989-08-02 | 1993-11-16 | E. Heller And Company | Enzyme electrodes |
US5264105A (en) * | 1989-08-02 | 1993-11-23 | Gregg Brian A | Enzyme electrodes |
US5264104A (en) * | 1989-08-02 | 1993-11-23 | Gregg Brian A | Enzyme electrodes |
US5269891A (en) * | 1989-03-09 | 1993-12-14 | Novo Nordisk A/S | Method and apparatus for determination of a constituent in a fluid |
US5272087A (en) * | 1988-04-20 | 1993-12-21 | Centre National De La Recherche Scientifique (C.N.R.S.) | Enzymatic electrode and its preparation method |
US5286362A (en) * | 1990-02-03 | 1994-02-15 | Boehringer Mannheim Gmbh | Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor |
US5298411A (en) * | 1990-09-25 | 1994-03-29 | Toyo Boseki Kabushiki Kaisha | Glucose dehydrogenase from pseudomonas |
US5320725A (en) * | 1989-08-02 | 1994-06-14 | E. Heller & Company | Electrode and method for the detection of hydrogen peroxide |
US5356786A (en) * | 1991-03-04 | 1994-10-18 | E. Heller & Company | Interferant eliminating biosensor |
US5509410A (en) * | 1983-06-06 | 1996-04-23 | Medisense, Inc. | Strip electrode including screen printing of a single layer |
US5580527A (en) * | 1992-05-18 | 1996-12-03 | Moltech Corporation | Polymeric luminophores for sensing of oxygen |
US5589326A (en) * | 1993-12-30 | 1996-12-31 | Boehringer Mannheim Corporation | Osmium-containing redox mediator |
US5639672A (en) * | 1995-10-16 | 1997-06-17 | Lxn Corporation | Electrochemical determination of fructosamine |
US5682884A (en) * | 1983-05-05 | 1997-11-04 | Medisense, Inc. | Strip electrode with screen printing |
US5694932A (en) * | 1993-03-01 | 1997-12-09 | Disetronic Licensing Ag | Sensor array |
US5710011A (en) * | 1992-06-05 | 1998-01-20 | Medisense, Inc. | Mediators to oxidoreductase enzymes |
US5736188A (en) * | 1994-08-08 | 1998-04-07 | Alcock; Susan | Printed fluid transport devices |
US5746898A (en) * | 1990-08-10 | 1998-05-05 | Siemens Aktiengesellschaft | Electrochemical-enzymatic sensor |
US5795453A (en) * | 1996-01-23 | 1998-08-18 | Gilmartin; Markas A. T. | Electrodes and metallo isoindole ringed compounds |
US5830341A (en) * | 1996-01-23 | 1998-11-03 | Gilmartin; Markas A. T. | Electrodes and metallo isoindole ringed compounds |
US5863400A (en) * | 1994-04-14 | 1999-01-26 | Usf Filtration & Separations Group Inc. | Electrochemical cells |
US5922183A (en) * | 1997-06-23 | 1999-07-13 | Eic Laboratories, Inc. | Metal oxide matrix biosensors |
USRE36268E (en) * | 1988-03-15 | 1999-08-17 | Boehringer Mannheim Corporation | Method and apparatus for amperometric diagnostic analysis |
WO1999040848A1 (en) | 1998-02-17 | 1999-08-19 | Abbott Laboratories | Interstitial fluid collection and monitoring device |
US5942102A (en) * | 1995-11-16 | 1999-08-24 | Usf Filtration And Separations Group Inc. | Electrochemical method |
WO1999044508A1 (en) | 1998-03-06 | 1999-09-10 | Spectrx, Inc. | Integrated poration, harvesting and analysis device, and method therefor |
US5980709A (en) * | 1995-04-12 | 1999-11-09 | Usf Filtration And Separations Group | Method of defining an electrode area |
US6051392A (en) * | 1998-06-10 | 2000-04-18 | Matsushita Electric Industrial Co., Ltd. | Method for quantitating a substrate and measurement device used therefor |
US6059736A (en) * | 1998-02-24 | 2000-05-09 | Tapper; Robert | Sensor controlled analysis and therapeutic delivery system |
US6060327A (en) * | 1997-05-14 | 2000-05-09 | Keensense, Inc. | Molecular wire injection sensors |
US6071251A (en) * | 1996-12-06 | 2000-06-06 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US6077660A (en) * | 1998-06-10 | 2000-06-20 | Abbott Laboratories | Diagnostic assay requiring a small sample of biological fluid |
US6103033A (en) * | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
US6120676A (en) * | 1997-02-06 | 2000-09-19 | Therasense, Inc. | Method of using a small volume in vitro analyte sensor |
US6134461A (en) * | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US6162611A (en) * | 1993-12-02 | 2000-12-19 | E. Heller & Company | Subcutaneous glucose electrode |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6251260B1 (en) | 1998-08-24 | 2001-06-26 | Therasense, Inc. | Potentiometric sensors for analytic determination |
US6262264B1 (en) | 1998-06-01 | 2001-07-17 | Roche Diagnostics Corporation | Redox reversible imidazole osmium complex conjugates |
US6284125B1 (en) | 1995-06-19 | 2001-09-04 | Usf Filtration And Separations Group, Inc. | Electrochemical cell |
WO2001000865A3 (en) * | 1999-06-29 | 2001-09-13 | Drew Scient Ltd | Amperometric sensor |
US6299757B1 (en) | 1998-10-08 | 2001-10-09 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US6325917B1 (en) | 1997-08-13 | 2001-12-04 | Usf Filtration And Separations Group, Inc. | Method and apparatus for automatic analysis |
DE10032042A1 (en) * | 2000-07-05 | 2002-01-24 | Inventus Biotec Gesellschaft Fuer Innovative Bioanalytik, Biosensoren Und Diagnostika Mbh & Co. Kg | Disposable electrochemical biosensor for the quantitative determination of analyte concentrations in liquids |
US6377894B1 (en) | 1998-11-30 | 2002-04-23 | Abbott Laboratories | Analyte test instrument having improved calibration and communication processes |
US6413410B1 (en) | 1996-06-19 | 2002-07-02 | Lifescan, Inc. | Electrochemical cell |
WO2002006788A3 (en) * | 2000-07-14 | 2002-08-29 | Usf Filtration & Separations | Electrochemical method for measuring chemical reaction rates |
US6444115B1 (en) | 2000-07-14 | 2002-09-03 | Lifescan, Inc. | Electrochemical method for measuring chemical reaction rates |
US20020130043A1 (en) * | 1998-03-12 | 2002-09-19 | Alastair Hodges | Heated electrochemical cell |
US6475360B1 (en) | 1998-03-12 | 2002-11-05 | Lifescan, Inc. | Heated electrochemical cell |
US6521110B1 (en) | 1995-11-16 | 2003-02-18 | Lifescan, Inc. | Electrochemical cell |
US20030064525A1 (en) * | 1997-12-22 | 2003-04-03 | Liess Martin Dieter | Meter |
WO2003033726A1 (en) * | 2001-10-18 | 2003-04-24 | Drew Scientific Limited | Amperometric sensor |
US20030094384A1 (en) * | 2001-09-14 | 2003-05-22 | Vreeke Mark S. | Reagents and methods for detecting analytes, and devices comprising reagents for detecting analytes |
US20030096420A1 (en) * | 2001-11-07 | 2003-05-22 | Heller Zindel Herbert | Instrument |
US6572745B2 (en) | 2001-03-23 | 2003-06-03 | Virotek, L.L.C. | Electrochemical sensor and method thereof |
US6576102B1 (en) | 2001-03-23 | 2003-06-10 | Virotek, L.L.C. | Electrochemical sensor and method thereof |
US6591125B1 (en) | 2000-06-27 | 2003-07-08 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US6616819B1 (en) | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
US6632349B1 (en) | 1996-11-15 | 2003-10-14 | Lifescan, Inc. | Hemoglobin sensor |
US6638415B1 (en) | 1995-11-16 | 2003-10-28 | Lifescan, Inc. | Antioxidant sensor |
US6654625B1 (en) | 1999-06-18 | 2003-11-25 | Therasense, Inc. | Mass transport limited in vivo analyte sensor |
US6652734B1 (en) | 1999-03-16 | 2003-11-25 | Lifescan, Inc. | Sensor with improved shelf life |
US6694158B2 (en) * | 2001-04-11 | 2004-02-17 | Motorola, Inc. | System using a portable detection device for detection of an analyte through body tissue |
US6699667B2 (en) | 1997-05-14 | 2004-03-02 | Keensense, Inc. | Molecular wire injection sensors |
US6731984B2 (en) | 2001-06-07 | 2004-05-04 | Medtronic, Inc. | Method for providing a therapy to a patient involving modifying the therapy after detecting an onset of sleep in the patient, and implantable medical device embodying same |
US20040115412A1 (en) * | 2002-12-17 | 2004-06-17 | Richard Baron | Adhesive articles which contain at least one hydrophilic or hydrophobic layer, method for making and uses for same |
US20040134779A1 (en) * | 2003-01-13 | 2004-07-15 | Tien-Tsai Hsu | Strips for analyzing samples |
US20040137283A1 (en) * | 2002-10-18 | 2004-07-15 | Johna Leddy | Magnetically modified electrodes containing at least one catalyst component that mediates a subatomic particle transfer process |
US20040138543A1 (en) * | 2003-01-13 | 2004-07-15 | Russell Geoffrey A. | Assembly of single use sensing elements |
US6773671B1 (en) | 1998-11-30 | 2004-08-10 | Abbott Laboratories | Multichemistry measuring device and test strips |
US6773564B1 (en) | 1998-09-29 | 2004-08-10 | Matsushita Electric Industrial Co., Ltd. | Glucose sensor |
US20040176809A1 (en) * | 2001-06-07 | 2004-09-09 | Medtronic, Inc. | Method and apparatus for modifying delivery of a therapy in response to onset of sleep |
US20040260348A1 (en) * | 2003-06-19 | 2004-12-23 | Bakken Earl E. | Method and apparatus for temporarily varying a parameter in an implantable medical device |
US6863801B2 (en) | 1995-11-16 | 2005-03-08 | Lifescan, Inc. | Electrochemical cell |
US20050067278A1 (en) * | 2001-03-13 | 2005-03-31 | Koji Sode | Oxygen electrode |
US20050121826A1 (en) * | 2003-12-03 | 2005-06-09 | Kiamars Hajizadeh | Multi-sensor device for motorized meter and methods thereof |
US20050164328A1 (en) * | 2002-03-08 | 2005-07-28 | Susumu Kuwabata | Substrate determining method |
US20050196820A1 (en) * | 2004-03-03 | 2005-09-08 | Zweig Stephen E. | Apoenzyme reactivation electrochemical detection method and assay |
US20050203578A1 (en) * | 2001-08-15 | 2005-09-15 | Weiner Michael L. | Process and apparatus for treating biological organisms |
US6952604B2 (en) | 2001-12-21 | 2005-10-04 | Becton, Dickinson And Company | Minimally-invasive system and method for monitoring analyte levels |
US20050234315A1 (en) * | 2002-03-20 | 2005-10-20 | Avraham Mayevsky | Diagnosis of body metabolic emergency state |
US20050230252A1 (en) * | 2004-02-23 | 2005-10-20 | Tsai Fu H | Microfluidic test device |
US20050258050A1 (en) * | 2004-05-21 | 2005-11-24 | Agamatrix, Inc. | Connector configuration for electrochemical cells and meters for use in combination therewith |
US7005048B1 (en) | 1999-10-05 | 2006-02-28 | Matsushita Electric Industrial Co., Ltd. | Glucose sensor |
EP1630234A1 (en) * | 2004-08-31 | 2006-03-01 | Lifescan, Inc. | Electrochemical-based sensor with a redox polymer and redox enzyme entrapped by a dialysis membrane |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
US20060115857A1 (en) * | 1997-05-14 | 2006-06-01 | Keensense, Inc. | Molecular wire injection sensors |
US20060161055A1 (en) * | 2002-03-20 | 2006-07-20 | Critisense, Ltd. | Probe design |
US20060204399A1 (en) * | 2002-12-30 | 2006-09-14 | Freeman Dominique M | Method and apparatus using optical techniques to measure analyte levels |
US7182844B1 (en) | 2002-05-28 | 2007-02-27 | Michael Mallary | Lactose test apparatus |
US7198606B2 (en) | 2002-04-19 | 2007-04-03 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with analyte sensing |
AU2006203606B2 (en) * | 2000-07-14 | 2007-05-17 | Lifescan, Inc. | Electrochemical method for measuring chemical reaction rates |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20070131549A1 (en) * | 2005-12-14 | 2007-06-14 | Nova Biomedical Corporation | Glucose biosensor and method |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7244265B2 (en) | 2002-04-19 | 2007-07-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20070179366A1 (en) * | 2000-09-25 | 2007-08-02 | Critisense Ltd. | Apparatus and Method for Monitoring Tissue Vitality Parameters |
US7258693B2 (en) | 2002-04-19 | 2007-08-21 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7297151B2 (en) | 2002-04-19 | 2007-11-20 | Elikan Technologies, Inc. | Method and apparatus for body fluid sampling with improved sensing |
EP1867732A1 (en) * | 2001-09-14 | 2007-12-19 | Bayer Corporation | Reagents, methods and devices for detecting analytes |
US20070289880A1 (en) * | 2001-09-04 | 2007-12-20 | Zweig Stephen E | Apoenzyme reactivation electrochemical detection method and assay |
US7316700B2 (en) | 2001-06-12 | 2008-01-08 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7338639B2 (en) | 1997-12-22 | 2008-03-04 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
US7344894B2 (en) | 2001-10-16 | 2008-03-18 | Agilent Technologies, Inc. | Thermal regulation of fluidic samples within a diagnostic cartridge |
US20080099332A1 (en) * | 2006-10-31 | 2008-05-01 | Steve Scott | Analyte Monitoring Devices |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7374544B2 (en) | 2002-04-19 | 2008-05-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20080119709A1 (en) * | 2006-10-31 | 2008-05-22 | Yi Wang | Analyte Monitoring |
US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US7390667B2 (en) | 1997-12-22 | 2008-06-24 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using AC phase angle measurements |
US20080156662A1 (en) * | 2006-09-22 | 2008-07-03 | Bayer Healthcare Llc | Biosensor System Having Enhanced Stability And Hematocrit Performance |
US7407811B2 (en) | 1997-12-22 | 2008-08-05 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using AC excitation |
US7410468B2 (en) | 2002-04-19 | 2008-08-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20080234559A1 (en) * | 2006-12-26 | 2008-09-25 | Frederic Arbogast | Analyte Meter Protectors and Methods |
US7431820B2 (en) | 2001-10-10 | 2008-10-07 | Lifescan, Inc. | Electrochemical cell |
US7452457B2 (en) | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
WO2008157820A1 (en) | 2007-06-21 | 2008-12-24 | Abbott Diabetes Care, Inc. | Health management devices and methods |
US20090000959A1 (en) * | 2007-05-31 | 2009-01-01 | Feldman Benjamin J | Analyte determination methods and devices |
US7485128B2 (en) | 2002-04-19 | 2009-02-03 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7488601B2 (en) | 2003-06-20 | 2009-02-10 | Roche Diagnostic Operations, Inc. | System and method for determining an abused sensor during analyte measurement |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7524293B2 (en) | 2002-04-19 | 2009-04-28 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20090117574A1 (en) * | 2007-09-17 | 2009-05-07 | Siometrix Corporation | Self-actuating signal producing detection devices and methods |
US7537571B2 (en) | 2001-06-12 | 2009-05-26 | Pelikan Technologies, Inc. | Integrated blood sampling analysis system with multi-use sampling module |
US20090145775A1 (en) * | 2007-12-10 | 2009-06-11 | Bayer Healthcare Llc | Reagents and methods for detecting analytes |
US20090145756A1 (en) * | 2007-12-10 | 2009-06-11 | Bayer Healthcare Llc | Method of depositing reagent material in a test sensor |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20090162881A1 (en) * | 2005-11-14 | 2009-06-25 | Matsushita Electric Industrial Co., Ltd. | Method of measuring adenine nucleotide |
US20090171081A1 (en) * | 2007-12-10 | 2009-07-02 | Bayer Healthcare Llc | Process of making 3-phenylimino-3h-phenothiazine or 3-phenylimino-3h-phenoxazine mediator |
US7556723B2 (en) | 2004-06-18 | 2009-07-07 | Roche Diagnostics Operations, Inc. | Electrode design for biosensor |
US7563232B2 (en) | 2002-04-19 | 2009-07-21 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20090184004A1 (en) | 2008-01-17 | 2009-07-23 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
US7569126B2 (en) | 2004-06-18 | 2009-08-04 | Roche Diagnostics Operations, Inc. | System and method for quality assurance of a biosensor test strip |
US7597793B2 (en) | 2003-06-20 | 2009-10-06 | Roche Operations Ltd. | System and method for analyte measurement employing maximum dosing time delay |
US7604721B2 (en) | 2003-06-20 | 2009-10-20 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US7604592B2 (en) | 2003-06-13 | 2009-10-20 | Pelikan Technologies, Inc. | Method and apparatus for a point of care device |
US7613491B2 (en) | 2002-05-22 | 2009-11-03 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US7645421B2 (en) | 2003-06-20 | 2010-01-12 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US7645373B2 (en) | 2003-06-20 | 2010-01-12 | Roche Diagnostic Operations, Inc. | System and method for coding information on a biosensor test strip |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US20100015860A1 (en) * | 2008-07-17 | 2010-01-21 | Abbott Diabetes Care, Inc. | Strip connectors for measurement devices |
EP2154534A1 (en) | 1998-11-30 | 2010-02-17 | Abbott Laboratories | Multichemistry measuring device and test strips |
US7666149B2 (en) | 1997-12-04 | 2010-02-23 | Peliken Technologies, Inc. | Cassette of lancet cartridges for sampling blood |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7682318B2 (en) | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
US7699791B2 (en) | 2001-06-12 | 2010-04-20 | Pelikan Technologies, Inc. | Method and apparatus for improving success rate of blood yield from a fingerstick |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7718439B2 (en) | 2003-06-20 | 2010-05-18 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
AU2007209797B2 (en) * | 2000-07-14 | 2010-06-03 | Lifescan, Inc. | Electrochemical method for measuring chemical reaction rates |
US7749174B2 (en) | 2001-06-12 | 2010-07-06 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge |
US7761130B2 (en) | 2003-07-25 | 2010-07-20 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US20100198188A1 (en) * | 2009-02-05 | 2010-08-05 | Abbott Diabetes Care Inc. | Devices and Methods for Metering Insoluble Active Agent Particles |
WO2010091005A1 (en) | 2009-02-03 | 2010-08-12 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US7780631B2 (en) | 1998-03-30 | 2010-08-24 | Pelikan Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US7792562B2 (en) | 1997-03-04 | 2010-09-07 | Dexcom, Inc. | Device and method for determining analyte levels |
US7811231B2 (en) | 2002-12-31 | 2010-10-12 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US20100274181A1 (en) * | 2009-04-28 | 2010-10-28 | Abbott Diabetes Care Inc. | Smart sensor ports and methods of using same |
US7828728B2 (en) | 2003-07-25 | 2010-11-09 | Dexcom, Inc. | Analyte sensor |
US20100290956A1 (en) * | 2009-05-14 | 2010-11-18 | Abbott Diabetes Care Inc. | Cap-linked test strip carrier for vial augmentation |
WO2010138817A1 (en) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Glucose monitoring system with wireless communications |
WO2010141922A1 (en) | 2009-06-04 | 2010-12-09 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7862520B2 (en) | 2002-04-19 | 2011-01-04 | Pelikan Technologies, Inc. | Body fluid sampling module with a continuous compression tissue interface surface |
US20110011752A1 (en) * | 2006-03-31 | 2011-01-20 | Lifescan, Inc. | Systems and methods for discriminating contorl solution from a physiological sample |
US7885697B2 (en) | 2004-07-13 | 2011-02-08 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20110040164A1 (en) * | 2009-08-11 | 2011-02-17 | Analyte Sensor Ports | Analyte Sensor Ports |
US7892185B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US20110048940A1 (en) * | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Small volume test strips with large sample fill ports, supported test strips, and methods of making and using same |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7920907B2 (en) | 2006-06-07 | 2011-04-05 | Abbott Diabetes Care Inc. | Analyte monitoring system and method |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
WO2011053881A1 (en) | 2009-10-30 | 2011-05-05 | Abbott Diabetes Care Inc. | Method and apparatus for detecting false hypoglycemic conditions |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7976778B2 (en) | 2001-04-02 | 2011-07-12 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus |
US20110184264A1 (en) * | 2010-01-28 | 2011-07-28 | Abbott Diabetes Care Inc. | Universal Test Strip Port |
WO2011119896A1 (en) | 2010-03-24 | 2011-09-29 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
WO2011130545A1 (en) | 2010-04-16 | 2011-10-20 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US8050731B2 (en) | 2002-05-22 | 2011-11-01 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US8058077B2 (en) | 2003-06-20 | 2011-11-15 | Roche Diagnostics Operations, Inc. | Method for coding information on a biosensor test strip |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US8071384B2 (en) | 1997-12-22 | 2011-12-06 | Roche Diagnostics Operations, Inc. | Control and calibration solutions and methods for their use |
WO2012006210A2 (en) | 2010-07-07 | 2012-01-12 | Agamatrix, Inc. | Analyte test strip and analyte meter device |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US8148164B2 (en) | 2003-06-20 | 2012-04-03 | Roche Diagnostics Operations, Inc. | System and method for determining the concentration of an analyte in a sample fluid |
US8149117B2 (en) | 2007-05-08 | 2012-04-03 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
WO2012058237A1 (en) | 2010-10-26 | 2012-05-03 | Abbott Diabetes Care Inc. | Analyte measurement devices and systems, and components and methods related thereto |
USRE43399E1 (en) | 2003-07-25 | 2012-05-22 | Dexcom, Inc. | Electrode systems for electrochemical sensors |
US8197421B2 (en) | 2002-04-19 | 2012-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8206565B2 (en) | 2003-06-20 | 2012-06-26 | Roche Diagnostics Operation, Inc. | System and method for coding information on a biosensor test strip |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8255030B2 (en) | 2003-07-25 | 2012-08-28 | Dexcom, Inc. | Oxygen enhancing membrane systems for implantable devices |
US8262614B2 (en) | 2003-05-30 | 2012-09-11 | Pelikan Technologies, Inc. | Method and apparatus for fluid injection |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US8277713B2 (en) | 2004-05-03 | 2012-10-02 | Dexcom, Inc. | Implantable analyte sensor |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US8290559B2 (en) | 2007-12-17 | 2012-10-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8287454B2 (en) | 1998-04-30 | 2012-10-16 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
WO2012154286A1 (en) | 2011-02-28 | 2012-11-15 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US8333714B2 (en) | 2006-09-10 | 2012-12-18 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US8337421B2 (en) | 2001-06-12 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
USD680454S1 (en) | 2011-10-25 | 2013-04-23 | Abbott Diabetes Care Inc. | Analyte meter and strip port |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
WO2013093888A1 (en) * | 2011-12-23 | 2013-06-27 | Schlumberger Technology B.V. | Electrochemical sensors |
US8509871B2 (en) | 2001-07-27 | 2013-08-13 | Dexcom, Inc. | Sensor head for use with implantable devices |
US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US8545403B2 (en) | 2005-12-28 | 2013-10-01 | Abbott Diabetes Care Inc. | Medical device insertion |
US8551320B2 (en) | 2008-06-09 | 2013-10-08 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
US8560039B2 (en) | 2008-09-19 | 2013-10-15 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
US8556829B2 (en) | 2002-04-19 | 2013-10-15 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8562558B2 (en) | 2007-06-08 | 2013-10-22 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US8571624B2 (en) | 2004-12-29 | 2013-10-29 | Abbott Diabetes Care Inc. | Method and apparatus for mounting a data transmission device in a communication system |
WO2013163342A1 (en) | 2012-04-24 | 2013-10-31 | Abbott Diabetes Care Inc. | Methods of lag-compensation for analyte measurements, and devices related thereto |
US8583204B2 (en) | 2008-03-28 | 2013-11-12 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8602991B2 (en) | 2005-08-30 | 2013-12-10 | Abbott Diabetes Care Inc. | Analyte sensor introducer and methods of use |
US8612159B2 (en) | 1998-04-30 | 2013-12-17 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8613703B2 (en) | 2007-05-31 | 2013-12-24 | Abbott Diabetes Care Inc. | Insertion devices and methods |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US8652043B2 (en) | 2001-01-02 | 2014-02-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US8682408B2 (en) | 2008-03-28 | 2014-03-25 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8685714B2 (en) | 2000-07-14 | 2014-04-01 | Universal Biosensors Pty Ltd | Immunosensor |
US8702928B2 (en) | 2010-11-22 | 2014-04-22 | Abbott Diabetes Care Inc. | Modular analyte measurement system with extendable strip port |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US8721671B2 (en) | 2001-06-12 | 2014-05-13 | Sanofi-Aventis Deutschland Gmbh | Electric lancet actuator |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
US8771183B2 (en) | 2004-02-17 | 2014-07-08 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US8778168B2 (en) | 2007-09-28 | 2014-07-15 | Lifescan, Inc. | Systems and methods of discriminating control solution from a physiological sample |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
WO2014145049A2 (en) | 2013-03-15 | 2014-09-18 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US8852101B2 (en) | 2005-12-28 | 2014-10-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US8887911B2 (en) | 2011-12-09 | 2014-11-18 | Abbott Diabetes Care Inc. | Packages and kits for analyte monitoring devices, and methods related thereto |
US8929968B2 (en) | 2003-12-05 | 2015-01-06 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8993331B2 (en) | 2009-08-31 | 2015-03-31 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
US9031630B2 (en) | 2006-02-28 | 2015-05-12 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
US9046479B2 (en) | 2008-06-24 | 2015-06-02 | Panasonic Healthcare Holdings Co., Ltd. | Biosensor, method of producing the same and detection system comprising the same |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9085790B2 (en) | 2010-07-28 | 2015-07-21 | Abbott Diabetes Care Inc. | Analyte sensors having temperature independent membranes |
US9113828B2 (en) | 2006-10-25 | 2015-08-25 | Abbott Diabetes Care Inc. | Method and system for providing analyte monitoring |
US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9144401B2 (en) | 2003-06-11 | 2015-09-29 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US9198623B2 (en) | 2010-04-22 | 2015-12-01 | Abbott Diabetes Care Inc. | Devices, systems, and methods related to analyte monitoring and management |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9259175B2 (en) | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US9289164B2 (en) | 2011-06-30 | 2016-03-22 | Abbott Diabetes Care Inc. | Methods for generating hybrid analyte level output, and devices and systems related thereto |
EP3001194A1 (en) | 2009-08-31 | 2016-03-30 | Abbott Diabetes Care, Inc. | Medical devices and methods |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9314195B2 (en) | 2009-08-31 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US9320466B2 (en) | 2009-07-02 | 2016-04-26 | Dexcom, Inc. | Analyte sensor |
US9320432B2 (en) | 2010-04-16 | 2016-04-26 | Abbott Diabetes Care Inc. | Analyte meter communication module |
US9320461B2 (en) | 2009-09-29 | 2016-04-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
US9326707B2 (en) | 2008-11-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Alarm characterization for analyte monitoring devices and systems |
US9339229B2 (en) | 2009-02-26 | 2016-05-17 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods |
US9351669B2 (en) | 2009-09-30 | 2016-05-31 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US9398882B2 (en) | 2005-09-30 | 2016-07-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor and data processing device |
US9402570B2 (en) | 2011-12-11 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9439589B2 (en) | 1997-03-04 | 2016-09-13 | Dexcom, Inc. | Device and method for determining analyte levels |
US20160281077A1 (en) * | 2015-03-26 | 2016-09-29 | Euglena Co., Ltd. | Medium and method for culturing euglena and method for reducing photoinhibition in euglena |
US9474475B1 (en) | 2013-03-15 | 2016-10-25 | Abbott Diabetes Care Inc. | Multi-rate analyte sensor data collection with sample rate configurable signal processing |
US9501272B2 (en) | 2010-05-24 | 2016-11-22 | Abbott Diabetes Care Inc. | Systems and methods for updating a medical device |
US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
US9541556B2 (en) | 2008-05-30 | 2017-01-10 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
WO2017011346A1 (en) | 2015-07-10 | 2017-01-19 | Abbott Diabetes Care Inc. | System, device and method of dynamic glucose profile response to physiological parameters |
US9572534B2 (en) | 2010-06-29 | 2017-02-21 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US9622691B2 (en) | 2011-10-31 | 2017-04-18 | Abbott Diabetes Care Inc. | Model based variable risk false glucose threshold alarm prevention mechanism |
US9622689B2 (en) | 2011-09-28 | 2017-04-18 | Abbott Diabetes Care Inc. | Methods for analyte monitoring management and analyte measurement data management, and articles of manufacture related thereto |
US9636450B2 (en) | 2007-02-19 | 2017-05-02 | Udo Hoss | Pump system modular components for delivering medication and analyte sensing at seperate insertion sites |
US9662056B2 (en) | 2008-09-30 | 2017-05-30 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US9668684B2 (en) | 2009-02-26 | 2017-06-06 | Abbott Diabetes Care Inc. | Self-powered analyte sensor |
US9675290B2 (en) | 2012-10-30 | 2017-06-13 | Abbott Diabetes Care Inc. | Sensitivity calibration of in vivo sensors used to measure analyte concentration |
US9713440B2 (en) | 2010-12-08 | 2017-07-25 | Abbott Diabetes Care Inc. | Modular analyte measurement systems, modular components thereof and related methods |
TWI593964B (en) * | 2016-08-26 | 2017-08-01 | 超極生技股份有限公司 | Probe type detecting device and module |
US9743862B2 (en) | 2011-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Systems and methods for transcutaneously implanting medical devices |
US9760679B2 (en) | 2011-02-11 | 2017-09-12 | Abbott Diabetes Care Inc. | Data synchronization between two or more analyte detecting devices in a database |
US9763609B2 (en) | 2003-07-25 | 2017-09-19 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9788771B2 (en) | 2006-10-23 | 2017-10-17 | Abbott Diabetes Care Inc. | Variable speed sensor insertion devices and methods of use |
US9795326B2 (en) | 2009-07-23 | 2017-10-24 | Abbott Diabetes Care Inc. | Continuous analyte measurement systems and systems and methods for implanting them |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9863942B2 (en) | 2002-03-21 | 2018-01-09 | Universal Biosensors Pty Ltd | Biosensor apparatus and methods of use |
US9882660B2 (en) | 2006-10-26 | 2018-01-30 | Abbott Diabetes Care Inc. | Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors |
US9907492B2 (en) | 2012-09-26 | 2018-03-06 | Abbott Diabetes Care Inc. | Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data |
US9913600B2 (en) | 2007-06-29 | 2018-03-13 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
US9913599B2 (en) | 2011-02-11 | 2018-03-13 | Abbott Diabetes Care Inc. | Software applications residing on handheld analyte determining devices |
US9931075B2 (en) | 2008-05-30 | 2018-04-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US9974472B2 (en) | 2011-06-16 | 2018-05-22 | Abbott Diabetes Care Inc. | Temperature-compensated analyte monitoring devices, systems, and methods thereof |
US9980669B2 (en) | 2011-11-07 | 2018-05-29 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US9986942B2 (en) | 2004-07-13 | 2018-06-05 | Dexcom, Inc. | Analyte sensor |
US10004439B2 (en) | 2012-09-21 | 2018-06-26 | Abbott Diabetes Care Inc. | In vivo sensors having ceria nanoparticle electrodes |
US10010273B2 (en) | 2011-03-10 | 2018-07-03 | Abbott Diabetes Care, Inc. | Multi-function analyte monitor device and methods of use |
US10028680B2 (en) | 2006-04-28 | 2018-07-24 | Abbott Diabetes Care Inc. | Introducer assembly and methods of use |
US10076285B2 (en) | 2013-03-15 | 2018-09-18 | Abbott Diabetes Care Inc. | Sensor fault detection using analyte sensor data pattern comparison |
US10078380B2 (en) | 2010-03-10 | 2018-09-18 | Abbott Diabetes Care Inc. | Systems, devices and methods for managing glucose levels |
US10089446B2 (en) | 2009-01-29 | 2018-10-02 | Abbott Diabetes Care Inc. | Method and device for providing offset model based calibration for analyte sensor |
EP3381360A1 (en) | 2011-09-28 | 2018-10-03 | Abbott Diabetes Care, Inc. | Methods, devices and systems for analyte monitoring management |
US10092229B2 (en) | 2010-06-29 | 2018-10-09 | Abbott Diabetes Care Inc. | Calibration of analyte measurement system |
US10117614B2 (en) | 2006-02-28 | 2018-11-06 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US10159433B2 (en) | 2006-02-28 | 2018-12-25 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
US10188794B2 (en) | 2008-08-31 | 2019-01-29 | Abbott Diabetes Care Inc. | Closed loop control and signal attenuation detection |
US10194850B2 (en) | 2005-08-31 | 2019-02-05 | Abbott Diabetes Care Inc. | Accuracy of continuous glucose sensors |
US10194863B2 (en) | 2005-09-30 | 2019-02-05 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
US10213141B2 (en) | 2013-04-30 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for energy efficient electrical device activation |
US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
US10226207B2 (en) | 2004-12-29 | 2019-03-12 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
EP3473167A1 (en) | 2007-06-21 | 2019-04-24 | Abbott Diabetes Care, Inc. | Health monitor |
US10328201B2 (en) | 2008-07-14 | 2019-06-25 | Abbott Diabetes Care Inc. | Closed loop control system interface and methods |
US10433773B1 (en) | 2013-03-15 | 2019-10-08 | Abbott Diabetes Care Inc. | Noise rejection methods and apparatus for sparsely sampled analyte sensor data |
US10555695B2 (en) | 2011-04-15 | 2020-02-11 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US10610135B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10674944B2 (en) | 2015-05-14 | 2020-06-09 | Abbott Diabetes Care Inc. | Compact medical device inserters and related systems and methods |
US10685749B2 (en) | 2007-12-19 | 2020-06-16 | Abbott Diabetes Care Inc. | Insulin delivery apparatuses capable of bluetooth data transmission |
EP3714788A1 (en) | 2009-02-26 | 2020-09-30 | Abbott Diabetes Care, Inc. | Improved analyte sensors and methods of making and using the same |
US10791928B2 (en) | 2007-05-18 | 2020-10-06 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US10813577B2 (en) | 2005-06-21 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
USD902408S1 (en) | 2003-11-05 | 2020-11-17 | Abbott Diabetes Care Inc. | Analyte sensor control unit |
US10835672B2 (en) | 2004-02-26 | 2020-11-17 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US10872696B2 (en) | 2011-02-11 | 2020-12-22 | Abbott Diabetes Care Inc. | Method of hypoglycemia risk determination |
US10874338B2 (en) | 2010-06-29 | 2020-12-29 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US10888272B2 (en) | 2015-07-10 | 2021-01-12 | Abbott Diabetes Care Inc. | Systems, devices, and methods for meal information collection, meal assessment, and analyte data correlation |
US10963417B2 (en) | 2004-06-04 | 2021-03-30 | Abbott Diabetes Care Inc. | Systems and methods for managing diabetes care data |
US10966609B2 (en) | 2004-02-26 | 2021-04-06 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US11000215B1 (en) | 2003-12-05 | 2021-05-11 | Dexcom, Inc. | Analyte sensor |
US11054379B2 (en) | 2018-05-22 | 2021-07-06 | Strella Biotechnology, Inc. | Electrochemical ethylene biosensor |
USD924406S1 (en) | 2010-02-01 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
US11071478B2 (en) | 2017-01-23 | 2021-07-27 | Abbott Diabetes Care Inc. | Systems, devices and methods for analyte sensor insertion |
US11229382B2 (en) | 2013-12-31 | 2022-01-25 | Abbott Diabetes Care Inc. | Self-powered analyte sensor and devices using the same |
US11246990B2 (en) | 2004-02-26 | 2022-02-15 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
US11350862B2 (en) | 2017-10-24 | 2022-06-07 | Dexcom, Inc. | Pre-connected analyte sensors |
US11399745B2 (en) | 2006-10-04 | 2022-08-02 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US11717225B2 (en) | 2014-03-30 | 2023-08-08 | Abbott Diabetes Care Inc. | Method and apparatus for determining meal start and peak events in analyte monitoring systems |
US11730407B2 (en) | 2008-03-28 | 2023-08-22 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US11793936B2 (en) | 2009-05-29 | 2023-10-24 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
USD1015366S1 (en) | 2020-07-29 | 2024-02-20 | Abbott Diabetes Care Inc. | Display screen or portion thereof with graphical user interface |
US12239463B2 (en) | 2020-08-31 | 2025-03-04 | Abbott Diabetes Care Inc. | Systems, devices, and methods for analyte sensor insertion |
US12315630B2 (en) | 2023-02-28 | 2025-05-27 | Abbott Diabetes Care Inc. | Medical devices and methods |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60162957A (en) * | 1984-02-03 | 1985-08-24 | Kyowa Medetsukusu Kk | Method for measuring ceruloplasmin activity |
GB8504522D0 (en) * | 1985-02-21 | 1985-03-27 | Genetics Int Inc | Electrochemistry of mediators |
CA1249333A (en) * | 1985-06-28 | 1989-01-24 | James E. Jones | Electrochemical sensor and membrane therefor |
GB8523631D0 (en) * | 1985-09-25 | 1985-10-30 | Pena Ltd Paul De | Bioelectrochemical cell |
CA1254945A (en) * | 1986-02-27 | 1989-05-30 | Marco F. Cardosi | Application of tetrathiafulvalenes in bioelectrochemical processes |
GB8608700D0 (en) * | 1986-04-10 | 1986-05-14 | Genetics Int Inc | Measurement of electroactive species in solution |
GB8618022D0 (en) | 1986-07-23 | 1986-08-28 | Unilever Plc | Electrochemical measurements |
EP0278647A3 (en) * | 1987-02-09 | 1989-09-20 | AT&T Corp. | Electronchemical processes involving enzymes |
JPH021535A (en) * | 1987-10-05 | 1990-01-05 | Arden Medical Syst Inc | Sensor for measuring chemical seed allowing dehydrogenation from enzyme in aqueous solution |
GB2217447A (en) * | 1988-04-21 | 1989-10-25 | Atomic Energy Authority Uk | Bonding to metal surfaces |
GR880100664A (en) * | 1988-10-05 | 1994-03-31 | Arden Medical Systems Inc | Sensor for measurement of enzyme hydrogenetable/dehydrogenetable chemical species in aqueous solutions |
DE68925104T2 (en) * | 1988-10-07 | 1996-05-09 | Medisense Inc | Amperometric sensor |
DE4003194A1 (en) * | 1990-02-03 | 1991-08-08 | Boehringer Mannheim Gmbh | METHOD AND SENSOR ELECTRODE SYSTEM FOR THE ELECTROCHEMICAL DETERMINATION OF AN ANALYT, OR AN OXIDOR REDUCTASE, AND USE OF SUITABLE COMPOUNDS THEREFOR |
JPH06503472A (en) * | 1990-10-10 | 1994-04-21 | ノボ ノルディスク アクティーゼルスカブ | Utilization of benzene derivatives as charge transfer mediators |
FI905324A7 (en) * | 1990-10-29 | 1992-04-30 | Valtion Teknillinen | ENZYMATISKT BESTAEMNINGSFOERFARANDE FOER ALDOSER. |
GB0205455D0 (en) | 2002-03-07 | 2002-04-24 | Molecular Sensing Plc | Nucleic acid probes, their synthesis and use |
US9474282B2 (en) * | 2013-12-13 | 2016-10-25 | Tony John Hall | Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses |
CA2987770C (en) | 2015-06-08 | 2024-02-20 | Myco Sciences Limited | Antimicrobial and agrochemical compositions |
CN112955569B (en) * | 2018-10-19 | 2024-04-09 | 豪夫迈·罗氏有限公司 | Electric field-assisted binding for sequencing |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE154041C (en) * | ||||
US3438033A (en) * | 1968-01-30 | 1969-04-08 | United Aircraft Corp | Doppler resolution of interferometer ambiguities |
US3506544A (en) * | 1964-10-09 | 1970-04-14 | Magna Corp | Method of determining microbial populations,enzyme activities,and substrate concentrations by electrochemical analysis |
US3591480A (en) * | 1968-07-15 | 1971-07-06 | Ibm | Glucose measuring system |
US3623960A (en) * | 1970-04-07 | 1971-11-30 | Monsanto Res Corp | Glucose determination method |
US3770607A (en) * | 1970-04-07 | 1973-11-06 | Secretary | Glucose determination apparatus |
US4005002A (en) * | 1973-08-06 | 1977-01-25 | Hoffmann-La Roche Inc. | Apparatus for measuring substrate concentrations |
US4129478A (en) * | 1974-08-01 | 1978-12-12 | Hoffmann-La Roche Inc. | Method for measuring substrate concentrations |
US4144143A (en) * | 1977-10-25 | 1979-03-13 | Virginia Commonwealth University | Electrolytic production of stable methyl viologen film |
JPS5510583A (en) * | 1978-07-10 | 1980-01-25 | Matsushita Electric Ind Co Ltd | Enzyme electrode and its manufacture |
JPS5510584A (en) * | 1978-07-10 | 1980-01-25 | Matsushita Electric Ind Co Ltd | Enzyme electrode and its manufacture |
JPS5510581A (en) * | 1978-07-10 | 1980-01-25 | Matsushita Electric Ind Co Ltd | Enzyem electrode |
US4224125A (en) * | 1977-09-28 | 1980-09-23 | Matsushita Electric Industrial Co., Ltd. | Enzyme electrode |
JPS55124060A (en) * | 1979-03-16 | 1980-09-24 | Matsushita Electric Ind Co Ltd | Enzyme electrode |
US4356074A (en) * | 1980-08-25 | 1982-10-26 | The Yellow Springs Instrument Company, Inc. | Substrate specific galactose oxidase enzyme electrodes |
US4388166A (en) * | 1979-08-14 | 1983-06-14 | Tokyo Shibaura Denki Kabushiki Kaisha | Electrochemical measuring apparatus provided with an enzyme electrode |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4233144A (en) * | 1979-04-16 | 1980-11-11 | Technicon Instruments Corporation | Electrode for voltammetric immunoassay |
US4293310A (en) * | 1980-03-14 | 1981-10-06 | University Of Pittsburgh | Photoelectrochemical immunoassay |
DE3278334D1 (en) * | 1981-10-23 | 1988-05-19 | Genetics Int Inc | Sensor for components of a liquid mixture |
-
1984
- 1984-05-04 CA CA000453581A patent/CA1219040A/en not_active Expired
- 1984-05-07 US US06/607,699 patent/US4711245A/en not_active Expired - Lifetime
- 1984-05-08 EP EP84303087A patent/EP0125137B1/en not_active Expired
- 1984-05-08 DE DE8484303087T patent/DE3483019D1/en not_active Expired - Lifetime
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE154041C (en) * | ||||
US3506544A (en) * | 1964-10-09 | 1970-04-14 | Magna Corp | Method of determining microbial populations,enzyme activities,and substrate concentrations by electrochemical analysis |
US3438033A (en) * | 1968-01-30 | 1969-04-08 | United Aircraft Corp | Doppler resolution of interferometer ambiguities |
US3591480A (en) * | 1968-07-15 | 1971-07-06 | Ibm | Glucose measuring system |
US3623960A (en) * | 1970-04-07 | 1971-11-30 | Monsanto Res Corp | Glucose determination method |
US3770607A (en) * | 1970-04-07 | 1973-11-06 | Secretary | Glucose determination apparatus |
US4005002A (en) * | 1973-08-06 | 1977-01-25 | Hoffmann-La Roche Inc. | Apparatus for measuring substrate concentrations |
US4129478A (en) * | 1974-08-01 | 1978-12-12 | Hoffmann-La Roche Inc. | Method for measuring substrate concentrations |
US4224125A (en) * | 1977-09-28 | 1980-09-23 | Matsushita Electric Industrial Co., Ltd. | Enzyme electrode |
US4144143A (en) * | 1977-10-25 | 1979-03-13 | Virginia Commonwealth University | Electrolytic production of stable methyl viologen film |
JPS5510583A (en) * | 1978-07-10 | 1980-01-25 | Matsushita Electric Ind Co Ltd | Enzyme electrode and its manufacture |
JPS5510584A (en) * | 1978-07-10 | 1980-01-25 | Matsushita Electric Ind Co Ltd | Enzyme electrode and its manufacture |
JPS5510581A (en) * | 1978-07-10 | 1980-01-25 | Matsushita Electric Ind Co Ltd | Enzyem electrode |
JPS55124060A (en) * | 1979-03-16 | 1980-09-24 | Matsushita Electric Ind Co Ltd | Enzyme electrode |
US4388166A (en) * | 1979-08-14 | 1983-06-14 | Tokyo Shibaura Denki Kabushiki Kaisha | Electrochemical measuring apparatus provided with an enzyme electrode |
US4356074A (en) * | 1980-08-25 | 1982-10-26 | The Yellow Springs Instrument Company, Inc. | Substrate specific galactose oxidase enzyme electrodes |
Non-Patent Citations (22)
Title |
---|
Chao et al., (1983), J. Am. Chem. Soc. 105:181 188. * |
Chao et al., (1983), J. Am. Chem. Soc. 105:181-188. |
Chem. Abstracts (1983), vol. 98:80429h. * |
Epton et al., (1978), J. Organometallic Chemistry 149:231 244. * |
Epton et al., (1978), J. Organometallic Chemistry 149:231-244. |
Fujihira et al., (1974), Biochemical and Biophysical Research Communications 61(2):538 543. * |
Fujihira et al., (1974), Biochemical and Biophysical Research Communications 61(2):538-543. |
Hinkle (1973), Federation Proceedings 32(9):1988 1992. * |
Hinkle (1973), Federation Proceedings 32(9):1988-1992. |
Pladziewicz et al., (1983), J. Am. Chem. Soc. 104:3544 3545. * |
Pladziewicz et al., (1983), J. Am. Chem. Soc. 104:3544-3545. |
Plotkin et al., "Methanol Dehydrogenase Bioelectrochemical Cell and Cell and Alcohol Detector", Biotechnology Letters, 3, (No. 4): 187, (1981). |
Plotkin et al., Methanol Dehydrogenase Bioelectrochemical Cell and Cell and Alcohol Detector , Biotechnology Letters, 3, (No. 4): 187, (1981). * |
Shinbo et al., Potentiometric Enzyme Electrode for Lactate, Am. Chem. Soc. 51, No. 1): 100 101, (1978). * |
Shinbo et al., Potentiometric Enzyme Electrode for Lactate, Am. Chem. Soc. 51, No. 1): 100-101, (1978). |
Szentrimay et al. in D. Sawyer (ed.), Electrochemical Studies of Biological Systems, Ch. 6, p. 143, (Am. Chem. Soc., Wash. DC 1977). * |
Willman et al., (1983), Anal. Chem. 55:1139 1142. * |
Willman et al., (1983), Anal. Chem. 55:1139-1142. |
Wingard et al., "Direct Coupling of Glucose Oxidase to Platinum and Possible Use for In Vivo Glucose Determination", Journal of Solid-Phase Biochemistry, 4, (No. 4): 253, (1979). |
Wingard et al., Direct Coupling of Glucose Oxidase to Platinum and Possible Use for In Vivo Glucose Determination , Journal of Solid Phase Biochemistry, 4, (No. 4): 253, (1979). * |
Yeh et al., (1976), J. Electrochemical Society 123:1334 1339. * |
Yeh et al., (1976), J. Electrochemical Society 123:1334-1339. |
Cited By (1187)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5682884A (en) * | 1983-05-05 | 1997-11-04 | Medisense, Inc. | Strip electrode with screen printing |
US5727548A (en) * | 1983-05-05 | 1998-03-17 | Medisense, Inc. | Strip electrode with screen printing |
US5820551A (en) * | 1983-05-05 | 1998-10-13 | Hill; Hugh Allen Oliver | Strip electrode with screen printing |
US5509410A (en) * | 1983-06-06 | 1996-04-23 | Medisense, Inc. | Strip electrode including screen printing of a single layer |
US4840893A (en) * | 1983-12-16 | 1989-06-20 | Medisense, Inc. | Electrochemical assay for nucleic acids and nucleic acid probes |
US5149630A (en) * | 1984-01-26 | 1992-09-22 | Forrest Gordon C | Methods of assay |
US4929313A (en) * | 1984-11-23 | 1990-05-29 | Massachusetts Institute Of Technology | Amperometric electrochemical ion sensors and method for determining ion concentration |
US4836904A (en) * | 1985-03-28 | 1989-06-06 | Medisense, Inc. | Graphite electrode with modified surface |
US5185256A (en) * | 1985-06-21 | 1993-02-09 | Matsushita Electric Industrial Co., Ltd. | Method for making a biosensor |
US4897173A (en) * | 1985-06-21 | 1990-01-30 | Matsushita Electric Industrial Co., Ltd. | Biosensor and method for making the same |
US4876195A (en) * | 1985-12-26 | 1989-10-24 | Takeda Chemical Industries, Ltd. | Process for producing 2-keto-D-glucaric acid |
US4968400A (en) * | 1986-11-20 | 1990-11-06 | Terumo Kabushiki Kaisha | Enzyme sensor |
US5149629A (en) * | 1987-04-07 | 1992-09-22 | Ramot University Authority For Applied Research And Industrial Development Ltd. | Coulometric assay system |
AU600832B2 (en) * | 1987-06-05 | 1990-08-23 | Monsanto Company | Oxygen-stable substituted ferrocene reference electrode |
US4857167A (en) * | 1987-06-05 | 1989-08-15 | Monsanto Company | Oxygen-stable substituted ferrocene reference electrode |
USRE36268E (en) * | 1988-03-15 | 1999-08-17 | Boehringer Mannheim Corporation | Method and apparatus for amperometric diagnostic analysis |
US5030334A (en) * | 1988-03-31 | 1991-07-09 | Orbisphere Laboratories, Inc. | Ozone measuring method |
US4956063A (en) * | 1988-03-31 | 1990-09-11 | Orbisphere Laboratories (Inc.) | Ozone measuring method |
US5272087A (en) * | 1988-04-20 | 1993-12-21 | Centre National De La Recherche Scientifique (C.N.R.S.) | Enzymatic electrode and its preparation method |
US5063149A (en) * | 1988-08-04 | 1991-11-05 | Imperial Chemical Industries Plc | Performing an enzyme-catalyzed reaction |
US4997541A (en) * | 1988-12-10 | 1991-03-05 | Dragerwerk Aktiengesellschaft | Dosimeter having a reusable electrochemical measuring cell |
US5205920A (en) * | 1989-03-03 | 1993-04-27 | Noboru Oyama | Enzyme sensor and method of manufacturing the same |
US5269891A (en) * | 1989-03-09 | 1993-12-14 | Novo Nordisk A/S | Method and apparatus for determination of a constituent in a fluid |
US5089112A (en) * | 1989-03-20 | 1992-02-18 | Associated Universities, Inc. | Electrochemical biosensor based on immobilized enzymes and redox polymers |
US4953552A (en) * | 1989-04-21 | 1990-09-04 | Demarzo Arthur P | Blood glucose monitoring system |
US5176632A (en) * | 1989-05-29 | 1993-01-05 | Ampliscientifica S.R.L. | Wearable artificial pancreas |
US5236567A (en) * | 1989-05-31 | 1993-08-17 | Nakano Vinegar Co., Ltd. | Enzyme sensor |
US5264105A (en) * | 1989-08-02 | 1993-11-23 | Gregg Brian A | Enzyme electrodes |
US5320725A (en) * | 1989-08-02 | 1994-06-14 | E. Heller & Company | Electrode and method for the detection of hydrogen peroxide |
US5264104A (en) * | 1989-08-02 | 1993-11-23 | Gregg Brian A | Enzyme electrodes |
US5262035A (en) * | 1989-08-02 | 1993-11-16 | E. Heller And Company | Enzyme electrodes |
US5173165A (en) * | 1989-10-13 | 1992-12-22 | Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) | Enzyme electrode and the use thereof |
US5286362A (en) * | 1990-02-03 | 1994-02-15 | Boehringer Mannheim Gmbh | Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor |
US5746898A (en) * | 1990-08-10 | 1998-05-05 | Siemens Aktiengesellschaft | Electrochemical-enzymatic sensor |
US5298411A (en) * | 1990-09-25 | 1994-03-29 | Toyo Boseki Kabushiki Kaisha | Glucose dehydrogenase from pseudomonas |
US5262305A (en) * | 1991-03-04 | 1993-11-16 | E. Heller & Company | Interferant eliminating biosensors |
US7462264B2 (en) | 1991-03-04 | 2008-12-09 | Abbott Diabetes Care Inc. | Subcutaneous glucose electrode |
US8414750B2 (en) | 1991-03-04 | 2013-04-09 | Abbott Diabetes Care Inc. | Subcutaneous glucose electrode |
US6514718B2 (en) | 1991-03-04 | 2003-02-04 | Therasense, Inc. | Subcutaneous glucose electrode |
US8414749B2 (en) | 1991-03-04 | 2013-04-09 | Abbott Diabetes Care Inc. | Subcutaneous glucose electrode |
US5356786A (en) * | 1991-03-04 | 1994-10-18 | E. Heller & Company | Interferant eliminating biosensor |
US6881551B2 (en) | 1991-03-04 | 2005-04-19 | Therasense, Inc. | Subcutaneous glucose electrode |
US8741590B2 (en) | 1991-03-04 | 2014-06-03 | Abbott Diabetes Care Inc. | Subcutaneous glucose electrode |
US8588881B2 (en) | 1991-03-04 | 2013-11-19 | Abbott Diabetes Care Inc. | Subcutaneous glucose electrode |
US5208154A (en) * | 1991-04-08 | 1993-05-04 | The United States Of America As Represented By The Department Of Energy | Reversibly immobilized biological materials in monolayer films on electrodes |
US5580527A (en) * | 1992-05-18 | 1996-12-03 | Moltech Corporation | Polymeric luminophores for sensing of oxygen |
US5710011A (en) * | 1992-06-05 | 1998-01-20 | Medisense, Inc. | Mediators to oxidoreductase enzymes |
US5694932A (en) * | 1993-03-01 | 1997-12-09 | Disetronic Licensing Ag | Sensor array |
US6284478B1 (en) | 1993-12-02 | 2001-09-04 | E. Heller & Company | Subcutaneous glucose electrode |
US6162611A (en) * | 1993-12-02 | 2000-12-19 | E. Heller & Company | Subcutaneous glucose electrode |
US6329161B1 (en) | 1993-12-02 | 2001-12-11 | Therasense, Inc. | Subcutaneous glucose electrode |
US5846702A (en) * | 1993-12-30 | 1998-12-08 | Boehringer Mannheim Corporation | Reagent including an osmium-containing redox mediator |
US5589326A (en) * | 1993-12-30 | 1996-12-31 | Boehringer Mannheim Corporation | Osmium-containing redox mediator |
US5863400A (en) * | 1994-04-14 | 1999-01-26 | Usf Filtration & Separations Group Inc. | Electrochemical cells |
US5736188A (en) * | 1994-08-08 | 1998-04-07 | Alcock; Susan | Printed fluid transport devices |
US5980709A (en) * | 1995-04-12 | 1999-11-09 | Usf Filtration And Separations Group | Method of defining an electrode area |
US20050173246A1 (en) * | 1995-06-19 | 2005-08-11 | Lifescan, Inc. | Electrochemical cell |
US20050077176A1 (en) * | 1995-06-19 | 2005-04-14 | Lifescan, Inc. | Electrochemical cell |
US8075760B2 (en) | 1995-06-19 | 2011-12-13 | Lifescan, Inc. | Electrochemical cell |
US8101056B2 (en) | 1995-06-19 | 2012-01-24 | Lifescan, Inc. | Electrochemical cell |
US20050098431A1 (en) * | 1995-06-19 | 2005-05-12 | Lifescan, Inc. | Electrochemical cell |
USRE44330E1 (en) | 1995-06-19 | 2013-07-02 | Lifescan Inc. | Electrochemical cell |
US8597480B2 (en) | 1995-06-19 | 2013-12-03 | Lifescan, Inc. | Electrochemical cell |
US6284125B1 (en) | 1995-06-19 | 2001-09-04 | Usf Filtration And Separations Group, Inc. | Electrochemical cell |
US7608175B2 (en) | 1995-06-19 | 2009-10-27 | Lifescan, Inc. | Electrochemical cell |
US7604722B2 (en) | 1995-06-19 | 2009-10-20 | Lifescan, Inc. | Electrochemical cell |
US5639672A (en) * | 1995-10-16 | 1997-06-17 | Lxn Corporation | Electrochemical determination of fructosamine |
US20040026244A1 (en) * | 1995-11-16 | 2004-02-12 | Lifescan, Inc. | Antioxidant sensor |
US6179979B1 (en) | 1995-11-16 | 2001-01-30 | Usf Filtration & Separations Group, Inc. | Electrochemical cell |
US5942102A (en) * | 1995-11-16 | 1999-08-24 | Usf Filtration And Separations Group Inc. | Electrochemical method |
US6638415B1 (en) | 1995-11-16 | 2003-10-28 | Lifescan, Inc. | Antioxidant sensor |
US6521110B1 (en) | 1995-11-16 | 2003-02-18 | Lifescan, Inc. | Electrochemical cell |
USRE42567E1 (en) | 1995-11-16 | 2011-07-26 | Lifescan, Inc. | Electrochemical cell |
US7431814B2 (en) | 1995-11-16 | 2008-10-07 | Lifescan, Inc. | Electrochemical cell |
US6863801B2 (en) | 1995-11-16 | 2005-03-08 | Lifescan, Inc. | Electrochemical cell |
US5830341A (en) * | 1996-01-23 | 1998-11-03 | Gilmartin; Markas A. T. | Electrodes and metallo isoindole ringed compounds |
US5795453A (en) * | 1996-01-23 | 1998-08-18 | Gilmartin; Markas A. T. | Electrodes and metallo isoindole ringed compounds |
US6413410B1 (en) | 1996-06-19 | 2002-07-02 | Lifescan, Inc. | Electrochemical cell |
US9075004B2 (en) | 1996-06-19 | 2015-07-07 | Lifescan, Inc. | Electrochemical cell |
US20020112969A1 (en) * | 1996-06-19 | 2002-08-22 | Hodges Alastair Mcindoe | Electrochemical cell |
US6960289B2 (en) * | 1996-06-19 | 2005-11-01 | Lifescan, Inc. | Electrochemical cell |
US20030201177A1 (en) * | 1996-11-15 | 2003-10-30 | Alastair Hodges | Hemoglobin sensor |
US6632349B1 (en) | 1996-11-15 | 2003-10-14 | Lifescan, Inc. | Hemoglobin sensor |
US6837858B2 (en) | 1996-12-06 | 2005-01-04 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US6206841B1 (en) | 1996-12-06 | 2001-03-27 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US6306104B1 (en) | 1996-12-06 | 2001-10-23 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US6071251A (en) * | 1996-12-06 | 2000-06-06 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US6093156A (en) * | 1996-12-06 | 2000-07-25 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US6120676A (en) * | 1997-02-06 | 2000-09-19 | Therasense, Inc. | Method of using a small volume in vitro analyte sensor |
US6143164A (en) * | 1997-02-06 | 2000-11-07 | E. Heller & Company | Small volume in vitro analyte sensor |
US6576101B1 (en) | 1997-02-06 | 2003-06-10 | Therasense, Inc. | Small volume in vitro analyte sensor |
US8808531B2 (en) | 1997-02-06 | 2014-08-19 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8114270B2 (en) | 1997-02-06 | 2012-02-14 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US7988845B2 (en) | 1997-02-06 | 2011-08-02 | Abbott Diabetes Care Inc. | Integrated lancing and measurement device and analyte measuring methods |
US8142643B2 (en) | 1997-02-06 | 2012-03-27 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8105476B2 (en) | 1997-02-06 | 2012-01-31 | Abbott Diabetes Care Inc. | Integrated lancing and measurement device |
US7906009B2 (en) | 1997-02-06 | 2011-03-15 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US6551494B1 (en) | 1997-02-06 | 2003-04-22 | Therasense, Inc. | Small volume in vitro analyte sensor |
US8114271B2 (en) | 1997-02-06 | 2012-02-14 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9234864B2 (en) | 1997-02-06 | 2016-01-12 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8123929B2 (en) | 1997-02-06 | 2012-02-28 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8142642B2 (en) | 1997-02-06 | 2012-03-27 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8118992B2 (en) | 1997-02-06 | 2012-02-21 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US7909984B2 (en) | 1997-02-06 | 2011-03-22 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US7974672B2 (en) | 1997-03-04 | 2011-07-05 | Dexcom, Inc. | Device and method for determining analyte levels |
US9339223B2 (en) | 1997-03-04 | 2016-05-17 | Dexcom, Inc. | Device and method for determining analyte levels |
US9439589B2 (en) | 1997-03-04 | 2016-09-13 | Dexcom, Inc. | Device and method for determining analyte levels |
US9931067B2 (en) | 1997-03-04 | 2018-04-03 | Dexcom, Inc. | Device and method for determining analyte levels |
US7835777B2 (en) | 1997-03-04 | 2010-11-16 | Dexcom, Inc. | Device and method for determining analyte levels |
US7970448B2 (en) | 1997-03-04 | 2011-06-28 | Dexcom, Inc. | Device and method for determining analyte levels |
US7792562B2 (en) | 1997-03-04 | 2010-09-07 | Dexcom, Inc. | Device and method for determining analyte levels |
US8527025B1 (en) | 1997-03-04 | 2013-09-03 | Dexcom, Inc. | Device and method for determining analyte levels |
US8676288B2 (en) | 1997-03-04 | 2014-03-18 | Dexcom, Inc. | Device and method for determining analyte levels |
US6060327A (en) * | 1997-05-14 | 2000-05-09 | Keensense, Inc. | Molecular wire injection sensors |
US20060115857A1 (en) * | 1997-05-14 | 2006-06-01 | Keensense, Inc. | Molecular wire injection sensors |
US6326215B1 (en) | 1997-05-14 | 2001-12-04 | Keensense, Inc. | Molecular wire injection sensors |
US6979544B2 (en) | 1997-05-14 | 2005-12-27 | Keensense, Inc. | Molecular wire injection sensors |
US6699667B2 (en) | 1997-05-14 | 2004-03-02 | Keensense, Inc. | Molecular wire injection sensors |
US7220550B2 (en) | 1997-05-14 | 2007-05-22 | Keensense, Inc. | Molecular wire injection sensors |
US5922183A (en) * | 1997-06-23 | 1999-07-13 | Eic Laboratories, Inc. | Metal oxide matrix biosensors |
US6852212B2 (en) | 1997-08-13 | 2005-02-08 | Lifescan, Inc. | Method and apparatus for automatic analysis |
US20020117404A1 (en) * | 1997-08-13 | 2002-08-29 | Maxwell Ian Andrew | Method and apparatus for automatic analysis |
US6325917B1 (en) | 1997-08-13 | 2001-12-04 | Usf Filtration And Separations Group, Inc. | Method and apparatus for automatic analysis |
US20050126931A1 (en) * | 1997-08-13 | 2005-06-16 | Maxwell Ian A. | Method for automatic analysis |
US7666149B2 (en) | 1997-12-04 | 2010-02-23 | Peliken Technologies, Inc. | Cassette of lancet cartridges for sampling blood |
US8071384B2 (en) | 1997-12-22 | 2011-12-06 | Roche Diagnostics Operations, Inc. | Control and calibration solutions and methods for their use |
US7338639B2 (en) | 1997-12-22 | 2008-03-04 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement |
US7494816B2 (en) | 1997-12-22 | 2009-02-24 | Roche Diagnostic Operations, Inc. | System and method for determining a temperature during analyte measurement |
US20040005716A9 (en) * | 1997-12-22 | 2004-01-08 | Beaty Terry A. | Meter |
US20030064525A1 (en) * | 1997-12-22 | 2003-04-03 | Liess Martin Dieter | Meter |
US7390667B2 (en) | 1997-12-22 | 2008-06-24 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using AC phase angle measurements |
EP2085778A1 (en) | 1997-12-22 | 2009-08-05 | Roche Diagnostics Operations, Inc. | Meter |
EP2085779A1 (en) | 1997-12-22 | 2009-08-05 | Roche Diagnostics Operations, Inc. | Meter |
US7407811B2 (en) | 1997-12-22 | 2008-08-05 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using AC excitation |
US6679841B2 (en) | 1998-02-17 | 2004-01-20 | Abbott Laboratories | Fluid collection and monitoring device |
WO1999040848A1 (en) | 1998-02-17 | 1999-08-19 | Abbott Laboratories | Interstitial fluid collection and monitoring device |
US6059736A (en) * | 1998-02-24 | 2000-05-09 | Tapper; Robert | Sensor controlled analysis and therapeutic delivery system |
US7008384B2 (en) | 1998-02-24 | 2006-03-07 | Robert Tapper | Sensor controlled analysis and therapeutic delivery system |
US6843254B2 (en) | 1998-02-24 | 2005-01-18 | Robert Tapper | Sensor controlled analysis and therapeutic delivery system |
US20030040682A1 (en) * | 1998-02-24 | 2003-02-27 | Robert Tapper | Sensor controlled analysis and therapeutic delivery system |
US8273227B2 (en) | 1998-03-04 | 2012-09-25 | Abbott Diabetes Care Inc. | Sensor for in vitro determination of glucose |
US7996054B2 (en) | 1998-03-04 | 2011-08-09 | Abbott Diabetes Care Inc. | Electrochemical analyte sensor |
US7879213B2 (en) | 1998-03-04 | 2011-02-01 | Abbott Diabetes Care Inc. | Sensor for in vitro determination of glucose |
US6103033A (en) * | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
US8168051B2 (en) | 1998-03-04 | 2012-05-01 | Abbott Diabetes Care Inc. | Sensor for determination of glucose |
US8136220B2 (en) | 1998-03-04 | 2012-03-20 | Abbott Diabetes Care Inc. | Method of making an electrochemical sensor |
US8706180B2 (en) | 1998-03-04 | 2014-04-22 | Abbott Diabetes Care Inc. | Electrochemical analyte sensor |
US7003340B2 (en) | 1998-03-04 | 2006-02-21 | Abbott Diabetes Care Inc. | Electrochemical analyte sensor |
US8463351B2 (en) | 1998-03-04 | 2013-06-11 | Abbott Diabetes Care Inc. | Electrochemical analyte sensor |
US7721412B2 (en) | 1998-03-04 | 2010-05-25 | Abbott Diabetes Care Inc. | Method of making an electrochemical sensor |
US6484046B1 (en) | 1998-03-04 | 2002-11-19 | Therasense, Inc. | Electrochemical analyte sensor |
US6973706B2 (en) | 1998-03-04 | 2005-12-13 | Therasense, Inc. | Method of making a transcutaneous electrochemical sensor |
US7861397B2 (en) | 1998-03-04 | 2011-01-04 | Abbott Diabetes Care Inc. | Method of making an electrochemical sensor |
US6134461A (en) * | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US8117734B2 (en) | 1998-03-04 | 2012-02-21 | Abbott Diabetes Care Inc. | Method of making an electrochemical sensor |
WO1999044508A1 (en) | 1998-03-06 | 1999-09-10 | Spectrx, Inc. | Integrated poration, harvesting and analysis device, and method therefor |
US20030079987A1 (en) * | 1998-03-12 | 2003-05-01 | Alastair Hodges | Heated electrochemical cell |
US20030080001A1 (en) * | 1998-03-12 | 2003-05-01 | Alastair Hodges | Heated electrochemical cell |
US6878251B2 (en) | 1998-03-12 | 2005-04-12 | Lifescan, Inc. | Heated electrochemical cell |
US6475360B1 (en) | 1998-03-12 | 2002-11-05 | Lifescan, Inc. | Heated electrochemical cell |
US20020130043A1 (en) * | 1998-03-12 | 2002-09-19 | Alastair Hodges | Heated electrochemical cell |
US20040069657A1 (en) * | 1998-03-20 | 2004-04-15 | Lifescan, Inc. | Sensor with improved shelf life |
US7335292B2 (en) | 1998-03-20 | 2008-02-26 | Lifescan, Inc. | Sensor with improved shelf life |
US20080121533A1 (en) * | 1998-03-20 | 2008-05-29 | Lifescan, Inc. | Sensor with improved shelf life |
US8439872B2 (en) | 1998-03-30 | 2013-05-14 | Sanofi-Aventis Deutschland Gmbh | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US7780631B2 (en) | 1998-03-30 | 2010-08-24 | Pelikan Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8273022B2 (en) | 1998-04-30 | 2012-09-25 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8287454B2 (en) | 1998-04-30 | 2012-10-16 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8774887B2 (en) | 1998-04-30 | 2014-07-08 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8738109B2 (en) | 1998-04-30 | 2014-05-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8734346B2 (en) | 1998-04-30 | 2014-05-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US7869853B1 (en) | 1998-04-30 | 2011-01-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8306598B2 (en) | 1998-04-30 | 2012-11-06 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US7885699B2 (en) | 1998-04-30 | 2011-02-08 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8734348B2 (en) | 1998-04-30 | 2014-05-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US8346336B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8744545B2 (en) | 1998-04-30 | 2014-06-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8353829B2 (en) | 1998-04-30 | 2013-01-15 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8357091B2 (en) | 1998-04-30 | 2013-01-22 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8672844B2 (en) | 1998-04-30 | 2014-03-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8366614B2 (en) | 1998-04-30 | 2013-02-05 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8670815B2 (en) | 1998-04-30 | 2014-03-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8666469B2 (en) | 1998-04-30 | 2014-03-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8660627B2 (en) | 1998-04-30 | 2014-02-25 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6565509B1 (en) | 1998-04-30 | 2003-05-20 | Therasense, Inc. | Analyte monitoring device and methods of use |
US8840553B2 (en) | 1998-04-30 | 2014-09-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9326714B2 (en) | 1998-04-30 | 2016-05-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8162829B2 (en) | 1998-04-30 | 2012-04-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8649841B2 (en) | 1998-04-30 | 2014-02-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8641619B2 (en) | 1998-04-30 | 2014-02-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8175673B2 (en) | 1998-04-30 | 2012-05-08 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8622906B2 (en) | 1998-04-30 | 2014-01-07 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8177716B2 (en) | 1998-04-30 | 2012-05-15 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8617071B2 (en) | 1998-04-30 | 2013-12-31 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8612159B2 (en) | 1998-04-30 | 2013-12-17 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8880137B2 (en) | 1998-04-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8597189B2 (en) | 1998-04-30 | 2013-12-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US7860544B2 (en) | 1998-04-30 | 2010-12-28 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8224413B2 (en) | 1998-04-30 | 2012-07-17 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10478108B2 (en) | 1998-04-30 | 2019-11-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9014773B2 (en) | 1998-04-30 | 2015-04-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8226555B2 (en) | 1998-04-30 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9011331B2 (en) | 1998-04-30 | 2015-04-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8473021B2 (en) | 1998-04-30 | 2013-06-25 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8372005B2 (en) | 1998-04-30 | 2013-02-12 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8226557B2 (en) | 1998-04-30 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8226558B2 (en) | 1998-04-30 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9042953B2 (en) | 1998-04-30 | 2015-05-26 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8231532B2 (en) | 1998-04-30 | 2012-07-31 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066694B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8235896B2 (en) | 1998-04-30 | 2012-08-07 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066697B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9072477B2 (en) | 1998-04-30 | 2015-07-07 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8275439B2 (en) | 1998-04-30 | 2012-09-25 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8409131B2 (en) | 1998-04-30 | 2013-04-02 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8255031B2 (en) | 1998-04-30 | 2012-08-28 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8391945B2 (en) | 1998-04-30 | 2013-03-05 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8260392B2 (en) | 1998-04-30 | 2012-09-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8380273B2 (en) | 1998-04-30 | 2013-02-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8265726B2 (en) | 1998-04-30 | 2012-09-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
USRE40198E1 (en) | 1998-06-01 | 2008-04-01 | Roche Diagnostics Operations, Inc. | Method and device for electrochemical immunoassay of multiple analytes |
US20020090632A1 (en) * | 1998-06-01 | 2002-07-11 | Buck Harvey B. | Redox reversible bipyridyl-osmium complex conjugates |
US6352824B1 (en) | 1998-06-01 | 2002-03-05 | Roche Diagnostics Corporation | Redox reversible bipyridyl-osmium complex conjugates |
US6294062B1 (en) | 1998-06-01 | 2001-09-25 | Roche Diagnostics Corporation | Method and device for electrochemical immunoassay of multiple analytes |
US6262264B1 (en) | 1998-06-01 | 2001-07-17 | Roche Diagnostics Corporation | Redox reversible imidazole osmium complex conjugates |
US7045310B2 (en) | 1998-06-01 | 2006-05-16 | Roche Diagnostics Operations, Inc. | Redox reversible bipyridyl-osmium complex conjugates |
US6077660A (en) * | 1998-06-10 | 2000-06-20 | Abbott Laboratories | Diagnostic assay requiring a small sample of biological fluid |
US6051392A (en) * | 1998-06-10 | 2000-04-18 | Matsushita Electric Industrial Co., Ltd. | Method for quantitating a substrate and measurement device used therefor |
US6251260B1 (en) | 1998-08-24 | 2001-06-26 | Therasense, Inc. | Potentiometric sensors for analytic determination |
US6773564B1 (en) | 1998-09-29 | 2004-08-10 | Matsushita Electric Industrial Co., Ltd. | Glucose sensor |
US7550069B2 (en) | 1998-10-08 | 2009-06-23 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US6338790B1 (en) | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US8272125B2 (en) | 1998-10-08 | 2012-09-25 | Abbott Diabetes Care Inc. | Method of manufacturing in vitro analyte sensors |
US7058437B2 (en) | 1998-10-08 | 2006-06-06 | Therasense, Inc. | Methods of determining concentration of glucose |
US8372261B2 (en) | 1998-10-08 | 2013-02-12 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US9291592B2 (en) | 1998-10-08 | 2016-03-22 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8268163B2 (en) | 1998-10-08 | 2012-09-18 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8268144B2 (en) | 1998-10-08 | 2012-09-18 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US7563350B2 (en) | 1998-10-08 | 2009-07-21 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8262996B2 (en) | 1998-10-08 | 2012-09-11 | Abbott Diabetes Care Inc. | Small volume in vitro sensor and methods of making |
US9234863B2 (en) | 1998-10-08 | 2016-01-12 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8728297B2 (en) | 1998-10-08 | 2014-05-20 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9316609B2 (en) | 1998-10-08 | 2016-04-19 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8377378B2 (en) | 1998-10-08 | 2013-02-19 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8091220B2 (en) | 1998-10-08 | 2012-01-10 | Abbott Diabetes Care Inc. | Methods of making small volume in vitro analyte sensors |
US8425758B2 (en) | 1998-10-08 | 2013-04-23 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8425743B2 (en) | 1998-10-08 | 2013-04-23 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US9891185B2 (en) | 1998-10-08 | 2018-02-13 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US8226815B2 (en) | 1998-10-08 | 2012-07-24 | Abbott Diabetes Care Inc. | Small volume in vitro sensor and methods of making |
US8449758B2 (en) | 1998-10-08 | 2013-05-28 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8087162B2 (en) | 1998-10-08 | 2012-01-03 | Abbott Diabetes Care Inc. | Methods of making small volume in vitro analyte sensors |
US8701282B2 (en) | 1998-10-08 | 2014-04-22 | Abbott Diabetes Care Inc. | Method for manufacturing a biosensor |
US8083924B2 (en) | 1998-10-08 | 2011-12-27 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US6299757B1 (en) | 1998-10-08 | 2001-10-09 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US8221685B2 (en) | 1998-10-08 | 2012-07-17 | Abbott Diabetes Care Inc. | Small volume in vitro sensor and methods of making |
US6461496B1 (en) | 1998-10-08 | 2002-10-08 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US8211363B2 (en) | 1998-10-08 | 2012-07-03 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8192611B2 (en) | 1998-10-08 | 2012-06-05 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8186044B2 (en) | 1998-10-08 | 2012-05-29 | Abbott Diabetes Care Inc. | Method of manufacturing small volume in vitro analyte sensors |
US8187895B2 (en) | 1998-10-08 | 2012-05-29 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8182671B2 (en) | 1998-10-08 | 2012-05-22 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8182670B2 (en) | 1998-10-08 | 2012-05-22 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US20100015326A1 (en) * | 1998-10-08 | 2010-01-21 | Feldman Benjamin J | Small Volume In Vitro Sensor and Methods of Making |
US8273241B2 (en) | 1998-10-08 | 2012-09-25 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8083928B2 (en) | 1998-10-08 | 2011-12-27 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8083929B2 (en) | 1998-10-08 | 2011-12-27 | Abbott Diabetes Care Inc. | Small volume in vitro sensor and methods of making |
US9341591B2 (en) | 1998-10-08 | 2016-05-17 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US6618934B1 (en) | 1998-10-08 | 2003-09-16 | Therasense, Inc. | Method of manufacturing small volume in vitro analyte sensor |
US7225535B2 (en) | 1998-10-08 | 2007-06-05 | Abbott Diabetes Care, Inc. | Method of manufacturing electrochemical sensors |
US8163164B2 (en) | 1998-10-08 | 2012-04-24 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8153063B2 (en) | 1998-10-08 | 2012-04-10 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8118993B2 (en) | 1998-10-08 | 2012-02-21 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor and methods of making |
US8650751B2 (en) | 1998-10-08 | 2014-02-18 | Abbott Diabetes Care Inc. | Methods of making small volume in vitro analyte sensors |
US6592745B1 (en) | 1998-10-08 | 2003-07-15 | Therasense, Inc. | Method of using a small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
EP2228653A2 (en) | 1998-11-30 | 2010-09-15 | Abbott Laboratories | Multichemistry measuring device and test strips |
US6600997B2 (en) | 1998-11-30 | 2003-07-29 | Abbott Laboratories | Analyte test instrument having improved calibration and communication processes |
EP2230513A2 (en) | 1998-11-30 | 2010-09-22 | Abbott Laboratories | Multichemistry measuring device and test strips |
EP2154534A1 (en) | 1998-11-30 | 2010-02-17 | Abbott Laboratories | Multichemistry measuring device and test strips |
US6377894B1 (en) | 1998-11-30 | 2002-04-23 | Abbott Laboratories | Analyte test instrument having improved calibration and communication processes |
EP2251433A2 (en) | 1998-11-30 | 2010-11-17 | Abbott Laboratories | Multichemistry measuring device and test strips |
US6773671B1 (en) | 1998-11-30 | 2004-08-10 | Abbott Laboratories | Multichemistry measuring device and test strips |
US6652734B1 (en) | 1999-03-16 | 2003-11-25 | Lifescan, Inc. | Sensor with improved shelf life |
US6975893B2 (en) | 1999-06-18 | 2005-12-13 | Therasense, Inc. | Mass transport limited in vivo analyte sensor |
US6654625B1 (en) | 1999-06-18 | 2003-11-25 | Therasense, Inc. | Mass transport limited in vivo analyte sensor |
US20060096859A1 (en) * | 1999-06-29 | 2006-05-11 | Drew Scientific Limited | Amperometric sensor |
WO2001000865A3 (en) * | 1999-06-29 | 2001-09-13 | Drew Scient Ltd | Amperometric sensor |
US7135100B1 (en) | 1999-06-29 | 2006-11-14 | Drew Scientific Ventures Llc | Amperometric sensor |
US7608180B2 (en) | 1999-06-29 | 2009-10-27 | Drew Scientific Holdings, Inc. | Amperometric sensor |
US7005048B1 (en) | 1999-10-05 | 2006-02-28 | Matsushita Electric Industrial Co., Ltd. | Glucose sensor |
US6942518B2 (en) | 1999-11-04 | 2005-09-13 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
US6616819B1 (en) | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
US8066858B2 (en) | 1999-11-04 | 2011-11-29 | Abbott Diabetes Care Inc. | Analyte sensor with insertion monitor, and methods |
US6749740B2 (en) | 1999-11-04 | 2004-06-15 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
US9017259B2 (en) | 2000-06-27 | 2015-04-28 | Abbott Diabetes Care Inc. | Integrated sample acquisition and analyte measurement device |
US6591125B1 (en) | 2000-06-27 | 2003-07-08 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US8795176B2 (en) | 2000-06-27 | 2014-08-05 | Abbott Diabetes Care Inc. | Integrated sample acquisition and analyte measurement device |
US9271669B2 (en) | 2000-06-27 | 2016-03-01 | Abbott Diabetes Care Inc. | Method for integrated sample acquisition and analyte measurement device |
US8532731B2 (en) | 2000-06-27 | 2013-09-10 | Abbott Diabetes Care Inc. | Methods of determining analyte concentration |
US9662057B2 (en) | 2000-06-27 | 2017-05-30 | Abbott Diabetes Care Inc. | Integrated sample acquisition and analyte measurement method |
DE10032042A1 (en) * | 2000-07-05 | 2002-01-24 | Inventus Biotec Gesellschaft Fuer Innovative Bioanalytik, Biosensoren Und Diagnostika Mbh & Co. Kg | Disposable electrochemical biosensor for the quantitative determination of analyte concentrations in liquids |
US8685714B2 (en) | 2000-07-14 | 2014-04-01 | Universal Biosensors Pty Ltd | Immunosensor |
US6444115B1 (en) | 2000-07-14 | 2002-09-03 | Lifescan, Inc. | Electrochemical method for measuring chemical reaction rates |
AU2006203606B2 (en) * | 2000-07-14 | 2007-05-17 | Lifescan, Inc. | Electrochemical method for measuring chemical reaction rates |
WO2002006788A3 (en) * | 2000-07-14 | 2002-08-29 | Usf Filtration & Separations | Electrochemical method for measuring chemical reaction rates |
AU2007209797B2 (en) * | 2000-07-14 | 2010-06-03 | Lifescan, Inc. | Electrochemical method for measuring chemical reaction rates |
US20020175087A1 (en) * | 2000-07-14 | 2002-11-28 | Alastair Hodges | Electrochemical method for measuring chemical reaction rates |
US7022217B2 (en) | 2000-07-14 | 2006-04-04 | Lifescan, Inc. | Electrochemical method for measuring chemical reaction rates |
US20070179366A1 (en) * | 2000-09-25 | 2007-08-02 | Critisense Ltd. | Apparatus and Method for Monitoring Tissue Vitality Parameters |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US8652043B2 (en) | 2001-01-02 | 2014-02-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9498159B2 (en) | 2001-01-02 | 2016-11-22 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9610034B2 (en) | 2001-01-02 | 2017-04-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8668645B2 (en) | 2001-01-02 | 2014-03-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9011332B2 (en) | 2001-01-02 | 2015-04-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US20050067278A1 (en) * | 2001-03-13 | 2005-03-31 | Koji Sode | Oxygen electrode |
US6576102B1 (en) | 2001-03-23 | 2003-06-10 | Virotek, L.L.C. | Electrochemical sensor and method thereof |
US6572745B2 (en) | 2001-03-23 | 2003-06-03 | Virotek, L.L.C. | Electrochemical sensor and method thereof |
US6849216B2 (en) | 2001-03-23 | 2005-02-01 | Virotek, L.L.C. | Method of making sensor |
US8236242B2 (en) | 2001-04-02 | 2012-08-07 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus and methods |
US8765059B2 (en) | 2001-04-02 | 2014-07-01 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus |
US7976778B2 (en) | 2001-04-02 | 2011-07-12 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus |
US9477811B2 (en) | 2001-04-02 | 2016-10-25 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus and methods |
US8268243B2 (en) | 2001-04-02 | 2012-09-18 | Abbott Diabetes Care Inc. | Blood glucose tracking apparatus and methods |
US6694158B2 (en) * | 2001-04-11 | 2004-02-17 | Motorola, Inc. | System using a portable detection device for detection of an analyte through body tissue |
US20040176809A1 (en) * | 2001-06-07 | 2004-09-09 | Medtronic, Inc. | Method and apparatus for modifying delivery of a therapy in response to onset of sleep |
US7206635B2 (en) | 2001-06-07 | 2007-04-17 | Medtronic, Inc. | Method and apparatus for modifying delivery of a therapy in response to onset of sleep |
US6731984B2 (en) | 2001-06-07 | 2004-05-04 | Medtronic, Inc. | Method for providing a therapy to a patient involving modifying the therapy after detecting an onset of sleep in the patient, and implantable medical device embodying same |
US8123700B2 (en) | 2001-06-12 | 2012-02-28 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US8845550B2 (en) | 2001-06-12 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7699791B2 (en) | 2001-06-12 | 2010-04-20 | Pelikan Technologies, Inc. | Method and apparatus for improving success rate of blood yield from a fingerstick |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7988645B2 (en) | 2001-06-12 | 2011-08-02 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US7537571B2 (en) | 2001-06-12 | 2009-05-26 | Pelikan Technologies, Inc. | Integrated blood sampling analysis system with multi-use sampling module |
US9802007B2 (en) | 2001-06-12 | 2017-10-31 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US8282577B2 (en) | 2001-06-12 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US8622930B2 (en) | 2001-06-12 | 2014-01-07 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8641643B2 (en) | 2001-06-12 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Sampling module device and method |
US8360991B2 (en) | 2001-06-12 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
US7682318B2 (en) | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
US7909775B2 (en) | 2001-06-12 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US8211037B2 (en) | 2001-06-12 | 2012-07-03 | Pelikan Technologies, Inc. | Tissue penetration device |
US8206319B2 (en) | 2001-06-12 | 2012-06-26 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8216154B2 (en) | 2001-06-12 | 2012-07-10 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8679033B2 (en) | 2001-06-12 | 2014-03-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7850622B2 (en) | 2001-06-12 | 2010-12-14 | Pelikan Technologies, Inc. | Tissue penetration device |
US8337421B2 (en) | 2001-06-12 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7041068B2 (en) | 2001-06-12 | 2006-05-09 | Pelikan Technologies, Inc. | Sampling module device and method |
US8382683B2 (en) | 2001-06-12 | 2013-02-26 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9694144B2 (en) | 2001-06-12 | 2017-07-04 | Sanofi-Aventis Deutschland Gmbh | Sampling module device and method |
US7981055B2 (en) | 2001-06-12 | 2011-07-19 | Pelikan Technologies, Inc. | Tissue penetration device |
US7749174B2 (en) | 2001-06-12 | 2010-07-06 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge |
US8721671B2 (en) | 2001-06-12 | 2014-05-13 | Sanofi-Aventis Deutschland Gmbh | Electric lancet actuator |
US8016774B2 (en) | 2001-06-12 | 2011-09-13 | Pelikan Technologies, Inc. | Tissue penetration device |
US8206317B2 (en) | 2001-06-12 | 2012-06-26 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7316700B2 (en) | 2001-06-12 | 2008-01-08 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US9937298B2 (en) | 2001-06-12 | 2018-04-10 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9328371B2 (en) | 2001-07-27 | 2016-05-03 | Dexcom, Inc. | Sensor head for use with implantable devices |
US8509871B2 (en) | 2001-07-27 | 2013-08-13 | Dexcom, Inc. | Sensor head for use with implantable devices |
US9804114B2 (en) | 2001-07-27 | 2017-10-31 | Dexcom, Inc. | Sensor head for use with implantable devices |
US20080287856A1 (en) * | 2001-08-15 | 2008-11-20 | Biomed Solutions Llc | Process and apparatus for treating biological organisms |
US20050203578A1 (en) * | 2001-08-15 | 2005-09-15 | Weiner Michael L. | Process and apparatus for treating biological organisms |
US8118991B2 (en) | 2001-09-04 | 2012-02-21 | Stephen Eliot Zweig | Apoenzyme reactivation electrochemical detection method and assay |
US20070289880A1 (en) * | 2001-09-04 | 2007-12-20 | Zweig Stephen E | Apoenzyme reactivation electrochemical detection method and assay |
US20030094384A1 (en) * | 2001-09-14 | 2003-05-22 | Vreeke Mark S. | Reagents and methods for detecting analytes, and devices comprising reagents for detecting analytes |
US7163616B2 (en) | 2001-09-14 | 2007-01-16 | Bayer Corporation | Reagents and methods for detecting analytes, and devices comprising reagents for detecting analytes |
EP1867732A1 (en) * | 2001-09-14 | 2007-12-19 | Bayer Corporation | Reagents, methods and devices for detecting analytes |
EP1293574A3 (en) * | 2001-09-14 | 2004-03-03 | Bayer Corporation | Reagents, methods and devices for detecting analytes |
US7431820B2 (en) | 2001-10-10 | 2008-10-07 | Lifescan, Inc. | Electrochemical cell |
US8801907B2 (en) | 2001-10-10 | 2014-08-12 | Lifescan, Inc. | Electrochemical cell |
US8486243B2 (en) | 2001-10-10 | 2013-07-16 | Lifescan, Inc. | Electrochemical cell |
US7344894B2 (en) | 2001-10-16 | 2008-03-18 | Agilent Technologies, Inc. | Thermal regulation of fluidic samples within a diagnostic cartridge |
US20040265940A1 (en) * | 2001-10-18 | 2004-12-30 | Slater Jonathan M | Amperometer sensor |
WO2003033726A1 (en) * | 2001-10-18 | 2003-04-24 | Drew Scientific Limited | Amperometric sensor |
US7923258B2 (en) | 2001-11-07 | 2011-04-12 | Roche Diagnostics Operations, Inc. | Instrument |
US20030096420A1 (en) * | 2001-11-07 | 2003-05-22 | Heller Zindel Herbert | Instrument |
US7018843B2 (en) | 2001-11-07 | 2006-03-28 | Roche Diagnostics Operations, Inc. | Instrument |
US7927882B2 (en) | 2001-11-07 | 2011-04-19 | Roche Diagnostics Operations, Inc. | Instrument |
US9560993B2 (en) | 2001-11-21 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US6952604B2 (en) | 2001-12-21 | 2005-10-04 | Becton, Dickinson And Company | Minimally-invasive system and method for monitoring analyte levels |
US20050164328A1 (en) * | 2002-03-08 | 2005-07-28 | Susumu Kuwabata | Substrate determining method |
US20060161055A1 (en) * | 2002-03-20 | 2006-07-20 | Critisense, Ltd. | Probe design |
US7313424B2 (en) * | 2002-03-20 | 2007-12-25 | Critisense Ltd. | Diagnosis of body metabolic emergency state |
US20050234315A1 (en) * | 2002-03-20 | 2005-10-20 | Avraham Mayevsky | Diagnosis of body metabolic emergency state |
US9863942B2 (en) | 2002-03-21 | 2018-01-09 | Universal Biosensors Pty Ltd | Biosensor apparatus and methods of use |
US7988644B2 (en) | 2002-04-19 | 2011-08-02 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9186468B2 (en) | 2002-04-19 | 2015-11-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7374544B2 (en) | 2002-04-19 | 2008-05-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9089294B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9089678B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8435190B2 (en) | 2002-04-19 | 2013-05-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8430828B2 (en) | 2002-04-19 | 2013-04-30 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US9072842B2 (en) | 2002-04-19 | 2015-07-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8079960B2 (en) | 2002-04-19 | 2011-12-20 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US8414503B2 (en) | 2002-04-19 | 2013-04-09 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US7731729B2 (en) | 2002-04-19 | 2010-06-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7410468B2 (en) | 2002-04-19 | 2008-08-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8491500B2 (en) | 2002-04-19 | 2013-07-23 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US8403864B2 (en) | 2002-04-19 | 2013-03-26 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
US7708701B2 (en) | 2002-04-19 | 2010-05-04 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device |
US7862520B2 (en) | 2002-04-19 | 2011-01-04 | Pelikan Technologies, Inc. | Body fluid sampling module with a continuous compression tissue interface surface |
US8388551B2 (en) | 2002-04-19 | 2013-03-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for multi-use body fluid sampling device with sterility barrier release |
US8062231B2 (en) | 2002-04-19 | 2011-11-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9724021B2 (en) | 2002-04-19 | 2017-08-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8382682B2 (en) | 2002-04-19 | 2013-02-26 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8496601B2 (en) | 2002-04-19 | 2013-07-30 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US8157748B2 (en) | 2002-04-19 | 2012-04-17 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US8905945B2 (en) | 2002-04-19 | 2014-12-09 | Dominique M. Freeman | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7875047B2 (en) | 2002-04-19 | 2011-01-25 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US8845549B2 (en) | 2002-04-19 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Method for penetrating tissue |
US8808201B2 (en) | 2002-04-19 | 2014-08-19 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for penetrating tissue |
US8366637B2 (en) | 2002-04-19 | 2013-02-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7485128B2 (en) | 2002-04-19 | 2009-02-03 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7874994B2 (en) | 2002-04-19 | 2011-01-25 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9498160B2 (en) | 2002-04-19 | 2016-11-22 | Sanofi-Aventis Deutschland Gmbh | Method for penetrating tissue |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8197423B2 (en) | 2002-04-19 | 2012-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8197421B2 (en) | 2002-04-19 | 2012-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8202231B2 (en) | 2002-04-19 | 2012-06-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8007446B2 (en) | 2002-04-19 | 2011-08-30 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8556829B2 (en) | 2002-04-19 | 2013-10-15 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8562545B2 (en) | 2002-04-19 | 2013-10-22 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7524293B2 (en) | 2002-04-19 | 2009-04-28 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7892185B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7833171B2 (en) | 2002-04-19 | 2010-11-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7297151B2 (en) | 2002-04-19 | 2007-11-20 | Elikan Technologies, Inc. | Method and apparatus for body fluid sampling with improved sensing |
US8690796B2 (en) | 2002-04-19 | 2014-04-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8235915B2 (en) | 2002-04-19 | 2012-08-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9907502B2 (en) | 2002-04-19 | 2018-03-06 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7938787B2 (en) | 2002-04-19 | 2011-05-10 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9339612B2 (en) | 2002-04-19 | 2016-05-17 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7258693B2 (en) | 2002-04-19 | 2007-08-21 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7914465B2 (en) | 2002-04-19 | 2011-03-29 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7244265B2 (en) | 2002-04-19 | 2007-07-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7901365B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7198606B2 (en) | 2002-04-19 | 2007-04-03 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with analyte sensing |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909777B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US7563232B2 (en) | 2002-04-19 | 2009-07-21 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8636673B2 (en) | 2002-04-19 | 2014-01-28 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9839386B2 (en) | 2002-04-19 | 2017-12-12 | Sanofi-Aventis Deustschland Gmbh | Body fluid sampling device with capacitive sensor |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9549693B2 (en) | 2002-05-22 | 2017-01-24 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US8053018B2 (en) | 2002-05-22 | 2011-11-08 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US8543184B2 (en) | 2002-05-22 | 2013-09-24 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US10154807B2 (en) | 2002-05-22 | 2018-12-18 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US11020026B2 (en) | 2002-05-22 | 2021-06-01 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US9801574B2 (en) | 2002-05-22 | 2017-10-31 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US9179869B2 (en) | 2002-05-22 | 2015-11-10 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US10052051B2 (en) | 2002-05-22 | 2018-08-21 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US7613491B2 (en) | 2002-05-22 | 2009-11-03 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US8064977B2 (en) | 2002-05-22 | 2011-11-22 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US8865249B2 (en) | 2002-05-22 | 2014-10-21 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US8050731B2 (en) | 2002-05-22 | 2011-11-01 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US7182844B1 (en) | 2002-05-28 | 2007-02-27 | Michael Mallary | Lactose test apparatus |
US20040137283A1 (en) * | 2002-10-18 | 2004-07-15 | Johna Leddy | Magnetically modified electrodes containing at least one catalyst component that mediates a subatomic particle transfer process |
US7041401B2 (en) | 2002-10-18 | 2006-05-09 | University Of Iowa Research Foundation | Magnetically modified electrodes containing at least one catalyst component that mediates a subatomic particle transfer process |
US8029442B2 (en) | 2002-11-05 | 2011-10-04 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US9980670B2 (en) | 2002-11-05 | 2018-05-29 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US7582059B2 (en) | 2002-11-05 | 2009-09-01 | Abbott Diabetes Care Inc. | Sensor inserter methods of use |
US11141084B2 (en) | 2002-11-05 | 2021-10-12 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US10973443B2 (en) | 2002-11-05 | 2021-04-13 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US11116430B2 (en) | 2002-11-05 | 2021-09-14 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US20040115412A1 (en) * | 2002-12-17 | 2004-06-17 | Richard Baron | Adhesive articles which contain at least one hydrophilic or hydrophobic layer, method for making and uses for same |
US20050147811A1 (en) * | 2002-12-17 | 2005-07-07 | Richard Baron | Adhesive articles which contain at least one hydrophilic or hydrophobic layer, method for making and uses for same |
US7175897B2 (en) | 2002-12-17 | 2007-02-13 | Avery Dennison Corporation | Adhesive articles which contain at least one hydrophilic or hydrophobic layer, method for making and uses for same |
US8574895B2 (en) * | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US9034639B2 (en) | 2002-12-30 | 2015-05-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US20060204399A1 (en) * | 2002-12-30 | 2006-09-14 | Freeman Dominique M | Method and apparatus using optical techniques to measure analyte levels |
US10039881B2 (en) | 2002-12-31 | 2018-08-07 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US7811231B2 (en) | 2002-12-31 | 2010-10-12 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US10750952B2 (en) | 2002-12-31 | 2020-08-25 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US7120483B2 (en) * | 2003-01-13 | 2006-10-10 | Isense Corporation | Methods for analyte sensing and measurement |
USRE43187E1 (en) | 2003-01-13 | 2012-02-14 | Isense Corporation | Methods for analyte sensing and measurement |
US20040134779A1 (en) * | 2003-01-13 | 2004-07-15 | Tien-Tsai Hsu | Strips for analyzing samples |
US20040138543A1 (en) * | 2003-01-13 | 2004-07-15 | Russell Geoffrey A. | Assembly of single use sensing elements |
US7144485B2 (en) | 2003-01-13 | 2006-12-05 | Hmd Biomedical Inc. | Strips for analyzing samples |
US8262614B2 (en) | 2003-05-30 | 2012-09-11 | Pelikan Technologies, Inc. | Method and apparatus for fluid injection |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US8251921B2 (en) | 2003-06-06 | 2012-08-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US8647269B2 (en) | 2003-06-10 | 2014-02-11 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US9730584B2 (en) | 2003-06-10 | 2017-08-15 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US8512239B2 (en) | 2003-06-10 | 2013-08-20 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US9144401B2 (en) | 2003-06-11 | 2015-09-29 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US10034628B2 (en) | 2003-06-11 | 2018-07-31 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US7604592B2 (en) | 2003-06-13 | 2009-10-20 | Pelikan Technologies, Inc. | Method and apparatus for a point of care device |
US7133718B2 (en) | 2003-06-19 | 2006-11-07 | Medtronic, Inc. | Method and apparatus for temporarily varying a parameter in an implantable medical device |
US20040260348A1 (en) * | 2003-06-19 | 2004-12-23 | Bakken Earl E. | Method and apparatus for temporarily varying a parameter in an implantable medical device |
US7645421B2 (en) | 2003-06-20 | 2010-01-12 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US8507289B1 (en) | 2003-06-20 | 2013-08-13 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US8083993B2 (en) | 2003-06-20 | 2011-12-27 | Riche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US7604721B2 (en) | 2003-06-20 | 2009-10-20 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US8586373B2 (en) | 2003-06-20 | 2013-11-19 | Roche Diagnostics Operations, Inc. | System and method for determining the concentration of an analyte in a sample fluid |
US8663442B2 (en) | 2003-06-20 | 2014-03-04 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
US8859293B2 (en) | 2003-06-20 | 2014-10-14 | Roche Diagnostics Operations, Inc. | Method for determining whether a disposable, dry regent, electrochemical test strip is unsuitable for use |
US7597793B2 (en) | 2003-06-20 | 2009-10-06 | Roche Operations Ltd. | System and method for analyte measurement employing maximum dosing time delay |
US8293538B2 (en) | 2003-06-20 | 2012-10-23 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US7488601B2 (en) | 2003-06-20 | 2009-02-10 | Roche Diagnostic Operations, Inc. | System and method for determining an abused sensor during analyte measurement |
US7718439B2 (en) | 2003-06-20 | 2010-05-18 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US8206565B2 (en) | 2003-06-20 | 2012-06-26 | Roche Diagnostics Operation, Inc. | System and method for coding information on a biosensor test strip |
US7645373B2 (en) | 2003-06-20 | 2010-01-12 | Roche Diagnostic Operations, Inc. | System and method for coding information on a biosensor test strip |
US8058077B2 (en) | 2003-06-20 | 2011-11-15 | Roche Diagnostics Operations, Inc. | Method for coding information on a biosensor test strip |
US7452457B2 (en) | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
US8148164B2 (en) | 2003-06-20 | 2012-04-03 | Roche Diagnostics Operations, Inc. | System and method for determining the concentration of an analyte in a sample fluid |
US7977112B2 (en) | 2003-06-20 | 2011-07-12 | Roche Diagnostics Operations, Inc. | System and method for determining an abused sensor during analyte measurement |
US8298828B2 (en) | 2003-06-20 | 2012-10-30 | Roche Diagnostics Operations, Inc. | System and method for determining the concentration of an analyte in a sample fluid |
US8255030B2 (en) | 2003-07-25 | 2012-08-28 | Dexcom, Inc. | Oxygen enhancing membrane systems for implantable devices |
USRE43399E1 (en) | 2003-07-25 | 2012-05-22 | Dexcom, Inc. | Electrode systems for electrochemical sensors |
US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US9993186B2 (en) | 2003-07-25 | 2018-06-12 | Dexcom, Inc. | Oxygen enhancing membrane systems for implantable devices |
US8255033B2 (en) | 2003-07-25 | 2012-08-28 | Dexcom, Inc. | Oxygen enhancing membrane systems for implantable devices |
US7828728B2 (en) | 2003-07-25 | 2010-11-09 | Dexcom, Inc. | Analyte sensor |
US10610140B2 (en) | 2003-07-25 | 2020-04-07 | Dexcom, Inc. | Oxygen enhancing membrane systems for implantable devices |
US8255032B2 (en) | 2003-07-25 | 2012-08-28 | Dexcom, Inc. | Oxygen enhancing membrane systems for implantable devices |
US8909314B2 (en) | 2003-07-25 | 2014-12-09 | Dexcom, Inc. | Oxygen enhancing membrane systems for implantable devices |
US9763609B2 (en) | 2003-07-25 | 2017-09-19 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US10376143B2 (en) | 2003-07-25 | 2019-08-13 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US7761130B2 (en) | 2003-07-25 | 2010-07-20 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US9597027B2 (en) | 2003-07-25 | 2017-03-21 | Dexcom, Inc. | Oxygen enhancing membrane systems for implantable devices |
US8945910B2 (en) | 2003-09-29 | 2015-02-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
USD914881S1 (en) | 2003-11-05 | 2021-03-30 | Abbott Diabetes Care Inc. | Analyte sensor electronic mount |
USD902408S1 (en) | 2003-11-05 | 2020-11-17 | Abbott Diabetes Care Inc. | Analyte sensor control unit |
US20050121826A1 (en) * | 2003-12-03 | 2005-06-09 | Kiamars Hajizadeh | Multi-sensor device for motorized meter and methods thereof |
US8929968B2 (en) | 2003-12-05 | 2015-01-06 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US11627900B2 (en) | 2003-12-05 | 2023-04-18 | Dexcom, Inc. | Analyte sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US11020031B1 (en) | 2003-12-05 | 2021-06-01 | Dexcom, Inc. | Analyte sensor |
US11000215B1 (en) | 2003-12-05 | 2021-05-11 | Dexcom, Inc. | Analyte sensor |
US10188333B2 (en) | 2003-12-05 | 2019-01-29 | Dexcom, Inc. | Calibration techniques for a continuous analyte sensor |
US9561000B2 (en) | 2003-12-31 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US8296918B2 (en) | 2003-12-31 | 2012-10-30 | Sanofi-Aventis Deutschland Gmbh | Method of manufacturing a fluid sampling device with improved analyte detecting member configuration |
US8771183B2 (en) | 2004-02-17 | 2014-07-08 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US20050230252A1 (en) * | 2004-02-23 | 2005-10-20 | Tsai Fu H | Microfluidic test device |
US7807043B2 (en) | 2004-02-23 | 2010-10-05 | Oakville Hong Kong Company Limited | Microfluidic test device |
US10835672B2 (en) | 2004-02-26 | 2020-11-17 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US12102410B2 (en) | 2004-02-26 | 2024-10-01 | Dexcom, Inc | Integrated medicament delivery device for use with continuous analyte sensor |
US11246990B2 (en) | 2004-02-26 | 2022-02-15 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US12226617B2 (en) | 2004-02-26 | 2025-02-18 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US10966609B2 (en) | 2004-02-26 | 2021-04-06 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US12115357B2 (en) | 2004-02-26 | 2024-10-15 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US7166208B2 (en) | 2004-03-03 | 2007-01-23 | Stephen Eliot Zweig | Apoenzyme reactivation electrochemical detection method and assay |
US20050196820A1 (en) * | 2004-03-03 | 2005-09-08 | Zweig Stephen E. | Apoenzyme reactivation electrochemical detection method and assay |
US8277713B2 (en) | 2004-05-03 | 2012-10-02 | Dexcom, Inc. | Implantable analyte sensor |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
US9261476B2 (en) | 2004-05-20 | 2016-02-16 | Sanofi Sa | Printable hydrogel for biosensors |
US8268145B2 (en) | 2004-05-21 | 2012-09-18 | Agamatrix, Inc. | Electrochemical cell and method of making an electrochemical cell |
US20050258050A1 (en) * | 2004-05-21 | 2005-11-24 | Agamatrix, Inc. | Connector configuration for electrochemical cells and meters for use in combination therewith |
US20050258035A1 (en) * | 2004-05-21 | 2005-11-24 | Agamatrix, Inc. | Electrochemical Cell and Method of Making an Electrochemical Cell |
US8182636B2 (en) | 2004-05-21 | 2012-05-22 | Agamatrix, Inc. | Electrochemical cell and method of making an electrochemical cell |
US10203298B2 (en) | 2004-05-21 | 2019-02-12 | Agamatrix, Inc. | Electrochemical cell and method of making an electrochemical cell |
US7527716B2 (en) | 2004-05-21 | 2009-05-05 | Agamatrix, Inc. | Connector configuration for electrochemical cells and meters for use in combination therewith |
EP3059580A1 (en) | 2004-05-21 | 2016-08-24 | Agamatrix, Inc. | Electrochemical cell device for electrochemical measurement |
US20110173801A1 (en) * | 2004-05-21 | 2011-07-21 | Agamatrix, Inc. | Electrochemical Cell and Method of Making an Electrochemical Cell |
US9329150B2 (en) | 2004-05-21 | 2016-05-03 | Agamatrix, Inc. | Electrochemical cell and method of making an electrochemical cell |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US12056079B2 (en) | 2004-06-04 | 2024-08-06 | Abbott Diabetes Care Inc. | Systems and methods for managing diabetes care data |
US11507530B2 (en) | 2004-06-04 | 2022-11-22 | Abbott Diabetes Care Inc. | Systems and methods for managing diabetes care data |
US11182332B2 (en) | 2004-06-04 | 2021-11-23 | Abbott Diabetes Care Inc. | Systems and methods for managing diabetes care data |
US10963417B2 (en) | 2004-06-04 | 2021-03-30 | Abbott Diabetes Care Inc. | Systems and methods for managing diabetes care data |
US7569126B2 (en) | 2004-06-18 | 2009-08-04 | Roche Diagnostics Operations, Inc. | System and method for quality assurance of a biosensor test strip |
US8092668B2 (en) | 2004-06-18 | 2012-01-10 | Roche Diagnostics Operations, Inc. | System and method for quality assurance of a biosensor test strip |
US7556723B2 (en) | 2004-06-18 | 2009-07-07 | Roche Diagnostics Operations, Inc. | Electrode design for biosensor |
US9410915B2 (en) | 2004-06-18 | 2016-08-09 | Roche Operations Ltd. | System and method for quality assurance of a biosensor test strip |
US10980452B2 (en) | 2004-07-13 | 2021-04-20 | Dexcom, Inc. | Analyte sensor |
US10799159B2 (en) | 2004-07-13 | 2020-10-13 | Dexcom, Inc. | Analyte sensor |
US10799158B2 (en) | 2004-07-13 | 2020-10-13 | Dexcom, Inc. | Analyte sensor |
US11045120B2 (en) | 2004-07-13 | 2021-06-29 | Dexcom, Inc. | Analyte sensor |
US9414777B2 (en) | 2004-07-13 | 2016-08-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10918313B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US10524703B2 (en) | 2004-07-13 | 2020-01-07 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10932700B2 (en) | 2004-07-13 | 2021-03-02 | Dexcom, Inc. | Analyte sensor |
US10993641B2 (en) | 2004-07-13 | 2021-05-04 | Dexcom, Inc. | Analyte sensor |
US10993642B2 (en) | 2004-07-13 | 2021-05-04 | Dexcom, Inc. | Analyte sensor |
US10813576B2 (en) | 2004-07-13 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
US7885697B2 (en) | 2004-07-13 | 2011-02-08 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10918315B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US11026605B1 (en) | 2004-07-13 | 2021-06-08 | Dexcom, Inc. | Analyte sensor |
US11883164B2 (en) | 2004-07-13 | 2024-01-30 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10709363B2 (en) | 2004-07-13 | 2020-07-14 | Dexcom, Inc. | Analyte sensor |
US9986942B2 (en) | 2004-07-13 | 2018-06-05 | Dexcom, Inc. | Analyte sensor |
US10918314B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US10722152B2 (en) | 2004-07-13 | 2020-07-28 | Dexcom, Inc. | Analyte sensor |
US10827956B2 (en) | 2004-07-13 | 2020-11-10 | Dexcom, Inc. | Analyte sensor |
US11064917B2 (en) | 2004-07-13 | 2021-07-20 | Dexcom, Inc. | Analyte sensor |
US10709362B2 (en) | 2004-07-13 | 2020-07-14 | Dexcom, Inc. | Analyte sensor |
US8792953B2 (en) | 2004-07-13 | 2014-07-29 | Dexcom, Inc. | Transcutaneous analyte sensor |
CN1776414B (en) * | 2004-08-31 | 2010-11-03 | 生命扫描有限公司 | Electrochemical-based sensor with a redox polymer and redox enzyme entrapped by a dialysis membrane |
EP1630234A1 (en) * | 2004-08-31 | 2006-03-01 | Lifescan, Inc. | Electrochemical-based sensor with a redox polymer and redox enzyme entrapped by a dialysis membrane |
US7572356B2 (en) | 2004-08-31 | 2009-08-11 | Lifescan Scotland Limited | Electrochemical-based sensor with a redox polymer and redox enzyme entrapped by a dialysis membrane |
US20060042944A1 (en) * | 2004-08-31 | 2006-03-02 | Rodgers James I | Electrochemical-based sensor with a redox polymer and redox enzyme entrapped by a dialysis membrane |
US8571624B2 (en) | 2004-12-29 | 2013-10-29 | Abbott Diabetes Care Inc. | Method and apparatus for mounting a data transmission device in a communication system |
US10226207B2 (en) | 2004-12-29 | 2019-03-12 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
US11160475B2 (en) | 2004-12-29 | 2021-11-02 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US10898114B2 (en) | 2005-03-10 | 2021-01-26 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10925524B2 (en) | 2005-03-10 | 2021-02-23 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918316B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11051726B2 (en) | 2005-03-10 | 2021-07-06 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918318B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10716498B2 (en) | 2005-03-10 | 2020-07-21 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10743801B2 (en) | 2005-03-10 | 2020-08-18 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918317B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10856787B2 (en) | 2005-03-10 | 2020-12-08 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10617336B2 (en) | 2005-03-10 | 2020-04-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610135B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610137B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11000213B2 (en) | 2005-03-10 | 2021-05-11 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610136B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10709364B2 (en) | 2005-03-10 | 2020-07-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
US10300507B2 (en) | 2005-05-05 | 2019-05-28 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
US10813577B2 (en) | 2005-06-21 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
US8602991B2 (en) | 2005-08-30 | 2013-12-10 | Abbott Diabetes Care Inc. | Analyte sensor introducer and methods of use |
US10194850B2 (en) | 2005-08-31 | 2019-02-05 | Abbott Diabetes Care Inc. | Accuracy of continuous glucose sensors |
US11957463B2 (en) | 2005-08-31 | 2024-04-16 | Abbott Diabetes Care Inc. | Accuracy of continuous glucose sensors |
US9398882B2 (en) | 2005-09-30 | 2016-07-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor and data processing device |
US9480421B2 (en) | 2005-09-30 | 2016-11-01 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US10342489B2 (en) | 2005-09-30 | 2019-07-09 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US11457869B2 (en) | 2005-09-30 | 2022-10-04 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
US9775563B2 (en) | 2005-09-30 | 2017-10-03 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US10194863B2 (en) | 2005-09-30 | 2019-02-05 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
US10201301B2 (en) | 2005-11-01 | 2019-02-12 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11103165B2 (en) | 2005-11-01 | 2021-08-31 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11911151B1 (en) | 2005-11-01 | 2024-02-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11363975B2 (en) | 2005-11-01 | 2022-06-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11272867B2 (en) | 2005-11-01 | 2022-03-15 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8915850B2 (en) | 2005-11-01 | 2014-12-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9326716B2 (en) | 2005-11-01 | 2016-05-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8920319B2 (en) | 2005-11-01 | 2014-12-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10952652B2 (en) | 2005-11-01 | 2021-03-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10231654B2 (en) | 2005-11-01 | 2019-03-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11399748B2 (en) | 2005-11-01 | 2022-08-02 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9078607B2 (en) | 2005-11-01 | 2015-07-14 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9323898B2 (en) | 2005-11-04 | 2016-04-26 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US9669162B2 (en) | 2005-11-04 | 2017-06-06 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US11538580B2 (en) | 2005-11-04 | 2022-12-27 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US8585591B2 (en) | 2005-11-04 | 2013-11-19 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US20090162881A1 (en) * | 2005-11-14 | 2009-06-25 | Matsushita Electric Industrial Co., Ltd. | Method of measuring adenine nucleotide |
US7955484B2 (en) | 2005-12-14 | 2011-06-07 | Nova Biomedical Corporation | Glucose biosensor and method |
US20070131549A1 (en) * | 2005-12-14 | 2007-06-14 | Nova Biomedical Corporation | Glucose biosensor and method |
US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US9332933B2 (en) | 2005-12-28 | 2016-05-10 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US8852101B2 (en) | 2005-12-28 | 2014-10-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US9795331B2 (en) | 2005-12-28 | 2017-10-24 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US10307091B2 (en) | 2005-12-28 | 2019-06-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US8545403B2 (en) | 2005-12-28 | 2013-10-01 | Abbott Diabetes Care Inc. | Medical device insertion |
US11179071B2 (en) | 2006-02-28 | 2021-11-23 | Abbott Diabetes Care Inc | Analyte sensor transmitter unit configuration for a data monitoring and management system |
US9844329B2 (en) | 2006-02-28 | 2017-12-19 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
US11872039B2 (en) | 2006-02-28 | 2024-01-16 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
US11179072B2 (en) | 2006-02-28 | 2021-11-23 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
US9031630B2 (en) | 2006-02-28 | 2015-05-12 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
US10945647B2 (en) | 2006-02-28 | 2021-03-16 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
US10159433B2 (en) | 2006-02-28 | 2018-12-25 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
US11064916B2 (en) | 2006-02-28 | 2021-07-20 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
US10117614B2 (en) | 2006-02-28 | 2018-11-06 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
US20110011752A1 (en) * | 2006-03-31 | 2011-01-20 | Lifescan, Inc. | Systems and methods for discriminating contorl solution from a physiological sample |
US8529751B2 (en) | 2006-03-31 | 2013-09-10 | Lifescan, Inc. | Systems and methods for discriminating control solution from a physiological sample |
US9039975B2 (en) | 2006-03-31 | 2015-05-26 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8593109B2 (en) | 2006-03-31 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US9625413B2 (en) | 2006-03-31 | 2017-04-18 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8597575B2 (en) | 2006-03-31 | 2013-12-03 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US9380971B2 (en) | 2006-03-31 | 2016-07-05 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US8933664B2 (en) | 2006-03-31 | 2015-01-13 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US8449740B2 (en) | 2006-03-31 | 2013-05-28 | Lifescan, Inc. | Systems and methods for discriminating control solution from a physiological sample |
US9274078B2 (en) | 2006-03-31 | 2016-03-01 | Lifescan, Inc. | Systems and methods of discriminating control solution from a physiological sample |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US9743863B2 (en) | 2006-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US10028680B2 (en) | 2006-04-28 | 2018-07-24 | Abbott Diabetes Care Inc. | Introducer assembly and methods of use |
US10736547B2 (en) | 2006-04-28 | 2020-08-11 | Abbott Diabetes Care Inc. | Introducer assembly and methods of use |
US7920907B2 (en) | 2006-06-07 | 2011-04-05 | Abbott Diabetes Care Inc. | Analyte monitoring system and method |
US9808186B2 (en) | 2006-09-10 | 2017-11-07 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US8333714B2 (en) | 2006-09-10 | 2012-12-18 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US10362972B2 (en) | 2006-09-10 | 2019-07-30 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US8862198B2 (en) | 2006-09-10 | 2014-10-14 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
EP3543348A1 (en) | 2006-09-22 | 2019-09-25 | Ascensia Diabetes Care Holdings AG | Biosensor system having enhanced stability and hematocrit performance |
US8728299B2 (en) | 2006-09-22 | 2014-05-20 | Bayer Healthcare Llc | Biosensor performance increasing methods having enhanced stability and hematocrit performance |
US8702965B2 (en) | 2006-09-22 | 2014-04-22 | Bayer Healthcare Llc | Biosensor methods having enhanced stability and hematocrit performance |
US20110115504A1 (en) * | 2006-09-22 | 2011-05-19 | Bayer Healthcare Llc | Biosensor Methods Having Enhanced Stability and Hematocrit Performance |
US9239312B2 (en) | 2006-09-22 | 2016-01-19 | Bayer Healthcare Llc | Methods of determining analyte concentration having enhanced stability and hematocrit performance |
US9459229B2 (en) | 2006-09-22 | 2016-10-04 | Ascenia Diabetes Care Holdings AG | Electrochemical test sensor |
US20080156662A1 (en) * | 2006-09-22 | 2008-07-03 | Bayer Healthcare Llc | Biosensor System Having Enhanced Stability And Hematocrit Performance |
US10261044B2 (en) | 2006-09-22 | 2019-04-16 | Ascensia Diabetes Care Holdings Ag | Electrochemical test sensor |
US7862696B2 (en) | 2006-09-22 | 2011-01-04 | Bayer Healthcare Llc | Biosensor system having enhanced stability and hematocrit performance |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US11399745B2 (en) | 2006-10-04 | 2022-08-02 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US12274548B2 (en) | 2006-10-23 | 2025-04-15 | Abbott Diabetes Care Inc. | Sensor insertion devices and methods of use |
US11724029B2 (en) | 2006-10-23 | 2023-08-15 | Abbott Diabetes Care Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US10363363B2 (en) | 2006-10-23 | 2019-07-30 | Abbott Diabetes Care Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US9259175B2 (en) | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US9788771B2 (en) | 2006-10-23 | 2017-10-17 | Abbott Diabetes Care Inc. | Variable speed sensor insertion devices and methods of use |
US11234621B2 (en) | 2006-10-23 | 2022-02-01 | Abbott Diabetes Care Inc. | Sensor insertion devices and methods of use |
US10070810B2 (en) | 2006-10-23 | 2018-09-11 | Abbott Diabetes Care Inc. | Sensor insertion devices and methods of use |
US9814428B2 (en) | 2006-10-25 | 2017-11-14 | Abbott Diabetes Care Inc. | Method and system for providing analyte monitoring |
US9113828B2 (en) | 2006-10-25 | 2015-08-25 | Abbott Diabetes Care Inc. | Method and system for providing analyte monitoring |
US11282603B2 (en) | 2006-10-25 | 2022-03-22 | Abbott Diabetes Care Inc. | Method and system for providing analyte monitoring |
US10194868B2 (en) | 2006-10-25 | 2019-02-05 | Abbott Diabetes Care Inc. | Method and system for providing analyte monitoring |
US11722229B2 (en) | 2006-10-26 | 2023-08-08 | Abbott Diabetes Care Inc. | Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors |
US10903914B2 (en) | 2006-10-26 | 2021-01-26 | Abbott Diabetes Care Inc. | Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors |
US9882660B2 (en) | 2006-10-26 | 2018-01-30 | Abbott Diabetes Care Inc. | Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors |
US20080099332A1 (en) * | 2006-10-31 | 2008-05-01 | Steve Scott | Analyte Monitoring Devices |
US20080119709A1 (en) * | 2006-10-31 | 2008-05-22 | Yi Wang | Analyte Monitoring |
US7740580B2 (en) | 2006-10-31 | 2010-06-22 | Abbott Diabetes Care Inc. | Analyte monitoring |
US8158081B2 (en) | 2006-10-31 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring devices |
US20090270706A1 (en) * | 2006-10-31 | 2009-10-29 | Abbott Diabetes Care Inc. | Analyte monitoring |
US20100022954A1 (en) * | 2006-12-26 | 2010-01-28 | Frederic Arbogast | Analyte Meter Protectors and Methods |
US20080234559A1 (en) * | 2006-12-26 | 2008-09-25 | Frederic Arbogast | Analyte Meter Protectors and Methods |
US7897107B2 (en) | 2006-12-26 | 2011-03-01 | Abbott Diabetes Care Inc. | Analyte meter protectors and methods |
US8080205B2 (en) | 2006-12-26 | 2011-12-20 | Abbott Diabetes Care Inc. | Analyte meter protectors and methods |
US7914742B2 (en) | 2006-12-26 | 2011-03-29 | Abbott Diabetes Care Inc. | Analyte meter protectors and methods |
US20090264717A1 (en) * | 2006-12-26 | 2009-10-22 | Abbott Diabetes Care Inc. | Analyte meter protectors and methods |
US20090264725A1 (en) * | 2006-12-26 | 2009-10-22 | Abbott Diabetes Care Inc. | Analyte meter protectors and methods |
US20100016788A1 (en) * | 2006-12-26 | 2010-01-21 | Frederic Arbogast | Analyte Meter Protectors and Methods |
US20090264726A1 (en) * | 2006-12-26 | 2009-10-22 | Abbott Diabetes Care Inc. | Analyte meter protectors and methods |
US7846386B2 (en) | 2006-12-26 | 2010-12-07 | Abbott Diabetes Care Inc. | Analyte meter protectors and methods |
US7842241B2 (en) | 2006-12-26 | 2010-11-30 | Abbott Diabetes Care Inc. | Analyte meter protectors and methods |
US7846388B2 (en) | 2006-12-26 | 2010-12-07 | Abbott Diabetes Care Inc. | Analyte meter protectors and methods |
US7846385B2 (en) | 2006-12-26 | 2010-12-07 | Abbott Diabetes Care Inc. | Analyte meter protectors and methods |
US7820105B2 (en) | 2006-12-26 | 2010-10-26 | Abbott Diabetes Care Inc. | Analyte meter protectors and methods |
US20090270697A1 (en) * | 2006-12-26 | 2009-10-29 | Frederic Arbogast | Analyte meter protectors and methods |
US20090270696A1 (en) * | 2006-12-26 | 2009-10-29 | Frederic Arbogast | Analyte meter protectors and methods |
US7867446B2 (en) | 2006-12-26 | 2011-01-11 | Abbott Diabetes Care Inc. | Analyte meter protectors and methods |
US7846387B2 (en) | 2006-12-26 | 2010-12-07 | Abbott Diabetes Care Inc. | Analyte meter protectors and methods |
US20100066535A1 (en) * | 2006-12-26 | 2010-03-18 | Abbott Diabetes Care Inc. | Analyte Meter Protectors and Methods |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US12040067B2 (en) | 2007-02-18 | 2024-07-16 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US9636450B2 (en) | 2007-02-19 | 2017-05-02 | Udo Hoss | Pump system modular components for delivering medication and analyte sensing at seperate insertion sites |
US9095290B2 (en) | 2007-03-01 | 2015-08-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US9801545B2 (en) | 2007-03-01 | 2017-10-31 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US10178954B2 (en) | 2007-05-08 | 2019-01-15 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9035767B2 (en) | 2007-05-08 | 2015-05-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8593287B2 (en) | 2007-05-08 | 2013-11-26 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9949678B2 (en) | 2007-05-08 | 2018-04-24 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US9574914B2 (en) | 2007-05-08 | 2017-02-21 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US11696684B2 (en) | 2007-05-08 | 2023-07-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US10952611B2 (en) | 2007-05-08 | 2021-03-23 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9177456B2 (en) | 2007-05-08 | 2015-11-03 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9314198B2 (en) | 2007-05-08 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9649057B2 (en) | 2007-05-08 | 2017-05-16 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9000929B2 (en) | 2007-05-08 | 2015-04-07 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US10653317B2 (en) | 2007-05-08 | 2020-05-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8149117B2 (en) | 2007-05-08 | 2012-04-03 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US8362904B2 (en) | 2007-05-08 | 2013-01-29 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US10791928B2 (en) | 2007-05-18 | 2020-10-06 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US8083925B2 (en) | 2007-05-31 | 2011-12-27 | Abbott Diabetes Care Inc. | Analyte determination methods and devices |
US8080153B2 (en) | 2007-05-31 | 2011-12-20 | Abbott Diabetes Care Inc. | Analyte determination methods and devices |
US20090000959A1 (en) * | 2007-05-31 | 2009-01-01 | Feldman Benjamin J | Analyte determination methods and devices |
US8414759B2 (en) | 2007-05-31 | 2013-04-09 | Abbott Diabetes Care Inc. | Analyte determination methods and devices |
US8613703B2 (en) | 2007-05-31 | 2013-12-24 | Abbott Diabetes Care Inc. | Insertion devices and methods |
US20100159570A1 (en) * | 2007-05-31 | 2010-06-24 | Abbott Diabetes Care Inc. | Analyte Determination Methods and Devices |
US10403012B2 (en) | 2007-06-08 | 2019-09-03 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US9741139B2 (en) | 2007-06-08 | 2017-08-22 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US8562558B2 (en) | 2007-06-08 | 2013-10-22 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US11373347B2 (en) | 2007-06-08 | 2022-06-28 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
EP3533387A2 (en) | 2007-06-21 | 2019-09-04 | Abbott Diabetes Care, Inc. | Health management devices and methods |
US11276492B2 (en) | 2007-06-21 | 2022-03-15 | Abbott Diabetes Care Inc. | Health management devices and methods |
US11264133B2 (en) | 2007-06-21 | 2022-03-01 | Abbott Diabetes Care Inc. | Health management devices and methods |
WO2008157820A1 (en) | 2007-06-21 | 2008-12-24 | Abbott Diabetes Care, Inc. | Health management devices and methods |
EP3473167A1 (en) | 2007-06-21 | 2019-04-24 | Abbott Diabetes Care, Inc. | Health monitor |
US11678821B2 (en) | 2007-06-29 | 2023-06-20 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
US10856785B2 (en) | 2007-06-29 | 2020-12-08 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
US9913600B2 (en) | 2007-06-29 | 2018-03-13 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
US11307201B2 (en) | 2007-09-17 | 2022-04-19 | Red Ivory Llc | Self-actuating signal producing detection devices and methods |
US20090117574A1 (en) * | 2007-09-17 | 2009-05-07 | Siometrix Corporation | Self-actuating signal producing detection devices and methods |
US8778168B2 (en) | 2007-09-28 | 2014-07-15 | Lifescan, Inc. | Systems and methods of discriminating control solution from a physiological sample |
US9157110B2 (en) | 2007-09-28 | 2015-10-13 | Lifescan, Inc. | Systems and methods of discriminating control solution from a physiological sample |
US11744943B2 (en) | 2007-10-09 | 2023-09-05 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US11160926B1 (en) | 2007-10-09 | 2021-11-02 | Dexcom, Inc. | Pre-connected analyte sensors |
US12246166B2 (en) | 2007-10-09 | 2025-03-11 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
US10182751B2 (en) | 2007-10-25 | 2019-01-22 | Dexcom, Inc. | Systems and methods for processing sensor data |
US11272869B2 (en) | 2007-10-25 | 2022-03-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9717449B2 (en) | 2007-10-25 | 2017-08-01 | Dexcom, Inc. | Systems and methods for processing sensor data |
US20090145756A1 (en) * | 2007-12-10 | 2009-06-11 | Bayer Healthcare Llc | Method of depositing reagent material in a test sensor |
US9039878B2 (en) | 2007-12-10 | 2015-05-26 | Bayer Healthcare Llc | Mediator for test sensor |
US9656976B2 (en) | 2007-12-10 | 2017-05-23 | Ascensia Diabetes Care Holdings Ag | Mediator for test sensor |
US10696998B2 (en) | 2007-12-10 | 2020-06-30 | Ascensia Diabetes Care Holdings Ag | Reagents and methods for detecting analytes |
US20090145775A1 (en) * | 2007-12-10 | 2009-06-11 | Bayer Healthcare Llc | Reagents and methods for detecting analytes |
US11442035B2 (en) | 2007-12-10 | 2022-09-13 | Ascensia Diabetes Care Holdings Ag | Electrochemical test sensor |
US9829459B2 (en) | 2007-12-10 | 2017-11-28 | Ascensia Diabetes Care Holdings Ag | Electrochemical test sensor and method of forming the same |
US8609180B2 (en) | 2007-12-10 | 2013-12-17 | Bayer Healthcare Llc | Method of depositing reagent material in a test sensor |
US11180790B2 (en) | 2007-12-10 | 2021-11-23 | Ascensia Diabetes Care Holdings Ag | Reagents and methods for detecting analytes |
US20090171081A1 (en) * | 2007-12-10 | 2009-07-02 | Bayer Healthcare Llc | Process of making 3-phenylimino-3h-phenothiazine or 3-phenylimino-3h-phenoxazine mediator |
US8022204B2 (en) | 2007-12-10 | 2011-09-20 | Bayer Healthcare Llc | Process of making 3-phenylimino-3H-phenothiazine |
US8357797B2 (en) | 2007-12-10 | 2013-01-22 | Bayer Healthcare Llc | Process of making 3-phenylimino-3H-phenoxazine mediator |
US8290559B2 (en) | 2007-12-17 | 2012-10-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9839395B2 (en) | 2007-12-17 | 2017-12-12 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9149234B2 (en) | 2007-12-17 | 2015-10-06 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9149233B2 (en) | 2007-12-17 | 2015-10-06 | Dexcom, Inc. | Systems and methods for processing sensor data |
US12165757B2 (en) | 2007-12-17 | 2024-12-10 | Dexcom, Inc. | Systems and methods for processing sensor data |
US10506982B2 (en) | 2007-12-17 | 2019-12-17 | Dexcom, Inc. | Systems and methods for processing sensor data |
US10827980B2 (en) | 2007-12-17 | 2020-11-10 | Dexcom, Inc. | Systems and methods for processing sensor data |
US11342058B2 (en) | 2007-12-17 | 2022-05-24 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9901307B2 (en) | 2007-12-17 | 2018-02-27 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9339238B2 (en) | 2007-12-17 | 2016-05-17 | Dexcom, Inc. | Systems and methods for processing sensor data |
US10685749B2 (en) | 2007-12-19 | 2020-06-16 | Abbott Diabetes Care Inc. | Insulin delivery apparatuses capable of bluetooth data transmission |
US8709739B2 (en) | 2008-01-17 | 2014-04-29 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
US9739749B2 (en) | 2008-01-17 | 2017-08-22 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
US8916040B2 (en) | 2008-01-17 | 2014-12-23 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
US8603768B2 (en) | 2008-01-17 | 2013-12-10 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
US20090184004A1 (en) | 2008-01-17 | 2009-07-23 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
US9566026B2 (en) | 2008-03-28 | 2017-02-14 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US11147483B2 (en) | 2008-03-28 | 2021-10-19 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US9549699B2 (en) | 2008-03-28 | 2017-01-24 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US9572523B2 (en) | 2008-03-28 | 2017-02-21 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US9173607B2 (en) | 2008-03-28 | 2015-11-03 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US10143410B2 (en) | 2008-03-28 | 2018-12-04 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US9173606B2 (en) | 2008-03-28 | 2015-11-03 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8583204B2 (en) | 2008-03-28 | 2013-11-12 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8682408B2 (en) | 2008-03-28 | 2014-03-25 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US11730407B2 (en) | 2008-03-28 | 2023-08-22 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8954128B2 (en) | 2008-03-28 | 2015-02-10 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US9693721B2 (en) | 2008-03-28 | 2017-07-04 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US9931075B2 (en) | 2008-05-30 | 2018-04-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US11735295B2 (en) | 2008-05-30 | 2023-08-22 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US9541556B2 (en) | 2008-05-30 | 2017-01-10 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US9795328B2 (en) | 2008-05-30 | 2017-10-24 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US12165751B2 (en) | 2008-05-30 | 2024-12-10 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US10327682B2 (en) | 2008-05-30 | 2019-06-25 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US9784707B2 (en) | 2008-06-09 | 2017-10-10 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
US8551320B2 (en) | 2008-06-09 | 2013-10-08 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
US9046479B2 (en) | 2008-06-24 | 2015-06-02 | Panasonic Healthcare Holdings Co., Ltd. | Biosensor, method of producing the same and detection system comprising the same |
US10328201B2 (en) | 2008-07-14 | 2019-06-25 | Abbott Diabetes Care Inc. | Closed loop control system interface and methods |
US11621073B2 (en) | 2008-07-14 | 2023-04-04 | Abbott Diabetes Care Inc. | Closed loop control system interface and methods |
US7914335B2 (en) | 2008-07-17 | 2011-03-29 | Abbott Diabetes Care Inc. | Strip connectors for measurement devices |
US7896704B2 (en) | 2008-07-17 | 2011-03-01 | Abbott Diabetes Care Inc. | Strip connectors for measurement devices |
US20100015860A1 (en) * | 2008-07-17 | 2010-01-21 | Abbott Diabetes Care, Inc. | Strip connectors for measurement devices |
US20100065426A1 (en) * | 2008-07-17 | 2010-03-18 | Abbott Diabetes Care Inc. | Strip Connectors For Measurement Devices |
US7896703B2 (en) | 2008-07-17 | 2011-03-01 | Abbott Diabetes Care Inc. | Strip connectors for measurement devices |
US20100315106A1 (en) * | 2008-07-17 | 2010-12-16 | Abbott Diabetes Care Inc. | Strip Connectors For Measurement Devices |
US9645105B2 (en) | 2008-07-17 | 2017-05-09 | Abbott Diabetes Care Inc. | Analyte measurement devices and systems, and components and methods related thereto |
US9417205B2 (en) | 2008-07-17 | 2016-08-16 | Abbott Diabetes Care Inc. | Analyte measurement devices and systems, and components and methods related thereto |
US11679200B2 (en) | 2008-08-31 | 2023-06-20 | Abbott Diabetes Care Inc. | Closed loop control and signal attenuation detection |
US10188794B2 (en) | 2008-08-31 | 2019-01-29 | Abbott Diabetes Care Inc. | Closed loop control and signal attenuation detection |
US10028683B2 (en) | 2008-09-19 | 2018-07-24 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
US10028684B2 (en) | 2008-09-19 | 2018-07-24 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
US8560039B2 (en) | 2008-09-19 | 2013-10-15 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
US9339222B2 (en) | 2008-09-19 | 2016-05-17 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
US10561352B2 (en) | 2008-09-19 | 2020-02-18 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
US11918354B2 (en) | 2008-09-19 | 2024-03-05 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
US11013439B2 (en) | 2008-09-30 | 2021-05-25 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US11484234B2 (en) | 2008-09-30 | 2022-11-01 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US11202592B2 (en) | 2008-09-30 | 2021-12-21 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US9662056B2 (en) | 2008-09-30 | 2017-05-30 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US11464434B2 (en) | 2008-09-30 | 2022-10-11 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US12274549B2 (en) | 2008-09-30 | 2025-04-15 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US12279868B2 (en) | 2008-09-30 | 2025-04-22 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US10980461B2 (en) | 2008-11-07 | 2021-04-20 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US9326707B2 (en) | 2008-11-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Alarm characterization for analyte monitoring devices and systems |
US11272890B2 (en) | 2008-11-10 | 2022-03-15 | Abbott Diabetes Care Inc. | Alarm characterization for analyte monitoring devices and systems |
US9730650B2 (en) | 2008-11-10 | 2017-08-15 | Abbott Diabetes Care Inc. | Alarm characterization for analyte monitoring devices and systems |
US11678848B2 (en) | 2008-11-10 | 2023-06-20 | Abbott Diabetes Care Inc. | Alarm characterization for analyte monitoring devices and systems |
US9066709B2 (en) | 2009-01-29 | 2015-06-30 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US8676513B2 (en) | 2009-01-29 | 2014-03-18 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US11464430B2 (en) | 2009-01-29 | 2022-10-11 | Abbott Diabetes Care Inc. | Method and device for providing offset model based calibration for analyte sensor |
US8473220B2 (en) | 2009-01-29 | 2013-06-25 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US10089446B2 (en) | 2009-01-29 | 2018-10-02 | Abbott Diabetes Care Inc. | Method and device for providing offset model based calibration for analyte sensor |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
EP3329842A1 (en) | 2009-02-03 | 2018-06-06 | Abbott Diabetes Care, Inc. | Compact on-body physiological monitoring device |
US11006871B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
EP4477243A2 (en) | 2009-02-03 | 2024-12-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US10786190B2 (en) | 2009-02-03 | 2020-09-29 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
EP3730044A1 (en) | 2009-02-03 | 2020-10-28 | Abbott Diabetes Care, Inc. | Compact on-body physiological monitoring device |
EP3730045A1 (en) | 2009-02-03 | 2020-10-28 | Abbott Diabetes Care Inc. | Method for inserting analyte sensor |
US11202591B2 (en) | 2009-02-03 | 2021-12-21 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
EP4545118A2 (en) | 2009-02-03 | 2025-04-30 | Abbott Diabetes Care, Inc. | Compact on-body physiological monitoring devices and methods thereof |
US9993188B2 (en) | 2009-02-03 | 2018-06-12 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US9402544B2 (en) | 2009-02-03 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
EP3542712A1 (en) | 2009-02-03 | 2019-09-25 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006872B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006870B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US9636068B2 (en) | 2009-02-03 | 2017-05-02 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11213229B2 (en) | 2009-02-03 | 2022-01-04 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
EP3977921A1 (en) | 2009-02-03 | 2022-04-06 | Abbott Diabetes Care, Inc. | Analyte sensor and apparatus for insertion of the sensor |
EP3960072A1 (en) | 2009-02-03 | 2022-03-02 | Abbott Diabetes Care, Inc. | Compact on-body physiological monitoring devices and methods thereof |
WO2010091005A1 (en) | 2009-02-03 | 2010-08-12 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11166656B2 (en) | 2009-02-03 | 2021-11-09 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US20100198188A1 (en) * | 2009-02-05 | 2010-08-05 | Abbott Diabetes Care Inc. | Devices and Methods for Metering Insoluble Active Agent Particles |
US9668684B2 (en) | 2009-02-26 | 2017-06-06 | Abbott Diabetes Care Inc. | Self-powered analyte sensor |
US9724029B2 (en) | 2009-02-26 | 2017-08-08 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
EP3912551A1 (en) | 2009-02-26 | 2021-11-24 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte sensor |
EP3714788A1 (en) | 2009-02-26 | 2020-09-30 | Abbott Diabetes Care, Inc. | Improved analyte sensors and methods of making and using the same |
US10022077B2 (en) | 2009-02-26 | 2018-07-17 | Abbott Diabeetes Care Inc. | Analyte monitoring devices and methods |
EP4252638A2 (en) | 2009-02-26 | 2023-10-04 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte sensor |
US9339229B2 (en) | 2009-02-26 | 2016-05-17 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods |
US8965477B2 (en) | 2009-02-26 | 2015-02-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
EP4449989A2 (en) | 2009-02-26 | 2024-10-23 | Abbott Diabetes Care, Inc. | Improved analyte sensors and methods of making and using the same |
US9526453B2 (en) | 2009-02-26 | 2016-12-27 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods |
EP4252639A2 (en) | 2009-02-26 | 2023-10-04 | Abbott Diabetes Care Inc. | Method of calibrating an analyte sensor |
US10631768B2 (en) | 2009-02-26 | 2020-04-28 | Abbott Diabetes Inc. | Self-powered analyte sensor |
US20100270150A1 (en) * | 2009-04-28 | 2010-10-28 | Abbott Diabetes Care Inc. | Smart Sensor Ports and Methods of Using Same |
US20100274181A1 (en) * | 2009-04-28 | 2010-10-28 | Abbott Diabetes Care Inc. | Smart sensor ports and methods of using same |
US10058653B2 (en) | 2009-04-28 | 2018-08-28 | Abbott Diabetes Care Inc. | Smart sensor ports and methods of using same |
US8758583B2 (en) | 2009-04-28 | 2014-06-24 | Abbott Diabetes Care Inc. | Smart sensor ports and methods of using same |
US20100270149A1 (en) * | 2009-04-28 | 2010-10-28 | Abbott Diabetes Care Inc. | Smart Sensor Ports and Methods of Using Same |
US9207201B2 (en) | 2009-04-28 | 2015-12-08 | Abbott Diabetes Care Inc. | Smart sensor ports and methods of using same |
US8764954B2 (en) | 2009-04-28 | 2014-07-01 | Abbott Diabetes Care Inc. | Smart sensor ports and methods of using same |
US9494546B2 (en) | 2009-04-28 | 2016-11-15 | Abbott Diabetes Care Inc. | Smart sensor ports and methods of using same |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
US8771486B2 (en) | 2009-04-28 | 2014-07-08 | Abbott Diabetes Care Inc. | Smart sensor ports and methods of using same |
US8236254B2 (en) | 2009-05-14 | 2012-08-07 | Abbott Diabetes Care Inc. | Cap-linked test strip carrier for vial augmentation |
US20100290956A1 (en) * | 2009-05-14 | 2010-11-18 | Abbott Diabetes Care Inc. | Cap-linked test strip carrier for vial augmentation |
US11793936B2 (en) | 2009-05-29 | 2023-10-24 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
WO2010138817A1 (en) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Glucose monitoring system with wireless communications |
US11872370B2 (en) | 2009-05-29 | 2024-01-16 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11309078B2 (en) | 2009-06-04 | 2022-04-19 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
US9940436B2 (en) | 2009-06-04 | 2018-04-10 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
WO2010141922A1 (en) | 2009-06-04 | 2010-12-09 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
US11152112B2 (en) | 2009-06-04 | 2021-10-19 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
US11854693B2 (en) | 2009-06-04 | 2023-12-26 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
US11559229B2 (en) | 2009-07-02 | 2023-01-24 | Dexcom, Inc. | Analyte sensor |
US9320466B2 (en) | 2009-07-02 | 2016-04-26 | Dexcom, Inc. | Analyte sensor |
US9907497B2 (en) | 2009-07-02 | 2018-03-06 | Dexcom, Inc. | Analyte sensor |
US10420494B2 (en) | 2009-07-02 | 2019-09-24 | Dexcom, Inc. | Analyte sensor |
US12011266B2 (en) | 2009-07-02 | 2024-06-18 | Dexcom, Inc. | Analyte sensor |
EP4252648A2 (en) | 2009-07-23 | 2023-10-04 | Abbott Diabetes Care Inc. | Continuous analyte measurement systems and systems and methods for implanting them |
US10827954B2 (en) | 2009-07-23 | 2020-11-10 | Abbott Diabetes Care Inc. | Continuous analyte measurement systems and systems and methods for implanting them |
EP4289355A2 (en) | 2009-07-23 | 2023-12-13 | Abbott Diabetes Care Inc. | Continuous analyte measurement system |
EP3689237A1 (en) | 2009-07-23 | 2020-08-05 | Abbott Diabetes Care, Inc. | System and method for continuous analyte measurement |
US9795326B2 (en) | 2009-07-23 | 2017-10-24 | Abbott Diabetes Care Inc. | Continuous analyte measurement systems and systems and methods for implanting them |
EP3932309A1 (en) | 2009-07-23 | 2022-01-05 | Abbott Diabetes Care, Inc. | Continuous analyte measurement system |
EP4309580A2 (en) | 2009-07-23 | 2024-01-24 | Abbott Diabetes Care Inc. | Continuous analyte measurement system |
EP4473908A2 (en) | 2009-07-23 | 2024-12-11 | Abbott Diabetes Care, Inc. | Continuous analyte measurement system |
US9101303B2 (en) | 2009-08-11 | 2015-08-11 | Abbott Diabetes Care Inc. | Analyte sensor ports |
US10031124B2 (en) | 2009-08-11 | 2018-07-24 | Abbott Diabetes Care Inc. | Analyte sensor ports |
US20110040246A1 (en) * | 2009-08-11 | 2011-02-17 | Galasso John R | Analyte sensor ports |
US20110040164A1 (en) * | 2009-08-11 | 2011-02-17 | Analyte Sensor Ports | Analyte Sensor Ports |
US9125603B2 (en) | 2009-08-11 | 2015-09-08 | Abbott Diabetes Care Inc. | Analyte sensor ports |
US9968302B2 (en) | 2009-08-31 | 2018-05-15 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US20110048940A1 (en) * | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Small volume test strips with large sample fill ports, supported test strips, and methods of making and using same |
US10492685B2 (en) | 2009-08-31 | 2019-12-03 | Abbott Diabetes Care Inc. | Medical devices and methods |
US8993331B2 (en) | 2009-08-31 | 2015-03-31 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
US12279894B2 (en) | 2009-08-31 | 2025-04-22 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US11150145B2 (en) | 2009-08-31 | 2021-10-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
US9314195B2 (en) | 2009-08-31 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US8357276B2 (en) | 2009-08-31 | 2013-01-22 | Abbott Diabetes Care Inc. | Small volume test strips with large sample fill ports, supported test strips, and methods of making and using same |
US9011656B2 (en) | 2009-08-31 | 2015-04-21 | Abbott Diabetes Care Inc. | Small volume test strips with large sample fill ports, supported test strips, and methods of making and using same |
US8679311B2 (en) | 2009-08-31 | 2014-03-25 | Abbott Diabetes Care Inc. | Small volume test strips with large sample fill ports, supported test strips, and methods of making and using same |
US11635332B2 (en) | 2009-08-31 | 2023-04-25 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
EP3923295A1 (en) | 2009-08-31 | 2021-12-15 | Abbott Diabetes Care, Inc. | Medical devices and methods |
US11045147B2 (en) | 2009-08-31 | 2021-06-29 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
EP3001194A1 (en) | 2009-08-31 | 2016-03-30 | Abbott Diabetes Care, Inc. | Medical devices and methods |
US10429250B2 (en) | 2009-08-31 | 2019-10-01 | Abbott Diabetes Care, Inc. | Analyte monitoring system and methods for managing power and noise |
US10136816B2 (en) | 2009-08-31 | 2018-11-27 | Abbott Diabetes Care Inc. | Medical devices and methods |
USD1010133S1 (en) | 2009-08-31 | 2024-01-02 | Abbott Diabetes Care Inc. | Analyte sensor assembly |
US9320461B2 (en) | 2009-09-29 | 2016-04-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
US9750439B2 (en) | 2009-09-29 | 2017-09-05 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
US10349874B2 (en) | 2009-09-29 | 2019-07-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
US9351669B2 (en) | 2009-09-30 | 2016-05-31 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US11259725B2 (en) | 2009-09-30 | 2022-03-01 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US10765351B2 (en) | 2009-09-30 | 2020-09-08 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US9750444B2 (en) | 2009-09-30 | 2017-09-05 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US10117606B2 (en) | 2009-10-30 | 2018-11-06 | Abbott Diabetes Care Inc. | Method and apparatus for detecting false hypoglycemic conditions |
US11207005B2 (en) | 2009-10-30 | 2021-12-28 | Abbott Diabetes Care Inc. | Method and apparatus for detecting false hypoglycemic conditions |
WO2011053881A1 (en) | 2009-10-30 | 2011-05-05 | Abbott Diabetes Care Inc. | Method and apparatus for detecting false hypoglycemic conditions |
US12048530B2 (en) | 2009-10-30 | 2024-07-30 | Abbott Diabetes Care Inc. | Method and apparatus for detecting false hypoglycemic conditions |
US8828330B2 (en) | 2010-01-28 | 2014-09-09 | Abbott Diabetes Care Inc. | Universal test strip port |
US9291591B2 (en) | 2010-01-28 | 2016-03-22 | Abbott Diabetes Care Inc. | Universal test strip port |
US20110184264A1 (en) * | 2010-01-28 | 2011-07-28 | Abbott Diabetes Care Inc. | Universal Test Strip Port |
USD924406S1 (en) | 2010-02-01 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
US11954273B2 (en) | 2010-03-10 | 2024-04-09 | Abbott Diabetes Care Inc. | Systems, devices and methods for managing glucose levels |
US11061491B2 (en) | 2010-03-10 | 2021-07-13 | Abbott Diabetes Care Inc. | Systems, devices and methods for managing glucose levels |
US10078380B2 (en) | 2010-03-10 | 2018-09-18 | Abbott Diabetes Care Inc. | Systems, devices and methods for managing glucose levels |
US10881340B2 (en) | 2010-03-24 | 2021-01-05 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US11064922B1 (en) | 2010-03-24 | 2021-07-20 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US10772547B1 (en) | 2010-03-24 | 2020-09-15 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
EP4434458A2 (en) | 2010-03-24 | 2024-09-25 | Abbott Diabetes Care, Inc. | Medical device inserters |
US11000216B2 (en) | 2010-03-24 | 2021-05-11 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US8764657B2 (en) | 2010-03-24 | 2014-07-01 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US11246519B2 (en) | 2010-03-24 | 2022-02-15 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US10959654B2 (en) | 2010-03-24 | 2021-03-30 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US10952657B2 (en) | 2010-03-24 | 2021-03-23 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
EP3622883A1 (en) | 2010-03-24 | 2020-03-18 | Abbott Diabetes Care, Inc. | Medical device inserters and processes of inserting and using medical devices |
US10945649B2 (en) | 2010-03-24 | 2021-03-16 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US11013440B2 (en) | 2010-03-24 | 2021-05-25 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US11266335B2 (en) | 2010-03-24 | 2022-03-08 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US10292632B2 (en) | 2010-03-24 | 2019-05-21 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US10010280B2 (en) | 2010-03-24 | 2018-07-03 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US9215992B2 (en) | 2010-03-24 | 2015-12-22 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
WO2011119896A1 (en) | 2010-03-24 | 2011-09-29 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
EP4066731A1 (en) | 2010-03-24 | 2022-10-05 | Abbott Diabetes Care, Inc. | Medical device inserters |
US9265453B2 (en) | 2010-03-24 | 2016-02-23 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US9687183B2 (en) | 2010-03-24 | 2017-06-27 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
EP3766408A1 (en) | 2010-03-24 | 2021-01-20 | Abbott Diabetes Care, Inc. | Medical device inserters and processes of inserting and using medical devices |
EP4245220A2 (en) | 2010-03-24 | 2023-09-20 | Abbott Diabetes Care, Inc. | Medical device inserters |
US10881341B1 (en) | 2010-03-24 | 2021-01-05 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
USD948722S1 (en) | 2010-03-24 | 2022-04-12 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
US11058334B1 (en) | 2010-03-24 | 2021-07-13 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US9186098B2 (en) | 2010-03-24 | 2015-11-17 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
EP4248866A2 (en) | 2010-03-24 | 2023-09-27 | Abbott Diabetes Care, Inc. | Medical device inserters |
US9320432B2 (en) | 2010-04-16 | 2016-04-26 | Abbott Diabetes Care Inc. | Analyte meter communication module |
US11992313B2 (en) | 2010-04-16 | 2024-05-28 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
WO2011130545A1 (en) | 2010-04-16 | 2011-10-20 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US10285632B2 (en) | 2010-04-16 | 2019-05-14 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US9198623B2 (en) | 2010-04-22 | 2015-12-01 | Abbott Diabetes Care Inc. | Devices, systems, and methods related to analyte monitoring and management |
US9339219B2 (en) | 2010-04-22 | 2016-05-17 | Abbott Diabetes Care Inc. | Devices, systems, and methods related to analyte monitoring and management |
US11169794B2 (en) | 2010-05-24 | 2021-11-09 | Abbott Diabetes Care Inc. | Systems and methods for updating a medical device |
US9501272B2 (en) | 2010-05-24 | 2016-11-22 | Abbott Diabetes Care Inc. | Systems and methods for updating a medical device |
US10255055B2 (en) | 2010-05-24 | 2019-04-09 | Abbott Diabetes Care Inc. | Systems and methods for updating a medical device |
US11748088B2 (en) | 2010-05-24 | 2023-09-05 | Abbott Diabetes Care Inc. | Systems and methods for updating a medical device |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US10092229B2 (en) | 2010-06-29 | 2018-10-09 | Abbott Diabetes Care Inc. | Calibration of analyte measurement system |
US11478173B2 (en) | 2010-06-29 | 2022-10-25 | Abbott Diabetes Care Inc. | Calibration of analyte measurement system |
US10973449B2 (en) | 2010-06-29 | 2021-04-13 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US10959653B2 (en) | 2010-06-29 | 2021-03-30 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US11064921B2 (en) | 2010-06-29 | 2021-07-20 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US10966644B2 (en) | 2010-06-29 | 2021-04-06 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US9572534B2 (en) | 2010-06-29 | 2017-02-21 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US10874338B2 (en) | 2010-06-29 | 2020-12-29 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
WO2012006210A2 (en) | 2010-07-07 | 2012-01-12 | Agamatrix, Inc. | Analyte test strip and analyte meter device |
US9244000B2 (en) | 2010-07-07 | 2016-01-26 | Agamatrix, Inc. | Analyte test strip and analyte meter device |
US10288577B2 (en) | 2010-07-07 | 2019-05-14 | Agamatrix, Inc. | Analyte test strip and analyte meter device |
US9632056B2 (en) | 2010-07-07 | 2017-04-25 | Agamatrix, Inc. | Analyte test strip and analyte meter device |
EP3395240A1 (en) | 2010-07-28 | 2018-10-31 | Abbott Diabetes Care, Inc. | Methods of monitoring a level of an analyte in a subject, using analyte sensors having temperature independent membranes |
US9085790B2 (en) | 2010-07-28 | 2015-07-21 | Abbott Diabetes Care Inc. | Analyte sensors having temperature independent membranes |
US9662055B2 (en) | 2010-07-28 | 2017-05-30 | Abbott Diabetes Care Inc. | Analyte sensors having temperature independent membranes |
US10022076B2 (en) | 2010-07-28 | 2018-07-17 | Abbott Diabetes Care Inc. | Analyte sensors having temperature independent membranes |
EP3009065A1 (en) | 2010-07-28 | 2016-04-20 | Abbott Diabetes Care Inc. | Analyte sensors having temperature independent membranes |
US9952172B2 (en) | 2010-10-26 | 2018-04-24 | Abbott Diabetes Care Inc. | Analyte measurement devices and systems, and components and methods related thereto |
WO2012058237A1 (en) | 2010-10-26 | 2012-05-03 | Abbott Diabetes Care Inc. | Analyte measurement devices and systems, and components and methods related thereto |
US8632731B2 (en) | 2010-10-26 | 2014-01-21 | Abbott Diabetes Care Inc. | Analyte measurement devices and systems, and components and methods related thereto |
US8475732B2 (en) | 2010-10-26 | 2013-07-02 | Abbott Diabetes Care Inc. | Analyte measurement devices and systems, and components and methods related thereto |
US9465034B2 (en) | 2010-11-22 | 2016-10-11 | Abbott Diabetes Care Inc. | Modular analyte measurement system with extendable strip port |
US9770202B2 (en) | 2010-11-22 | 2017-09-26 | Abbott Diabetes Care Inc. | Modular analyte measurement system with extendable strip port |
US9103777B2 (en) | 2010-11-22 | 2015-08-11 | Abbott Diabetes Care Inc. | Modular analyte measurement system with extendable strip port |
US8702928B2 (en) | 2010-11-22 | 2014-04-22 | Abbott Diabetes Care Inc. | Modular analyte measurement system with extendable strip port |
US9713440B2 (en) | 2010-12-08 | 2017-07-25 | Abbott Diabetes Care Inc. | Modular analyte measurement systems, modular components thereof and related methods |
US11017890B2 (en) | 2011-02-11 | 2021-05-25 | Abbott Diabetes Care Inc. | Systems and methods for aggregating analyte data |
US9913599B2 (en) | 2011-02-11 | 2018-03-13 | Abbott Diabetes Care Inc. | Software applications residing on handheld analyte determining devices |
US10923218B2 (en) | 2011-02-11 | 2021-02-16 | Abbott Diabetes Care Inc. | Data synchronization between two or more analyte detecting devices in a database |
US12112854B2 (en) | 2011-02-11 | 2024-10-08 | Abbott Diabetes Care Inc. | Software applications residing on handheld analyte determining devices |
US9760679B2 (en) | 2011-02-11 | 2017-09-12 | Abbott Diabetes Care Inc. | Data synchronization between two or more analyte detecting devices in a database |
US10872696B2 (en) | 2011-02-11 | 2020-12-22 | Abbott Diabetes Care Inc. | Method of hypoglycemia risk determination |
US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
WO2012154286A1 (en) | 2011-02-28 | 2012-11-15 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
EP3583901A2 (en) | 2011-02-28 | 2019-12-25 | Abbott Diabetes Care, Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US11534089B2 (en) | 2011-02-28 | 2022-12-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US9532737B2 (en) | 2011-02-28 | 2017-01-03 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US11627898B2 (en) | 2011-02-28 | 2023-04-18 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US12121350B2 (en) | 2011-03-10 | 2024-10-22 | Abbott Diabetes Care Inc. | Multi-function analyte monitor device and methods of use |
US10010273B2 (en) | 2011-03-10 | 2018-07-03 | Abbott Diabetes Care, Inc. | Multi-function analyte monitor device and methods of use |
US9743862B2 (en) | 2011-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Systems and methods for transcutaneously implanting medical devices |
US10555695B2 (en) | 2011-04-15 | 2020-02-11 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US10624568B2 (en) | 2011-04-15 | 2020-04-21 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US10561354B2 (en) | 2011-04-15 | 2020-02-18 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US10835162B2 (en) | 2011-04-15 | 2020-11-17 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US10722162B2 (en) | 2011-04-15 | 2020-07-28 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US10682084B2 (en) | 2011-04-15 | 2020-06-16 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US10610141B2 (en) | 2011-04-15 | 2020-04-07 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US11033211B2 (en) | 2011-04-20 | 2021-06-15 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods |
EP3556285A1 (en) | 2011-06-16 | 2019-10-23 | Abbott Diabetes Care, Inc. | Temperature-compensated analyte monitoring devices, systems, and methods thereof |
US9974472B2 (en) | 2011-06-16 | 2018-05-22 | Abbott Diabetes Care Inc. | Temperature-compensated analyte monitoring devices, systems, and methods thereof |
US11571147B2 (en) | 2011-06-16 | 2023-02-07 | Abbott Diabetes Care Inc. | Temperature-compensated analyte monitoring devices, systems, and methods thereof |
US12290354B2 (en) | 2011-06-16 | 2025-05-06 | Abbott Diabetes Care Inc. | Temperature-compensated analyte monitoring devices, systems, and methods thereof |
EP4122384A1 (en) | 2011-06-16 | 2023-01-25 | Abbott Diabetes Care, Inc. | Temperature-compensated analyte monitoring devices, systems, and methods thereof |
US10028686B2 (en) | 2011-06-30 | 2018-07-24 | Abbott Diabetes Care Inc. | Methods for generating hybrid analyte level output, and devices and systems related thereto |
US9289164B2 (en) | 2011-06-30 | 2016-03-22 | Abbott Diabetes Care Inc. | Methods for generating hybrid analyte level output, and devices and systems related thereto |
US12102428B2 (en) | 2011-09-28 | 2024-10-01 | Abbott Diabetes Care Inc. | Methods, devices and systems for analyte monitoring management |
US11087868B2 (en) | 2011-09-28 | 2021-08-10 | Abbott Diabetes Care Inc. | Methods, devices and systems for analyte monitoring management |
EP4060673A1 (en) | 2011-09-28 | 2022-09-21 | Abbott Diabetes Care, Inc. | Methods, devices and systems for analyte monitoring management |
US11832973B2 (en) | 2011-09-28 | 2023-12-05 | Abbott Diabetes Care Inc. | Methods for analyte monitoring management and analyte measurement data management, and articles of manufacture related thereto |
EP3689235A1 (en) | 2011-09-28 | 2020-08-05 | Abbott Diabetes Care, Inc. | Methods for analyte monitoring management and analyte measurement data management, and articles of manufacture related thereto |
EP3381360A1 (en) | 2011-09-28 | 2018-10-03 | Abbott Diabetes Care, Inc. | Methods, devices and systems for analyte monitoring management |
EP4400043A2 (en) | 2011-09-28 | 2024-07-17 | Abbott Diabetes Care, Inc. | Methods for analyte monitoring management and analyte measurement data management, and articles of manufacture related thereto |
US10945646B2 (en) | 2011-09-28 | 2021-03-16 | Abbott Diabetes Care Inc. | Methods for analyte monitoring management and analyte measurement data management, and articles of manufacture related thereto |
US9622689B2 (en) | 2011-09-28 | 2017-04-18 | Abbott Diabetes Care Inc. | Methods for analyte monitoring management and analyte measurement data management, and articles of manufacture related thereto |
USD680454S1 (en) | 2011-10-25 | 2013-04-23 | Abbott Diabetes Care Inc. | Analyte meter and strip port |
US9622691B2 (en) | 2011-10-31 | 2017-04-18 | Abbott Diabetes Care Inc. | Model based variable risk false glucose threshold alarm prevention mechanism |
US11406331B2 (en) | 2011-10-31 | 2022-08-09 | Abbott Diabetes Care Inc. | Model based variable risk false glucose threshold alarm prevention mechanism |
US9913619B2 (en) | 2011-10-31 | 2018-03-13 | Abbott Diabetes Care Inc. | Model based variable risk false glucose threshold alarm prevention mechanism |
US9980669B2 (en) | 2011-11-07 | 2018-05-29 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US8887911B2 (en) | 2011-12-09 | 2014-11-18 | Abbott Diabetes Care Inc. | Packages and kits for analyte monitoring devices, and methods related thereto |
US11051724B2 (en) | 2011-12-11 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
US9931066B2 (en) | 2011-12-11 | 2018-04-03 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
USD915601S1 (en) | 2011-12-11 | 2021-04-06 | Abbott Diabetes Care Inc. | Analyte sensor device |
US11051725B2 (en) | 2011-12-11 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
US9693713B2 (en) | 2011-12-11 | 2017-07-04 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
USD903877S1 (en) | 2011-12-11 | 2020-12-01 | Abbott Diabetes Care Inc. | Analyte sensor device |
USD915602S1 (en) | 2011-12-11 | 2021-04-06 | Abbott Diabetes Care Inc. | Analyte sensor device |
US11179068B2 (en) | 2011-12-11 | 2021-11-23 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
US9402570B2 (en) | 2011-12-11 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
US11965853B2 (en) | 2011-12-23 | 2024-04-23 | Schlumberger Technology Corporation | Electrochemical sensors |
GB2497972A (en) * | 2011-12-23 | 2013-07-03 | Schlumberger Holdings | Electrochemical sensor incorporating a ferrocenophane |
WO2013093888A1 (en) * | 2011-12-23 | 2013-06-27 | Schlumberger Technology B.V. | Electrochemical sensors |
GB2497972B (en) * | 2011-12-23 | 2016-03-16 | Schlumberger Holdings | Electrochemical sensors |
EP4541272A2 (en) | 2012-04-24 | 2025-04-23 | Abbott Diabetes Care, Inc. | Methods of lag-compensation for analyte measurements, and devices related thereto |
US10561372B2 (en) | 2012-04-24 | 2020-02-18 | Abbott Diabetes Care Inc. | Methods of lag-compensation for analyte measurements, and devices related thereto |
US9462970B2 (en) | 2012-04-24 | 2016-10-11 | Abbott Diabetes Care Inc. | Methods of lag-compensation for analyte measurements, and devices related thereto |
WO2013163342A1 (en) | 2012-04-24 | 2013-10-31 | Abbott Diabetes Care Inc. | Methods of lag-compensation for analyte measurements, and devices related thereto |
EP3777664A1 (en) | 2012-04-24 | 2021-02-17 | Abbott Diabetes Care, Inc. | Methods of lag-compensation for analyte measurements, and devices related thereto thereto |
US11950936B2 (en) | 2012-09-17 | 2024-04-09 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US11612363B2 (en) | 2012-09-17 | 2023-03-28 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US10004439B2 (en) | 2012-09-21 | 2018-06-26 | Abbott Diabetes Care Inc. | In vivo sensors having ceria nanoparticle electrodes |
US10006880B2 (en) | 2012-09-21 | 2018-06-26 | Abbott Diabetes Care Inc. | Test strips having ceria nanoparticle electrodes |
US11896371B2 (en) | 2012-09-26 | 2024-02-13 | Abbott Diabetes Care Inc. | Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data |
US10842420B2 (en) | 2012-09-26 | 2020-11-24 | Abbott Diabetes Care Inc. | Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data |
US9907492B2 (en) | 2012-09-26 | 2018-03-06 | Abbott Diabetes Care Inc. | Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data |
US9675290B2 (en) | 2012-10-30 | 2017-06-13 | Abbott Diabetes Care Inc. | Sensitivity calibration of in vivo sensors used to measure analyte concentration |
US12279866B2 (en) | 2012-10-30 | 2025-04-22 | Abbott Diabetes Care Inc. | Sensitivity calibration of in vivo sensors used to measure analyte concentration |
US9801577B2 (en) | 2012-10-30 | 2017-10-31 | Abbott Diabetes Care Inc. | Sensitivity calibration of in vivo sensors used to measure analyte concentration |
US10188334B2 (en) | 2012-10-30 | 2019-01-29 | Abbott Diabetes Care Inc. | Sensitivity calibration of in vivo sensors used to measure analyte concentration |
US12171548B2 (en) | 2013-03-15 | 2024-12-24 | Abbott Diabetes Care Inc. | Multi-rate analyte sensor data collection with sample rate configurable signal processing |
US10433773B1 (en) | 2013-03-15 | 2019-10-08 | Abbott Diabetes Care Inc. | Noise rejection methods and apparatus for sparsely sampled analyte sensor data |
US10874336B2 (en) | 2013-03-15 | 2020-12-29 | Abbott Diabetes Care Inc. | Multi-rate analyte sensor data collection with sample rate configurable signal processing |
US10076285B2 (en) | 2013-03-15 | 2018-09-18 | Abbott Diabetes Care Inc. | Sensor fault detection using analyte sensor data pattern comparison |
US9474475B1 (en) | 2013-03-15 | 2016-10-25 | Abbott Diabetes Care Inc. | Multi-rate analyte sensor data collection with sample rate configurable signal processing |
WO2014145049A2 (en) | 2013-03-15 | 2014-09-18 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US11207006B2 (en) | 2013-04-30 | 2021-12-28 | Abbott Diabetes Care Inc. | Systems, devices, and methods for energy efficient electrical device activation |
US10213141B2 (en) | 2013-04-30 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for energy efficient electrical device activation |
US11571149B1 (en) | 2013-04-30 | 2023-02-07 | Abbott Diabetes Care Inc. | Systems, devices, and methods for energy efficient electrical device activation |
US11229382B2 (en) | 2013-12-31 | 2022-01-25 | Abbott Diabetes Care Inc. | Self-powered analyte sensor and devices using the same |
US11717225B2 (en) | 2014-03-30 | 2023-08-08 | Abbott Diabetes Care Inc. | Method and apparatus for determining meal start and peak events in analyte monitoring systems |
US20160281077A1 (en) * | 2015-03-26 | 2016-09-29 | Euglena Co., Ltd. | Medium and method for culturing euglena and method for reducing photoinhibition in euglena |
US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
US10674944B2 (en) | 2015-05-14 | 2020-06-09 | Abbott Diabetes Care Inc. | Compact medical device inserters and related systems and methods |
WO2017011346A1 (en) | 2015-07-10 | 2017-01-19 | Abbott Diabetes Care Inc. | System, device and method of dynamic glucose profile response to physiological parameters |
US10888272B2 (en) | 2015-07-10 | 2021-01-12 | Abbott Diabetes Care Inc. | Systems, devices, and methods for meal information collection, meal assessment, and analyte data correlation |
DE202016009220U1 (en) | 2015-07-10 | 2024-07-09 | Abbott Diabetes Care, Inc. | Device and system for dynamic glucose profile response to physiological parameters |
TWI593964B (en) * | 2016-08-26 | 2017-08-01 | 超極生技股份有限公司 | Probe type detecting device and module |
US11071478B2 (en) | 2017-01-23 | 2021-07-27 | Abbott Diabetes Care Inc. | Systems, devices and methods for analyte sensor insertion |
US12268496B2 (en) | 2017-01-23 | 2025-04-08 | Abbott Diabetes Care Inc. | Systems, devices and methods for analyte sensor insertion |
US11350862B2 (en) | 2017-10-24 | 2022-06-07 | Dexcom, Inc. | Pre-connected analyte sensors |
US11706876B2 (en) | 2017-10-24 | 2023-07-18 | Dexcom, Inc. | Pre-connected analyte sensors |
US11943876B2 (en) | 2017-10-24 | 2024-03-26 | Dexcom, Inc. | Pre-connected analyte sensors |
US12150250B2 (en) | 2017-10-24 | 2024-11-19 | Dexcom, Inc. | Pre-connected analyte sensors |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
US11382540B2 (en) | 2017-10-24 | 2022-07-12 | Dexcom, Inc. | Pre-connected analyte sensors |
US11662330B2 (en) | 2018-05-22 | 2023-05-30 | Strella Biotechnology, Inc. | Ethylene receptor biosensor |
US11054379B2 (en) | 2018-05-22 | 2021-07-06 | Strella Biotechnology, Inc. | Electrochemical ethylene biosensor |
USD1015366S1 (en) | 2020-07-29 | 2024-02-20 | Abbott Diabetes Care Inc. | Display screen or portion thereof with graphical user interface |
US12239463B2 (en) | 2020-08-31 | 2025-03-04 | Abbott Diabetes Care Inc. | Systems, devices, and methods for analyte sensor insertion |
US12315630B2 (en) | 2023-02-28 | 2025-05-27 | Abbott Diabetes Care Inc. | Medical devices and methods |
Also Published As
Publication number | Publication date |
---|---|
EP0125137A3 (en) | 1987-01-07 |
CA1219040A (en) | 1987-03-10 |
EP0125137B1 (en) | 1990-08-22 |
EP0125137A2 (en) | 1984-11-14 |
DE3483019D1 (en) | 1990-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4711245A (en) | Sensor for components of a liquid mixture | |
EP0078636B2 (en) | Sensor for components of a liquid mixture | |
US7485212B2 (en) | Self-powered biosensor | |
Cass et al. | Ferrocene-mediated enzyme electrode for amperometric determination of glucose | |
Dzyadevych et al. | Amperometric enzyme biosensors: Past, present and future | |
Frew et al. | Electron-transfer biosensors | |
US5356786A (en) | Interferant eliminating biosensor | |
US4820636A (en) | Electrochemical assay for cis-diols | |
Wang et al. | Highly selective membrane-free, mediator-free glucose biosensor | |
CA1218704A (en) | Assay systems using more than one enzyme | |
US4882013A (en) | Application of tetrathiafulvalenes in bioelectrochemical processes | |
JP3242923B2 (en) | Electrode and method for detecting hydrogen peroxide | |
Álvarez-González et al. | Electrocatalytic detection of NADH and glycerol by NAD+-modified carbon electrodes | |
Iwuoha et al. | Organic phase enzyme electrodes: kinetics and analytical applications | |
Pantano et al. | Enzyme‐modified microelectrodes for in vivo neurochemical measurements | |
JP3965212B2 (en) | Electrochemical measurement of fructosamine | |
Palleschi et al. | Ideal hydrogen peroxide-based glucose sensor | |
JP2005501253A5 (en) | ||
KR960001501B1 (en) | Current method for quantitative determination of 1,4-dihydronicotinamide adenine dinucleotide (NADH) in solution and disposable enzyme electrode for use in this method | |
Jaffari et al. | Novel hexacyanoferrate (III)-modified carbon electrodes: application in miniaturized biosensors with potential for in vivo glucose sensing | |
Wang et al. | Amperometric enzyme electrode for theophylline | |
EP2679990B1 (en) | Enzyme electrode | |
Wilson et al. | Unmediated amperometric enzyme electrodes | |
JPS6017345A (en) | Electrode sensor | |
Zahir et al. | Fabrication of directly polymerized 4-vinylpyridine onto a pencil 2B graphite paste electrode for glucose monitoring |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: GENETICS INTERNATIONAL, INC., BOSTON, MA A CORP OF Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:HIGGINS, IRVING J.;HILL, HUGH A. O.;PLOTKIN, ELLIOT V.;REEL/FRAME:004359/0640 Effective date: 19840711 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
CC | Certificate of correction | ||
AS | Assignment |
Owner name: MEDISENSE, INC., 128 SIDNEY ST., CAMBRIDGE, MA 021 Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:SHAWMUT BANK, N.A.;REEL/FRAME:005587/0333 Effective date: 19901221 Owner name: STATE STREET BANK AND TRUST COMPANY, 225 FRANKLIN Free format text: SECURITY INTEREST;ASSIGNOR:MEDISENSE, INC., A CORP. OF MA;REEL/FRAME:005587/0327 Effective date: 19901211 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: FIRST NATIONAL BANK OF BOSTON, MASSACHUSETTS Free format text: SECURITY INTEREST;ASSIGNOR:MEDISENSE, INC.;REEL/FRAME:006094/0426 Effective date: 19920331 Owner name: MEDISENSE, INC., MASSACHUSETTS Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:STATE STREET BANK & TRUST COMPANY;REEL/FRAME:006094/0470 Effective date: 19920331 |
|
AS | Assignment |
Owner name: MEDISENSE, INC., MASSACHUSETTS Free format text: CHANGE OF NAME;ASSIGNOR:GENETICS INTERNATIONAL, INC.;REEL/FRAME:007089/0937 Effective date: 19871216 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
FPAY | Fee payment |
Year of fee payment: 12 |